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Archazolid A ist ein potenter V-ATPase Inhibitor aus dem Myxobacerium Archangium 
gephyra. Im Rahmen dieser Dissertation wurde eine erste Totalsynthese von Archazolid A 
realisiert. Die erfolgreiche Synthesestrategie zu diesem komplexen Polyketid beruht auf der 
Verknüpfung von drei Bausteinen durch eine Aldolkondensation, eine Heck-Reaktion und 
eine HWE-Makrocyclisierung. Sie verlief in insgesamt 20 Stufen und 4% Gesamtausbeute 
(längste lineare Sequenz) und etablierte eindeutig die relative und absolute Konfiguration 
dieses Naturstoffes. Eines der Hauptfragmente, die C14-C19 Untereinheit, wurde in einer 
direkten Route in 10 Stufen und 54% Gesamtausbeute erhalten. Schlüsselmerkmale der 
Synthese beinhalten eine optimierte Prozedur, um ein E-Vinyliodid herzustellen und eine 
hochenantio- und diastereoselektive Abiko-Masamune anti Aldol Reaktion zum Aufbau der 
C16 und C17 Stereozentren. In diesem Zusammhang wurde eine neuartige Methode zum 
direkten Austausch des Abiko-Masamune Auxiliars durch verschiedene Nucleophile unter 
Verwendung von iPrMgCl zur Carbonyl-Aktivierung entwickelt. 
Etnangien ist ein makrocylisches Polyketid aus dem Myxobakterium Sorangium cellulosum. 
Es zeigt antibiotische Aktivität gegen verschiedene Gram-positive Bakterien durch RNA- 
Polymerase Inhibierung. Im Rahmen dieser Arbeit wurde der makrocylische Kern von 
Etnangien erfolgreich aus drei Schlüsselbausteinen synthetisiert, die durch eine Ipc-Bor-
vermittelte Aldol-Reaktion, eine Yamaguchi Veresterung und eine hochgradig E-selektive 
Heck Makrocyclisierung verknüpft wurden. Die Synthese verläuft in 18 Stufen und 27% 
Gesamtausbeute (längste lineare Sequenz). Die C15-C23 Untereinheit wurde in 11 Stufen mit 
37% Ausbeute erhalten. Bemerkenswerte Kennzeichen beinhalten eine Paterson anti-Aldol 
Reaktion zum Aufbau der Stereozentren an C20/C21, ein optimiertes Protokoll für eine Wittig 
Reaktion, eine innovative TBS Schützungsmethode, die Protonenschwamm® als Base 
verwendet und eine hocheffiziente oxidative Diol-Spaltung durch Pb(OAc)4. 
Darüber hinaus wurde eine neue selektive Methode zur Entschützung von Silylethern 
entwickelt, die die Verwendung von NaIO4 beinhaltet. Die milden nichtsauren und basischen 
Bedingungen gestatten Anwendungen auch bei komplexen und säure- oder 
basenempfindlichen Substraten. 
Schließlich wurde eine effiziente Prozedur zur Synthese strukturell verschiedenartiger 
diverser tertiärer Amine unter Verwendung eines Thioharnstoff-katalysierten direkten 
reduktiven Aminierungsprotokolls entwickelt. Diese tertiären Amine erwiesen sich als potente 
wachstumshemmende Verbindungen. 
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Archazolid A is a potent V-ATPase inhibitor from the myxobacerium Archangium gephyra. 
During this thesis a first total synthesis of archazolid A was accomplished. The successful 
synthetic strategy for this complex polyketide involved coupling of three main building 
blocks, which was achieved by an aldol condensation, a Heck-reaction and a HWE 
macrocyclisation. In total, it proceeds in 20 steps and 4% overall yield (longest linear 
sequence) and unequivocally establishes the relative and absolute configuration of this natural 
product. One of the main fragments, the C14-C19 subunit was synthesized in 10 steps with 
54% overall yield. Key features of the synthesis included an optimized procedure to prepare 
an E-vinyliodide and a highly enantio- and diastereoselective Abiko-Masamune anti aldol 
reaction for the construction of the C16 and C17 stereocentres. Within this context, a novel 
method for a direct displacement of the Abiko-Masamune auxiliary by various nucleophiles 
was established by using iPrMgCl for carbonyl activation. 
Etnangien is a macrocyclic polyketide from the myxobacterium Sorangium cellulosum. It 
shows antibiotic activity against various gram-positive bacteria by inhibition of RNA 
polymerase. During this thesis the macrocyclic core of etnangien was successfully 
synthesized from three key building blocks using a Ipc-boron-mediated aldol reaction, a 
Yamaguchi esterification and highly E-selective Heck macrocyclization. It proceeds in 18 
steps and 27% overall yield (longest linear sequence). The C15-C23 subunit was synthesized 
in 11 steps and 37% yield. Notable features include a Paterson anti-aldol reaction to install 
the stereocentres at C20/C21, an optimized Wittig reaction procedure, an innovative method 
of TBS protection by use of proton sponge® as base and a highly efficient oxidative diol-
cleavage with Pb(OAc)4. 
Furthermore, a new selective method for deptrotection of silyl ethers was developed, which 
involves use of NaIO4. The mild nonacidic and -basic conditions enable applications to 
complex and acid- or base-sensitive substrates. 
Finally, an efficient procedure was developed to synthesize structurally diverse tertiary 
amines by employing a thiourea-catalyzed direct reductive amination protocol. These tertiary 
amines were shown to be potent antiproliferative agents. 
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Introduction and Research Objectives 1
1 Introduction and Research Objectives 
Nature presents us countless numbers of natural products with complex, fascinating chemical 
structures and useful, important biological properties. For thousands of years, natural products 
have been closely linked through the use of traditional medicines, as for example traditional 
chinese medicine. Today, more than 60% of new chemical entities introduced as drug are, or 
were derived by natural products, 1  that demonstrate that natural products play a highly 
significant role in the drug discovery and development process. 
 
Natural Products
New Skeletons
Bioactivity Organic Synthesis
- New Synthetic Strategy
- New Synthetic Method
- Supply of Natural Products
- Determination of Stereochemistry
- Synthesis of New Analogues
- Structure-Activity Relationship
- The Mode of Action
- Development of Medicine
 
 
Figure 1 Relationship of the natural products, organic synthesis and bioactivity. 
 
The synthesis of natural products commands an important role in organic and biological 
chemistry (Figure 1).2 The key challenge in total synthesis of natural products is to efficiently 
synthesize target compounds with unique, novel molecular skeletons by using short process 
pathways. The construction of novel molecular skeletons necessitates the development of new 
synthetic strategies and reactions, which lead to further progress in synthetic organic 
chemistry. Using synthetic approaches, it will also be possible to determine structures and the 
relative and absolute configuration of natural products. Furthermore, use of newly developed 
methods for the rapid assembly of molecular skeleton will allow the creation of a wide range 
of analogues, thereby leading to the production of compounds with properties that may 
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surpass those found in nature and heralding the promise of bioactivity. This also enables the 
study of structure-activity relationship with analogues of natural products. 
Among those producers of natural products are bacteria, lichens, fungi, plants or animals. One 
of them is a group of bacteria, named myxobacteria, which have increasingly gained attention 
over the last two decades because they produce a large variety of natural products with 
medically potentially useful biological activities.3 
1.1 Myxobacteria 
Myxobacteria are gram-negative bacteria which predominantly live in the soil and are most 
noted for their ability to form fruiting bodies upon starvation (Figure 2). They are a 
particularly rich source of structurally novel and biosynthetically intriguing secondary 
metabolites which exhibit a wide range of biological activities based on diverse molecular 
mechanisms of action.4 These mechanisms of action are diverse and include electron transport 
inhibition, destruction of the cytoskeleton, inhibition of nucleic acid polymerases and 
inhibition of fungal acetyl-CoA carboxylase. It is particularly remarkable that myxobacterial 
metabolites exhibit modes of action that are rarely observed with other microbial compounds, 
which makes them a promising source for novel drug leads.5 
 
   
 
Figure 2 Microscopic picture of spores and fruiting bodies from Myxococcus xanthus. 
 
Prominent examples of these secondary metabolites from myxobacteria are epothilone A (1) 
and B (2, Figure 3)6 whose analogue, Ixabepilone (3, Figure 3) (also know as azaepothilone B) 
has recently been approved by the US FDA as a chemotherapy agent for the treatment of 
aggressive metastatic or locally advanced breast cancer and marketed under the trade name 
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Ixempra (Bristol-Meyers Squibb company). It binds to β-tubulin subunits on microtubules, 
blocking cells in the mitotic phase of the cell-division cycle, leading to cell death.7 
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Figure 3 Structures of epothilone A, B (1, 2) and Ixabepilone (3). 
 
Structurally, myxobacteria produce an architecturally and functionally diverse class of natural 
products. The compounds thus far elucidated are mostly macrocyclic lactone and lactam rings 
or linear and cyclic peptides. Moreover, substances that would be classified as aromatics, 
heterocycles, polyenes, or alkaloids have also been found. Structures with triple bonds, a 
boron-complexing compound and, rather often, chlorinated substances do also occur. Under 
biosynthetic aspects, myxobacterial metabolites mostly belong to polyketides.8  
1.2 Archazolid A and B 
Archazolid A and B (4, 5, Figure 5)9 have been isolated from the culture broths of strains of 
the myxobacerium Archangium gephyra (Figure 4) and Cystobacter sp. After purification of 
300-liter fermentation of Archangium gephyra gave 249 mg archazolid A (4) and 54 mg 
archazolid B (5) have been obtained.10 
 
       
 
Figure 4 The myxobacerium Archangium gephyra. 
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Archazolid A (4) and B (5) are cytotoxic polyketides. They are highly effective against a wide 
range of mammalian cell lines and were shown to inhibit V-ATPase in vitro11 and in vivo10 
with IC50 values in low nanomolar range. Together with other polyketides such as 
chondropsin A (6) ,12 FD-891 (7),13 palmerolide A (8)14 and iejimalide A (9)15, archazolid A 
(4) and B (5) belong to an elite class of potent V-ATPase inhibitors (Figure 5). Recently, Huss 
et al. demonstrated that archazolid A (4) binds selectively to the transmembrane bound Vo 
subunit c11 As shown in Figure 6 (left side), this subunit forms an oligomer, building up a ring 
structure of six or more copies which transports protons across the membrane. 
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Figure 5 Potent V-ATPase inhibitors. 
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To visualize the impact of the inhibition, PtK2 (potooroo kidney) cells have been incubated 
with archazolid A (4) and stained for intact acidic lysosomes at our Institute by Florenz Sasse. 
Lysosomes (in red), which are labeled by pH-indicators, are shown in the fluorescent 
photographs in Figure 13 (right side). When this system is treated with archazolid A (4), the 
red staining disappears. This indicates that the proton pumps are stopped and suggests that 
archazolid A (4) is an inhibitor of the V-ATPases (Figure 6, right side).11 
 
 
 
 
Figure 6 X-ray derived model of subunit c of the Vo complex of V-ATPase, the binding 
site of the archazolids (left side) and inhibition of lysosomal acidification by 
archazolid A (right side). 
 
A malfunction of these V-ATPases is correlated with various diseases, like osteoporosis and 
cancer.16 This renders the development and understanding of novel potent inhibitors such as 
these polyketide macrolides, important research goals. 
The structure of the archazolids (4, 5, Figure 5) features a 24-membered macrolactone ring 
with seven alkenes (2E, 5E, 9Z, 11Z, 13E, 18E, 20E), a thiazole side chain and a characteristic 
sequence of eight methyl and hydroxyl-bearing stereocentres. The full stereostructure of the 
archazolids was determined by application of J-based configuration analysis in combination 
with extensive NOESY and ROESY experiments, molecular modeling and synthetic 
derivatization.17 
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1.3 Etnangien 
The polyketide natural product etnangien (14, Figure 9)18 was isolated from culture broths of 
various strains of the myxobacterium Sorangium cellulosum (Figure 7) including strains So 
ce750 and So ce1045. The cultivation was performed in the presence of 1% (w/v) of the 
neutral resin Amberlite XAD 16, which removed the metabolites from the broth during 
cultivation, resulting in an average production of 5 mg/L.19 
 
 
       
 
Figure 7 The myxobacterium Sorangium cellulosum. 
 
Etnangien (14) shows pronounced antibiotic activity against various gram-positive bacteria 
(IC50: ~100 nM) by inhibition of RNA polymerase. Moreover, it shows no cross-resistance to 
rifampicin (10, Figure 9) a clinically valued RNA polymerase inhibiting antibiotic.19 RNA 
polymerase (RNAP or RNApol) is the enzyme that generates RNA from DNA. RNA 
polymerase enzymes are essential to life and are found in all organisms and many viruses 
(Figure 8).20 
 
 
       
 
Figure 8 Bacterial DNA-dependent RNA polymerase. 
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Bacterial DNA-dependent RNA polymerase is an attractive drug target because RNA chain 
elongation is essential for bacterial growth. 21  There are several known, or suspected, 
inhibitors of bacterial DNA-dependent RNA polymerase of myxobacterial origin (Figure 9, 
11-14) that are promising candidates for further development. These agents include the 
corallopyronins22, ripostatins,23 and sorangicins24 (11, 12, 13, Figure 9). 
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Figure 9 Inhibitors of bacterial DNA-dependent RNA polymerase. 
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Bacterial resistance has been increasingly developing to the rifamycins (10), the only class of 
RNA polymerase inhibitor that is in use clinically. Therefore, the development of novel types 
of RNA polymerase inhibitors is an important research goal.25 
The constitution of etnangien (14) consists of a 22-membered macrolactone with two alkenes 
(30Z, 32E) and a polyunsaturated side chain with seven trans configured alkenes. In total, it 
comprises an array of 12 stereogenic centres. The full stereostructure of etnangien (14) was 
determined by a combination of high field NMR method, including Murata’s method of J-
based configurational analysis, molecular modelling and genetic methods, relying on the 
development of a biosynthetic model based on a highly complex megasynthetase.26 
1.4 Research Objectives 
In summary, archazolid A, B (4, 5) and etnangien (14) present highly promising and 
synthetically challenging macrolide antibiotics. For further development of these polyketides, 
synthetic approaches are of critical importance. 
Specific research objectives of this project have been.  
(i) development of a synthetic route to the northwestern fragment of archazolids (4, 5); 
(ii)  fragment union and completion of the total synthesis of archazolids (4, 5); 
(iii)  development of a synthetic strategy to the central C15-C23 segment of etnangien (14); 
(iv)  preparation of sufficient quantities of the macrocyclic core of etnangien (14); and 
(v)  development of novel methods along the lines of these research objectives (i)-(iv). 
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2 Polyketide Synthesis 
Polyketides are a large family of structurally diverse natural products that possess a broad 
range of pharmacological properties and, together with their semi-synthetic analogues, play a 
vital role in human and veterinary medicine.27 Although diverse in structure and properties, 
polyketides can be grouped into two overall classes: the aromatic and the complex polyketides 
including marolides, polyethers, polyens and macrocyclic lactams. The complex polyketides 
are structurally more diverse than the aromatic ones. One example for an aromatic polyketide 
is the tetracycline (15, Figure 10), an antibiotic. On the contrary, the archazolids (4, 5, Figure 
10) and etnangien (14, Figure 10), secondary metabolites from myxobateria, may be classified 
as complex poliketides. 
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Figure 10 Examples of polyketides. 
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2.1 Biosynthesis 
Biosynthetically, polyketides are constructed by repetitive Claisen condensations of extender 
units derived from malonyl coenzyme A (CoA) with an activated carboxylic acid starter unit 
in a manner that closely parallels fatty acid biosynthesis. Polyketides derive their enormous 
diversity in structures through a number of programmed events that are dictated by the 
polyketide synthase (PKSs) and involve the selection of starter and extender units, carbon 
chain length, folding, degree of reduction, and termination. Post PKS tailoring events such as 
glycosylation, acylation, alkylation and oxidation further add to polyketides structural 
diversity. PKSs utilize a wide assortment of starter units, such as short-chain (branched) fatty 
acids, various alicyclic and aromatic acids, and amino acids in the assembly of their products. 
In many cases, the nature of the primer unit provides important structural and biological 
features to the molecule.28 
As shown in Figure 11,29 PKSs catalyze the modular chain extension by repetitious Claisen 
condensations between acetyl–SACP and malonyl-SACP to afford β-keto esters. Each 
condensation is followed by oxidation-state adjustment before subsequent reiteration of the 
cycle: keto reduction, dehydration, and enoyl reduction. In contrast to the biosynthesis of fatty 
acids, the whole reductive cycle need not be passed, allowing for a highly selective and 
controlled assembly of polyketide intermediates with a sheer endless number of possible 
combinations along the growing chain (pathway A–D). Virtually every imaginable array of 
relative configuration may be produced by the action of polyketide synthetases. The 
elimination step can be entirely omitted, reducing the cycle to condensation followed by keto-
reduction, giving rise to a regular array of 1,3-polyols (pathway B). The chain-extender unit is 
malonyl-SACP for the synthesis of fatty acids and aromatic polyketides, but varies for 
reduced polyketides: incorporation of propionate or butyrate residues (from methylmalonyl-
CoA or ethylmalonyl-CoA chain extenders) produces methyl or ethyl side chains in the 
polyketide product. 
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Figure 11 The basic pathway of fatty acid and polyketide biosynthesis. 
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2.2 Synthetic Approaches 
The inherent stereochemical complexity present in polyketides like archazolides (4, 5, Figure 
10) and etnangien (14, Figure 10) has captured the imagination of organic chemists. Their 
stereocontrolled, asymmetric total synthesis has stimulated the development of a host of new 
reactions and methods for C–C bond construction in the context of acyclic stereocontrol. 
As can be seen from the red labels in Figure 10, assemblies of alternating methyl- and 
hydroxyl-bearing stereogenic centres are characteristic features in polyketide natural products. 
Those units mostly are installed with propionate as starter and methylmalonyl-CoA as chain 
extender (Figure 12) in the biosynthesis of polyketides30 and may be named propionate units. 
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Figure 12 Biosynthesis of propionate units. 
 
Synthetically, many stereocontrolled reactions and methods are established to introduce such 
propionate units in a stereospecific manner. They include: (i) auxiliary-controlled aldol 
reactions; (ii) asymmetric crotylation reactions; (iii) addition of chiral allenylzinc and indium 
reagents to aldehydes; (iv) epoxide opening; (v) 2,3-Wittig sigmatropic rearrangement; (vi) 
diastereoselective anti-SN2´ allylic displacement reactions. These various methods will be 
discussed in this section. 
 
2.2.1 Auxiliary-Controlled Diastereoselective Aldol Reactions 
The aldol addition reaction is one of the most versatile C-C bond forming processes available 
to synthetic chemists. The addition reaction involves readily accessible starting materials and 
can provide β-hydroxy carbonyl adducts possessing new stereocenters (Scheme 1). 
Nowadays, many auxiliary-controlled diasetreoseletive aldol reactions are available for the 
stereoselective synthesis of a variety of possible stereogenic permutations of propionate aldol 
additions in various polyketides. 
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Scheme 1 Propionate aldol additions. 
 
The relative configuration of the aldol adduct is determined by the geometry of the enolate 
component, (Z)-enolates giving syn products and (E)-enolates anti products. This may be 
rationalized via Zimmerman-Traxler transition states by minimizing 1,3-diaxial interactions 
between R1 and R2 in each chair-like transition state TS (Scheme 2)31. In practice, the 
stereochemistry can be highly metal dependent. 
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Scheme 2 Zimmerman-Traxler transition states for aldol reaction. 
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Thus, the enolization step is of prime importance in this type of additions, and reaction 
conditions were developed to generate either the Z- or the E-enolate. Auxiliary-controlled 
diasetereoseletive aldol reactions with various enolization concepts will first be discussed 
within this chapter. 
 
2.2.1.1 Evans syn Aldol Reaction 
One of the most successful and widely used methods for auxiliary-controlled diastereoseletive 
aldol addition reaction employs Evans’ imides like 16 and the derived dialkyl borylenolates.32 
The Evans’ syn aldol adducts are typically isolated in high diastereoisomeric purity (>250:1 
dr) and useful yield. 
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Scheme 3 Enolization of Evans’ imide 16. 
 
As show in scheme 3, enolization with dialkylboron triflates typically afford (Z)-enolates. 
One suspects that the transition state for deprotonation from the (Z)-enolate conformation 
(Scheme, 3) would be destabilized by 1,3-allylic strain interactions between the methyl group 
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and the substituents of the nitrogen atom. The carbonyl-carbonyl dipole interactions within 
the imide are minimized in the reactive conformation. Chiral controlled auxiliary biases 
enolate π-face such that one of the two diastereomeric syn transition states is greatly favoured 
(Scheme 4).33 
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Scheme 4 Evans syn aldol reaction. 
 
For the modification to the Evans syn aldol reaction, Heathcock developed a bimetallic 
intermediate aldol reaction. With the nBu2BOTf/TiCl4 system, non-Evans’ syn aldol adducts 
would be achieved. The nBu2BOTf/Et2AlCl system in turn provides non-Evans’ anti aldol 
adducts.34 Crimmins has reported the use of acyloxazolidinethione auxiliaries and TiCl4 for 
the preparation of either syn aldol adducts as a function of the stoichiometry of the amine base 
and metal.35 
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2.2.1.2 Evans anti Aldol Reaction 
As shown in Scheme 5, Evans has reported a highly diastereoselective direct anti-aldol 
reaction with chiral N-acyloxazolidinone 16 promoted by catalytic amounts of MgCl2 in the 
presence of triethylamine and chlorotrimethylsilane. 36  Only aromatic and unsaturated 
aldehydes are suitable substrates for this reaction. This method, however, does not allow β-
branching on the acyl substituent. Later, the extension of this methodology to chiral N-
acylthiazolidinethione 17 was described also by Evans.37 Use of this method affords aldol 
products with the opposite anti-diastereoselectivity. The yield, diastereomeric ratio and 
substrate scope are comparable to the MgCl2 catalyzed anti-aldol reactions of chiral N-
acyloxazolidinones. 
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Scheme 5 Evans anti aldol reaction. 
 
On the basis of the weight of circumstantial evidence, all enolization procedures to date to 
form boron, titanium, lithium, or sodium enolates with this family of imides implicate the 
intervention of (Z) metal enolates. Given the assumption that this is the geometry of the 
intervening enolate, the enolate face selectivity observed for the N-acyloxazolidinone-derived 
magnesium enolate is fully consistent with a chelate-controlled process. The intervention of a 
chair Zimmerman-Traxler transition state is precluded.31 
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2.2.1.3 Abiko–Masamune Aldol Reaction 
The boron-mediated aldol reaction of carboxylic ester 18 is shown to be particularly 
interesting and it is useful that the stereochemistry of the intermediate enolate can be 
controlled by the judicious choice of the enolization conditions. As shown in Scheme 6, 
enolization of the propionate ester 18 with (cHex)2BOTf and Et3N provide anti aldol 
adducts;38 on the contrary, with (nBu)2BOTf and iPr2NEt syn aldol adducts are formed.39 This 
implies that the conformations of the transition states leading to anti-aldol from (E)-enolate 
and syn-aldol from (Z)-enolate are different. 
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Scheme 6 Abiko-Masamune aldol reaction. 
 
Hulme has modified Abiko-Masamune aldol reaction with a thiol surrogate 19 for the 
conventional auxiliary (Scheme 7). 40  This modified anti selective aldol reaction provide 
similar diastereoselectivities and yields. In comparison to Abiko-Masamune norephedrine-
derived auxiliary 18, this new thiol auxiliary 19 promotes facile displacement with a range of 
nucleophiles. 
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Scheme 7 Modified Abiko-Masamune aldol reaction. 
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2.2.1.4 Paterson Aldol Reaction 
The lactate-derived keton 20, as developed by the group of Paterson, displays high levels of 
stereocontrol in boron-mediated anti aldol reactions.41 The origin of the high levels of π-face 
selectivity in the reactions of keton 20 can be traced to the relative steric and electronic 
contributions of the substituents (H, Me, OBz) at the enolate stereocentre in the chair 
transition state for the aldol addition (Scheme 8). For such (E)-enol borinates, there is a strong 
preference for the proton to eclipse the double bond to minimise A(1,3) allylic strain. In the 
competing transition structures, TS-I and TS-II, the benzoate group is directed either inwards 
or outwards of the chair arrangement. In TS-II (re-face attack on aldehyde), there is likely to 
be a destabilising lone-pair repulsion between the benzoate and enolate oxygens. TS-I (si-face 
attack on aldehyde) may be favoured due to a stabilising H-bond between the benzoate 
oxygen with the aldehyde proton. Taken together, this analysis accounts for the apparent 
contra-steric preference for the benzoate to occupy the inside position.42 
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Scheme 8 Paterson anti-aldol reaction. 
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The related lactate-derived ketones, 21, 43  22 44  and 23 45  are also useful auxiliaries for 
diasetreeoseletive aldol reactions. 
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Figure 13 Related lactate-derived ketones for diastereoselective aldol reactions. 
 
Oppolzer has reported N-propionylsultam 24 which undergoes Lewis acid promoted addition 
of aromatic and aliphatic aldehydes to give diastereomerical aldols46 and used this method for 
the asymmetric synthesis of (-)-denticulatins A and B.47 
The camphor-derived chiral auxiliary 25 was studied by Yan.48 Chiral boryl enolates of the 
camphor-derived auxiliary 25 are highly reactive and highly anti-stereoselective enolate 
synthon systems in aldol addition reactions promoted by a TiCl4 or SnCl4 co-catalyst. More 
significantly, this high-yield reaction exhibits remarkable generality with respect to the 
aldehyde nature, as illustrated by the rapid and anti-stereoselective aldolizations with the 
simple saturated and unsaturated aliphatic aldehydes, and aromatic aldehydes at temperatures 
as low as -90 °C. 
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Figure 14 Further useful chiral auxiliaries for diastereoselective aldol reactions. 
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Myers has studied the chemistry of cyclic O-silyl ketene N,O-acetals 26 prepared from 
optically active (S)-prolinol propionamides and dichlorodimethylsilane.49 O-silyl ketene N,O-
acetals have been shown to undergo a facile and highly diastereoselective carbon-carbon 
bond-forming reaction with aldehydes. 
Gosh has reported amino indanol derived chiral esters such as 27 which provide titanium 
enolate aldol reactions with various aldehydes. This represents a highly effective synthetic 
protocol which gives excess of anti-aldol products with high levels of diastereo- and 
enantioselectivity. 50  Both enantiomers of cis-1-arylsulfonamido-2-indanol are readily 
prepared from commercially available optically active cis-1-amino-2-indanols. 
2.2.2 Asymmetric Crotylation Reactions 
Over the last decades, asymmetric allylation and crotylation reactions have been explosively 
developed and extensively used for the stereocontrolled assembly of polyketides. The 
allylmetal-aldehyde addition reaction has proven to be enormously successful for the 
construction of adjacent stereocentres. The reasons for the success of this method are (i) the 
high degree of enantio- and diastereoinduction; (ii) the extreme diversity of reagent reactivity 
based on metal; (iii) the ability to access different stereodyads and triads; (iv) the inherent 
versatility of the obtained products towards further functionalization.51 
The asymmetric allylation and crotylation reactions can be classified into two groups: (i) 
stoichiomeric asymmetric allylation and crotylation reactions and (ii) catalytic asymmetric 
allylation and crotylation reactions. Besides, one of the most intriguing features of these 
reactions is the dramatic relationship between the configuration of the product and the 
geometry of the starting alkene, dividing them into three mechanistically distinct types: Type 
I syn/anti diastereoselectivity reflects the Z/E ratio of the starting allylic geometry; Type II 
predominantly syn diastereoselective independent of the starting double bond configuration; 
Type III predominantly anti diastereoselective independent of the starting double bond 
configuration.52 
The catalytic asymmetric allylation and crotylation reactions can be grouped into three main 
categories (Scheme 9): (i) addition of allylic organometallic reagents (Si, Sn, B) catalyzed by 
chiral Lewis acids (LA*) (type II); (ii) addition of allylic organometallic reagents (Cr, Zn, In) 
generated in situ from the corresponding allylic halides catalyzed by chelating chiral ligands 
(L*) (type III), and (iii) addition of allylic trichlorosilanes catalyzed by chiral Lewis bases 
(LB*) (type I).53 
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Scheme 9 The asymmetric allylation and crotylation reactions. 
 
The stoichiomeric asymmetric allylation and crotylation reactions belong to type I reactions. 
In this category excellent results have been obtained from the use of chirally modified allylic 
borane and allylic titanium reagents. Recently, the success of this approach has been extended 
to include allylic silanes and allylic stannanes54 as well (Scheme 10). 
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Scheme 10 Stoichiometric asymmetric allylation and crotylation reactions. 
 
In the context of this dissertation, only stoichiometric asymmetric crotylation reactions will be 
discussed, as they are more generally used in natural product synthesis. For reviews on 
catalytic variants,55, 56 see Ref. 51(c), 53, 54, 55, 56. 
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2.2.2.1 B-Crotylation Reactions 
Chiral allylic borane reagents are important in synthetic organic chemistry as reagents for 
acyclic stereocontrol and stereoselective annulation processes. 57  One effective and 
successfully used B-crotylation reaction is the Brown B-crotylation reaction.58  
The high stereospecificity has been explained by a closed chair-like transition state, where the 
boron is coordinated to the carbonyl oxygen. The aldehyde is oriented in such a manner that 
the R group is placed in an equatorial position of the chair to minimize steric interactions 
between the Ipc-group on boron and the allyl unit. This model explains the high degree of 
stereoselection observed when isomerically pure (E)- or (Z)-crotylboronates react with 
aldehydes. Thus, the (E)-crotyl isomer leads to the anti homoallylic alcohol while the (Z)-
crotylboronate gives the syn product (scheme 11). 
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Scheme 11 B-crotylation reactions. 
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The transition state for the allyboration of carbonyl compounds have also been modelled with 
computer calculations. Ab initio calculations identified a strong preference for the chair-like 
arrangement of the two components in the addition of allylboranes to aldehydes, in close 
agreement with the experimental results.59 
Solvents have a significant effect on the rates of allylboration reactions.60 Polar solvents, 
including chloroform, dichloromethane and diethylether, which are either poorly coordinating 
or non-coordinating, enhance the rate of allylboration, while solvents capable of stronger 
coordination with boron, such as tetrahydrofuran, retard the rate. Highly substituted aldehydes 
react significantly more slowly than less substituted aldehydes. 
The high degree of organization that characterizes the putative transition state for the Type I 
reactions in that they proceed through closed transition states and do not require the use of an 
external Lewis acid, has stimulated the development of a myriad of modified chiral allylic 
boron reagents such as 28, 61  29, 62  30, 63  31, 64  32, 65  and 3366  (Figure 15) for asymmetric 
crotylation of carbonyl compounds, as shown in Scheme 10. 
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Figure 15 Modified chiral allylic boron reagents. 
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2.2.2.2 Duthaler-Hafner Ti-Crotylation Reactions 
The chiral crotyltitanium complexes such as 34 (Scheme 12)67 are prepared from readily 
available nontoxic materials; the source of chirality, tartaric acid, is available in both 
enantiomeric forms. Contrary to crotylboron reagents, these crotyltitanium compounds can be 
prepared by transmetalation with a variety of crotyl Grignard, crotyllithium and 
crotylpotassium/-lithium compounds and isolation or purification is not necessary. In addition, 
their potential for large-scale conversions is better than that of any other stoichiometric chiral 
crotyl-transferring reagent known. 
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Scheme 12 Duthaler-Hafner Ti-crotylation reactions. 
 
The reactions of the crotyltitanium compound 34 with benzaldehyde and decanal are highly 
enantio- and diastereoselective, affording the homoallylic alcohol in excellent yield (Scheme 
12). The major product in all cases is the anti diastereomer, obtained by attack on the Si face 
of the substituted terminus of the crotyltitanium complex. On the other hand, NMR analysis 
of the crotyl reagents (crotyl Grignard, crotyllithium, and crotylpotassium/-lithium) revealed a 
fast 1,3-migration of titanium, favoring the (E)-isomer with titanium η1 bound to the 
unsubstituted terminus of the crotyl group. This explains the almost exclusive formation of 
the anti diastereomers, a clear restriction of this method.68 
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2.2.2.3 Leighton Si-Crotylation Reactions 
The cis- and trans-crotylsilane reagents 35 (Scheme 13) are easily prepared in bulk and are 
storable crystalline solids, even though their synthesis requires a few steps. A survey of the 
performance of crotylsilane reagents was carried out with a variety of aliphatic, aromatic, and 
α,β-unsaturated aldehydes. In every case, the cis- and trans-crotylsilane reagents 
demonstrated their use in highly enantioselective syn- and anti-selective aldehyde crotylation 
reactions, respectively. The crotylation reactions are experimentally trivial and the chiral 
diamine controller may be easily recovered in high yield.69 
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Scheme 13 Leighton Si-crotylation reactions. 
 
 
2.2.3 Addition of Chiral Allenylzinc and Indium Reagents to Aldehydes 
Marshall has reported a methodology for preparing nonracemic homopropargylic alcohols 
from enantioenriched propargylic mesylates such as 36 as precursors to chiral allenylzinc70 or 
indium reagents71 for the coupling to aldehydes. These reagents are generated in situ through 
“oxidative transmetalation” of transient allenylpalladium intermediates (Scheme 14).72 In fact, 
when the reaction is performed on allenylzinc reagent in the presence of various aliphatic 
aldehydes, homopropargylic alcohol adducts of 86-96% ee are isolated in high yield. The 
diastereoselectivity of the addition with allenylindium reagent is similar to that with 
allenylzinc reagent. 
 
Polyketide Synthesis 26
.
MsOPd
H
H
Me
PPh3
PPh3
.
MsOZn
H
H
Me
MsO
Me
H
Me
HOH
R
R H
O
Et2Zn
Pd(OAc)2PPh3
R H
O
Pd(dppf)Cl2
.
MsOPd
H
H
Me
Ln
Ln
.
In
H
H
MeInI
I
OMs
Ln
Ln = diphenylphosphinoferrocene
36
 
 
Scheme 14 Addition of chiral allenylzinc and indium reagents from 36 to aldehydes. 
 
Later, Marshall published other addition reactions of aldehydes with allenylzinc or indium 
reagent which are generated in situ with 37 or 38 and Et2Zn or InI in the presence of 
Pd(OAc)2PPh3 (Scheme 15).73 The additions of aldehydes with α-TMS-substituted allenylzinc 
reagents proceed with excellent diastereoselectivity and only slight loss of enantioselectivity. 
In contrast, the additions of aldehydes with α-TMS-substituted allenylindium reagents afford 
anti products with er values of 99:1 or higher and with virtually no trace of syn products. 
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Scheme 15 Addition of chiral allenylzinc and indium reagents from 37 and 38 to aldehydes. 
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2.2.4 Epoxide Opening 
Allylic alcohols such as 39 may be easily converted into the optically active epoxy alcohols 
like 40 using the D-(-)-diisopropyl tartrate [D-(-)-DIPT] as the chiral catalyst following the 
Sharpless method. Treatment of the epoxy alcohol 40 with Lewis acid such as TBSOTf, 
TESOTf or BF3 provids the syn aldol product in high yield and excellent enantioselectivity. 
The proposed mechanism of this transformation involves activation of the epoxide oxygen 
with Lewis acid followed by intramolecular hydride transfer as shown in 42 to generate the 
new stereocenter at the methyl substituted carbon in 43. The Lewis acid may then 
decoordinate to give the product 44 (Scheme 16).74 The (E)-allylic alcohols give the syn 
products, while the (Z)-allylic alcohol afford the anti products. 
 
 
R
CH3
OH
R
CH3
OH
O
R
CH3
OTBS
O
R
CH3
O
O
TBS
R H
O
CH3
O
R H
O
CH3
O
TBSTBS TBS
H
tBuOOH
Ti(OiPr)4
D-(-)-DIPT
TBSOTf
iPr2NEt
TBS
OTf
39 40 41
424344  
 
Scheme 16 Stereoselective epoxide opening with Lewis acid. 
 
An application of this nonaldol-aldol methodology in the total synthesis of polyketides has 
also been reported.75 
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2.2.5 2,3-Wittig Sigmatropic Rearrangement 
[2,3]-sigmatropic rearrangements constitute an exceptionally versatile type of bond 
reorganization which have many applications in organic synthesis. Acyclic stereocontrol is 
particularly pronounced. The [2,3]-sigmatropic reaction, as generalized in Scheme 17, can be 
defined as a thermal isomerization that proceeds through a six-electron, five-membered cyclic 
transition state.76 
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Scheme 17 The [2,3]-sigmatropic rearrangement reaction. 
 
Midland has reported that the [2,3]-Wittig rearrangement of optically active (Z)-allylic ether 
45 provides allylic alcohol 46 with complete control of olefin geometry and chirality transfer 
and a high degree of diastereoselectivity. Probably, the relative stereochemistry is fixed with a 
high degree of control by way of a five-membered cyclic transition state. For the 
rearrangement of (Z)-allylic ethers, the isopropyl group is less hindered in the equatorial 
position and leads to the (E)-olefin with a high degree of stereoselectivity (Scheme 18).77 
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Scheme 18 The [2,3]-Wittig rearrangement of (Z)-allylic ethers. 
 
Midland has also used this reaction for synthesis of the (+)-Prelog-Djerassi lactone 50 from 
(Z)-allylic ether 47 (Scheme 19).78 
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Scheme 19 Synthesis of (+)-Prelog-Djerassi lactone 50. 
 
Recently, the application of the [2,3]-Wittig rearrangement reactions of (Z)-allylic ether 52 via 
the cyclohexanecarboxaldehyde-derived intermediate for synthesis of polypropionate building 
block 54 was described by Parker (Scheme 20).79 
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Scheme 20 Synthesis of polypropionate building block 54. 
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2.2.6 Diastereoselective anti-SN2´ allylic Displacement Reactions 
Hanson has reported a strategy employing phosphate tethers 57 in which a phosphate ester 
serves a dual role as both tether for coupling two allylic alcohols 56 via ring closing 
metathesis (RCM) and as a subsequent leaving group in selective anti-SN2´ displacement 
reactions with organocuprate nucleophiles (Scheme 21). Syn-(E)-homoallylic alcohol 59 as 
product was achieved in high yield and diastereoselectivity.80 
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Scheme 21 Synthesis of syn-(E)-homoallylic alcohol 59. 
 
The remarkable selectivity for this transformation can be rationalized using Corey’s proposed 
concerted, asynchronous mechanism81 for cuprate additions as highlighted in Figure 16. In 
this mechanism, the reacting cuprate simultaneously coordinates both the π* orbital of the 
olefin and σ* orbital of the phosphate ester leaving group. The asynchronous nature of the 
transformation predicts a transition state in which substantial bond-lengthening occurs with 
respect to the σ* bonding orbital. 
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Figure 16  Corey model for rationalizing stereoselectivity. 
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3 Total Synthesis of Archazolids 
3.1 Retrosynthetic Analysis 
As outlined retrosynthetically in Scheme 22, our synthetic approach relies on the assembly of 
three main building blocks of similar complexity, that is 118, 71, and 83. The 13E-alkene 
moiety was planned to arise from a Horner-Wadsworth-Emmons (HWE) reaction between the 
corresponding ketophosphonate 118 and a respective aldehyde derived from 71, while a Heck 
cross-coupling of 118 with alkene 83 was envisioned to deliver the 18E,20E-diene. In 
principle, this methodology could be employed to close the macrocycle as an alternative to a 
Horner-Wadsworth-Emmons macrocyclization or a more conventional Yamaguchi reaction 
for ring closure, thus offering considerable flexibility in the synthesis. 
In turn, the C14-C19 subunit 118 should be accessible by an auxiliary-controlled 
diastereoseletive aldol reaction between ethyl ketone 18 and aldehyde 91 containing the 
required E vinyliodide. The C3-C13 fragment 71 was envisioned to be derived from 66 by 
two consecutive Still-Gennari olefinations. Intermediate 66 in turn should be accessible from 
aldehyde 64 by anti-aldol methodology. The enal 64 could be prepared by using Horner-
Wadsworth-Emmons olefination. The C20-C1’’ subunit 83 was planned to be derived by 
asymmetric B-crotylation from aldehyde 81, which in turn should be accessible from L-Leucin 
derived α-hydroxy-acid 73. 
Notably, the modular synthetic approach employed is flexible, highly convergent, and 
stereocontrolled, and thus offers the potential to provide useful quantities of archazolid A (4) 
as well as a range of structural derivatives for structure-activity relationship (SAR) studies. 
Key issues to be addressed include (i) two auxiliary-controlled diastereoseletive aldol 
reactions; (ii) an asymmetric B-crotylation reaction; (iii) two consecutive Still-Gennari 
olefinations reactions; (iv) HWE-olefination; (v) inter-molecular Heck-coupling reaction; (vi) 
HWE-macrocyclization or macrolactonation. 
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Scheme 22 Retrosynthetic analysis for archazolid A (4), leading to three main key building 
blocks 118, 71, and 83. 
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3.2 Synthesis of the C3-C13 Subunit – Dr. Jorma Hassfeld 
The synthesis of the C3-C13 subunit 71 was realised by Jorma Hassfeld in our group. As 
shown in Scheme 23, it began with PMB ether 61 of acetone-aldol 60, 82  which was 
homologated to 63 with the corresponding β-keto-phosphonate 62 using a HWE coupling 
employing KHMDS in toluene.83 The corresponding aldehyde 64 was readily available by a 
two step procedure using a reduction to the alcohol (DIBAL-H) and allylic oxidation (MnO2) 
in 87% yield. A boron-mediated Paterson anti aldol reaction84 of lactate-derived ethyl-ketone 
2042 with aldehyde 64 gave the secondary alcohol 65 with very high levels of 
diastereoselectivity and essentially quantitative yield. After TBS protection (TBSOTf, 2,6-
lutidine), the chiral auxiliary was then cleaved in a straightforward fashion using a two-step 
sequence (LiBH4, NaIO4)85 to give directly aldehyde 66 in 85% yield over three steps, which 
was  subsequently submitted to a Still-Gennari modification85 of the HWE-olefination with 
phosphonate 67. Coupling of aldehyde 66 with phosphonate 67, employing KHMDS as base 
in combination with 18-crown-6 gave Z-enone 68 in 87% yield as the only detectable isomer. 
The ester 68 was then converted into the enal 69 by DIBAL-H reduction and allylic oxidation 
using MnO2. The required 11E-alkene was then installed by another Still-Gennari olefination, 
which proceeds again with very high levels of stereoselectivity (d.r. > 20:1). Finally, the 
synthesis of the C3-C13 subunit 71 was completed in two steps involving ester reduction 
(DIBAL-H) and oxidation of the resulting primary alcohol with Dess-Martin periodinane 
(DMP). 
In summary, this route to the C3-C13 subunit 71 proved well-scalable and multigram 
quantities of required building block were obtained from 60 in 13 steps and 25% overall yield. 
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Scheme 23 Synthesis of the C3-C13 subunit 71. 
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3.3 Synthesis of the C20-C1'' Subunit – Sven Rudolph 
The preparation of the C11-C1´´ subunit 83, as realised by Sven Rudolph in our group is 
shown in Scheme 24. It starts with conversion of L-Leucin 72 to α-hydroxyacid 7386 which 
was then transformed into amide 74 in 63% yield by a three-step procedure involving 
formation of the acid chloride, introduction of the amide and TBS protection of the secondary 
alcohol. After treatment with the Lawesson reagent 75,87 the resulting thioamide 76 was 
cyclized with a bromo-oxo acid ethyl ester 77 to give thiazol 78 in 79% over two steps.88 
Cleavage of the TBS ether with TBAF liberated the secondary alcohol 79 in 96% yield. The 
carbamate was then introduced in a two step protocol by use of carbonylimidazol and trapping 
of the intermediate imide with methylamine.89 DIBAL-H reduction of the resulting ester 80 
gave aldehyde 81, which was C3-homologated by using an asymmetric Brown’s boron 
mediated crotylation 90  delivering 83 with excellent diastereoselectivity (d.r. > 20:1) and 
useful yield (65%). 
In total, this fragment was available in 11 steps in 24% yield. Likewise, this route was well-
scalable and allowed to obtain multi-gram quantities of the C11-C1´´ subunit 83. 
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Scheme 24 Synthesis of the C20-C1'' subunit 83. 
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3.4 Synthesis of the C14-C19 Subunit 
Synthesis of the C14-C19 subuint was realised within the research programme of this 
dissertation. 
3.4.1 Plan 1: Evans anti Aldol Reaction 
As the first plan, we wanted to establish the stereocentres at C16 and C17 by using a mild 
MgCl2-catalyzed anti aldol reaction that had been disclosed by Evans36 and was first used in 
the total synthesis of (+)-migrastatin by Danishefsky.91  
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Scheme 25 (a) 84: R = TBS, TBSCl, imidazol, DMAP, RT, 120 min, 82%; 85: R = 
TBDPS, TBDPSCl, imidazol, DCM, RT, 30 min, 100%; (b) MeMgBr, 
CuBr.SMe2, I2, THF, -45 °C; (c) Cp2ZrCl, Me3Al, DCM, 0 °C, then I2, Et2O, -
30 °C, 22%, (d) MnO2, Et2O, RT, 96%; (e) MgCl2, Et3N, TMSCl, EtOAc, RT, 
52 h; (f) MeOH, TFA, RT, 10 min, 29% over 2 steps, dr > 95:5. 
 
The known aldehyde 91 was prepared by zirconation-methylation-iodination of propargyl 
alcohol 8992 followed by oxidation of the allylic alcohol 90 with manganese dioxide. To our 
disappointment, the zirconation-methylation-iodination provided the allylic alcohol 90 in very 
low yield (22%). The carbocupration-methylation-iodination of the protected propargyl 
alcohol 84/85 with MeMgBr, CuBr·SMe2 and I2 gave no desired product 86/87.93 
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Treatment of Evans-amide 88 with catalytic MgCl2, Et3N as base, TMSCl and aldehyde 91 at 
RT for 52 h after cleavage of the TMS group with TFA in methanol gave the aldol product 92 
with very good stereoselectivity, albeit in low yield (29% over two steps, d.r. > 20:1). 
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Scheme 26 Proposed catalytic cycle of Evans anti aldol reaction. 
 
A proposed catalytic cycle37 is outlined in Scheme 26. Presumably, N-acyloxazolidinone-
magnesium complex I reacts with triethylamine, yielding magnesium enolate II, which then 
adds reversibly to the aldehyde, forming the magnesium aldolate III. Chlorotrimethylsilane 
then irreversibly trapped the aldolate III, which was subsequently displaced from the metal 
centre by another molecule of N-acyloxazolidinone and produced the aldol product 97. 
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3.4.2 Plan 2: Noyori’s Asymmetric Transfer Hydrogenation 
After the dissatisfaction with the results of zirconation-methylation-iodination of propargyl 
alcohol and the Evans anti aldol reaction, we made a second plan to construct the 
stereocentres at C16 and C17. The stereocentre at C17 could be configured with Noyori’s 
asymmetric transfer hydrogenation of α-chiral alkynones.94 The α-chiral alkynones could be 
prepared from (R)-methyl 3-hydroxy-2-methylpropanoate, which was wildly used as chiral 
starting material in the total synthesis of natural products and their analogues. 
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Scheme 27 (a) TBDMSCl, imidazol, DMAP, THF, RT, 1.5 h, 89%; (b) TBDPSCl, 
imidazol, DCM, 0 °C to RT, 30 min, 98%; (c) MeONHMe·HCl, iPrMgCl, THF, 
-20 to -10 °C, 30 min, 101 = 90%, 102 = 93%; (d) lithium acetylide, 
ethylenediamine complex, THF, 0 °C to RT, 1 h, 105 = 26%, 104 = 10%; (e) 
trimethylsilylacetylene, nBuLi, THF, - 78 °C to RT, 1 h, 106 = 39%, 105 = 
20%. 
 
At first, (R)-methyl 3-hydroxy-2-methylpropanoate 98 was protected as its TBS95 or TBDPS96 
ether 99/100 under standard conditions. Then, the ester 99/100 was converted to the Weinreb 
amide 101/102 with MeONHMe·HCl and iPrMgCl in THF in high yield.97 Treatment of the 
Weinreb amide 102 with lithium acetylide ethylenediamine complex, followed by hydrolysis 
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of the crude product with water, afforded ynones 105 and 104 in 26% and 10% yield, 
respectively. The same reaction with the Weinreb amide 101 gave no desired ynone 103. 
Addition of lithium trimethylsilylacetylide (freshly generated by using ethynyltrimethylsilane 
and nBuLi at -78 °C) to Weinreb amide 102 provided ynone 106 in 39% yield and ynone 105 
in 20% yield.98 
Due to these only moderate yields we turned our attention to an alternative strategy. 
 
3.4.3 Plan 3: Abiko-Masamune anti Aldol Reaction 
We then focused on an anti-selective asymmetric boron-mediated aldol reaction which was 
reported by Abiko and Masamune.38 The aldol product could be converted to the phosphonate 
118, which would be then connected with the C3-C13 subunit 71 by a Horner-Wadsworth-
Emmons (HWE) reaction. We considered three possibilities to prepare the phosphonate 118 
from the aldol product 114: (i) methylation of the hydroxyl group, reductive cleavage of the 
auxiliary, followed by oxidation of the resulting primary alcohol should give the aldehyde 116, 
that could then be converted to the phosphonate 118 by using a modified Wittig reaction; (ii) 
alternatively, the methylated aldol product 115 could be directly converted to the phosphonate 
118 or (iii) and the aldol product 114 would be directly transformed to the phosphonate 119. 
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Scheme 28 Synthetic plan for the preparation of phosphonate 118. 
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3.4.3.1 Synthesis of the Vinyliodide 
The synthesis of the C14-C19 subunit commenced with the preparation of the known 
aldehyde 91 from diethyl 2-methylmalonate 111 by a four-step reaction sequence reported by 
Baker and Castro in the course of their total synthesis of (+)-macbecin I.99 In the course of 
this study, this original four-step reaction sequence was optimized. Treatment of diethyl 2-
methylmalonate 111 with iodoform and sodium hydride in Et2O at reflux gave the 
intermediate 112, which after acidic workup and without further purification, was directly 
converted into the acid under basic conditions. This optimized procedure gave better yield and 
was amenable to the production of multigrams of acid 113. Then, reduction of the acid 113 
using lithium aluminum hydride, followed by oxidation of the resulting allylic alcohol 90 with 
manganese dioxide and 4Å molecular sieves (MS) at room temperature provided vinyliodide 
91 in quantitative yield, which was ready for Abiko-Masamune anti aldol reaction. 
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Scheme 29 (a) NaH, CHI3, Et2O, 50 °C, 32 h; (b) KOH, EtOH/H2O (3:1), 100 °C, 24 h, 
77% over two steps; (c) LiAlH4, Et2O, RT, 4 h, 90%; (d) MnO2/4Å MS, DCM, 
RT, 1 h, quant. 
 
To explain the very high E-selectivity of this transformation to acid 113, we propose a 
mechanism as shown in Scheme 30. Accordingly, the steps should be (i) dehydrogenation of 
diethyl 2-methylmalonate 111 with the strong base NaH; (ii) addition of the resulting 
nucleophilic malonate ion 120 to iodoform; (iii) loss of CO2 by a retro-ene-reaction and; (iv) 
removal of the proton with base and loss of iodide ion as leaving group. 
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Scheme 30 Proposed mechanism of the preparation of the acid 113. 
 
Following the E2-Elimination, a staggered conformation of the carboxyl and iodide should be 
favoured due to the electrostatic interaction of dipoles and stereochemical effects giving the 
desired product (Scheme 31). 
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Scheme 31 The electrostatic interaction of dipoles and the stereochemical effect. 
 
A proposed radical mechanism for the oxidation of primary allylic alcohol by manganese 
dioxide was showed in scheme 32.100 The suggested steps are (i) adsorption of aldehyde 124 
on manganese dioxide to give 125; (ii) formation of a coordinated complex 126; (iii) transfer 
of a hydrogen atom to give the stable radical 127, and (iv) intramolecular electron-transfer to 
give products 128-130. During the course of this study, it was realized that this oxidation 
reaction proceeds more effectively with molecular sieves (fewer equivalents of manganese 
dioxide and shorter reaction time). There are two possible causes: (i) molecular sieves should 
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remove water from the reaction as it proceeds (ii) the stirring should be more effectively with 
molecular sieves because manganese dioxide is heavy and can not be mixed with only one 
magnetic stir bar. Therefore, the contact between solid and liquid phase may be optimized. 
This is agreement with previous results on the beneficial use of ultrasonic baths on this 
reaction. 
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Scheme 32 A proposed radical mechanisms for the oxidation by manganese dioxide 
 
3.4.3.2 Abiko–Masamune anti Aldol Reaction 
Following the Abiko-Masamune protocol, enolization of propionate ester 18, which was 
readily prepared from commercial norephedrine 18a by selective sulfonylation, selective N-
benzylation and acylation reactions (Scheme 34), with (cHex)2BOTf and Et3N at -78 °C gave 
the intermediate E-enolate 131, that reacted with the aldehyde 91 to provide the anti aldol 
adduct 114 in high selectivity (d.r. > 20:1) and excellent yield (96%) (Scheme 33).101 
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Scheme 33 (a) (cHex)2BOTf, Et3N, DCM, -78 °C, 2 h; (b) aldehyde 91, -78 °C, 3 h, 96%, 
(d.r. > 20:1). 
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Scheme 34  (a) MesSO2Cl, Et3N, DCM, 0 °C, 2 h, 100%; (b) BnBr, tBuOK, DMF, RT, 3 h, 
95%; (c) EtCOCl, pyridine, DCM, 0 °C to RT, 15 h, 100%. 
 
3.4.3.3 O-Methylation of the Aldol Adduct 
Three methods were evaluated to convert the aldol product 114 into methyl ether 115, as 
shown in Table 1: methylation with Meerwein’s salt and proton sponge®102 provided the 
required methyl ether 115 in 71% yield; treatment with methyl triflate and 2,6-di-tert-
butylpyridine103 as base afforded the product 115 in 78% yield. Best results were obtained by 
using methyl iodide, silver(I) oxide104 and molecular sieves. The product may be readily 
isolated without silica gel chromatography, only by filtration. The proposed intermediate 132 
of this methylation using methyl iodide and silver(I) oxide is shown in scheme 35. During the 
course of this study, it was realized that this methylation reaction proceeds more effectively 
with molecular sieves (fewer equivalents of silver(I) oxide and shorter reaction time). In 
analogy to MnO2/MS discussed above, there are two possible causes: (i) molecular sieves 
should remove water from the reaction as it proceeds; (ii) the stirring should be more 
effectively with molecular sieves because silver (I) oxide is heavy and can not be mixed with 
only one magnetic stir bar. Therefore, the contact between solid and liquid phase may be 
optimized. 
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Scheme 35 O-Methylation of the aldol adduct and proposed transition state. 
 
 
Methylation 
Reagent 
Base Solvent
T 
(°C) 
Time 
(h) 
Yield 
(%) 
O
Me
MeMe
BF4  
N N
 
DCM 0 24 71 
S
O
O
OMeF3C
 
N
 
DCM RT 72 78 
C I
H
H
H
 
Ag2O/4 Å MS Et2O RT 48 91 
 
Table 1 O-methylation of the aldol addact 114 by use of different methods. 
 
3.4.3.4 The Phosphonate Fragment 
Subsequently, the conversion of the methyl ether 115 to phosphonate 118 was studied. Initial 
attempts for a direct conversion, however, were not successful. The phosphonate 118 was 
isolated only in 9% yield, giving mainly the elimination product 135 in 38% yield. We then 
had to resort to a 4 steps sequence. LiAlH4 reduction of the ester, followed by Dess-Martin 
oxidation of the resulting primary alcohol 133 gave the aldehyde 116. Addition of lithiated 
dimethyl methylphosphonate to the resulting aldehyde 116, followed by Dess-Martin 
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oxidation of the resulting secondary alcohol 117 afforded phosphonate 118 in satisfactory 
yield. 
To our surprise, if excess of Dess-Martin periodinane was used in the reaction, again 
substantial amounts of elimination were observed to give phosphonate 134. This may be due 
to the water and slightly acidic conditions, originating from the preparation of Dess-Martin 
periodinane 136 (Scheme 37),105 as acetic acid may not be completely removed from the 
reagent. 
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Scheme 36 (a) nBuLi, dimethyl methylphosphonate, THF, -20 °C, 118 = 9%, 135 = 38%; 
(b) LiAlH4, Et2O, 0 °C, 1.5 h, 97%; (c) DMP, DCM, 0 °C, 2 h; (d) nBuLi, 
dimethyl methylphosphonate, THF, -78 to 0 °C, 3 h; (e) DMP, DCM, RT, 118 
= 46% over 3 steps, 134 = 45% over 3 steps. 
 
 
I
CO2H
O
I
HO O
O
O
I
O
OAc
AcO OAc
a) b)
..
136136b136a  
 
Scheme 37 (a) Oxone®, H2O, 70 °C, 3 h; (b) Ac2O, pTsOH . H2O, 80 °C, 2 h. 
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Directly, as shown in Scheme 36, the methyl ether 115 underwent elimination of MeOH to the 
phosphonate 135. At this point it seemed desirable to avoid this type of elimination and to 
study the direct conversion of Abiko-Masamune anti aldol products to other functionalities 
like β-ketone phosphonate 119, which may be used for Horner-Wadsworth-Emmons 
reaction.106 With this consideration, the reactions between the aldol adduct 114 and dimethyl 
methylphosphonate were carried out by employing iPrMgCl and nBuLi as base. The 
deiodinated product 137 was achieved instead of the desired product 119. This could be 
explained with the iodine/metal exchange mechanism. 107  But using KHMDS as base to 
dehydrogenize dimethyl methylphosphonate, the desired phosphonat 119 was obtained in 
good yield. 
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Scheme 38 (a) iPrMgCl then CH3P(O)(OCH3)2, nBuLi, THF, -78 °C to RT, 15 h, 86%. (b) 
iPrMgCl then CH3P(O)(OCH3)2, KHMDS, THF, -78 °C to -20 °C, 2 h, 80%; 
 
This conversion could be understood with the transition state 138 (Figure 17). iPrMgCl 
coordinates the aldol adduct 114. The resulting Mg2+ then acts as protecting group for the 
hydroxyl108 and activates the carbonyl by chelation. 
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Figure 17 Proposed transition state of activation of β-hydroxy ester with iPrMgCl. 
Total Synthesis of Archazolids 48
3.4.3.5 The Methyl Ketone Fragment 
Synthesis of methyl ketone 142 began with the O-methylation of the Abiko-Masamune anti 
aldol product 114 with MeI, Ag2O and 4Å molecular sieves in Et2O to give the methyl ether 
115 in 91% yield, as discussed above. The conversion of the ester 115 with O,N-
dimethylhydroxylamine hydrochloride and iPrMgCl to give Weinreb amide 140 was not 
satisfactory.109 Two products 140 and 141 were obtained at the ratio of three to one. Then, we 
used again a 4 steps sequence, i.e. reductive cleavage of the auxiliary, Dess-Martin oxidation 
of the resulting primary alcohol, methylation of the aldehyde with MeMgBr, and Dess-Martin 
oxidation of the secondary alcohol to give the desired methyl ketone 142 in 88% yield over 
four steps. 
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Scheme 39 (a) MeI, Ag2O, 4Å Molecular Sieves, Et2O , RT, 48 h, 91%; (b) LiAlH4, Et2O, 
0 °C, 2 h, 97%; (c) DMP, NaHCO3, DCM, RT, 4 h; (d) MeMgBr, THF, -78 °C, 
30 min; (e) DMP, NaHCO3, DCM, RT, 1.5 h, 92% over 3 steps. (f) O,N-
dimethylhydroxylamine hydrochloride, iPrMgCl, THF, -20 °C to -10 °C, 3 h, 
72%; (g) MeI, Ag2O, 4Å MS, Et2O , RT, 72 h, 85%; (h) MeMgBr, THF, -20 °C 
to RT, 1 h, 93%. (i) O,N-dimethylhydroxylamine hydrochloride, iPrMgCl, THF, 
-20 °C to RT, 4 h, 22%, 140 : 141 = 3:1. 
 
Although this approach is effective (5 steps, 80%), we wanted to shorten the synthetic steps of 
the methyl ketone 142 and study the direct displacement of the auxiliary by Weinreb amide 
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nucleophile, which might then allow direct extension of the aldol adduct using a Grignard 
reaction. 110  However, direct conversion of aldol product 114 with O,N-dimethyl 
hydroxylamine hydrochloride and iPrMgCl to the corresponding Weinreb amide 139 was 
again successful. In analogy to the mechanism discussed above, this reaction is expected to 
proceed via the intermediate 138 as shown in Figure 17. Again, chelation of Mg to the 
carbonyl oxygen might activate the ester functionality. Thereby, the carbonyl carbon becomes 
more electrophilic. If Me3Al,111  Me2AlCl,112  DIBAL-H,113  nBuLi114  were used instead of 
iPrMgCl, no desired product was achieved. Then methylation of the free hydroxyl group, 
followed by transformation of Weinreb amide with MeMgBr gave the desired methyl ketone 
142 in 80% over 2 steps. 
3.4.3.6 Conclusion 
During the synthesis of the C14-C19 subunit, three strategies, namely Evans anti aldol, 
Noyori’s asymmetric transfer hydrogenation and Abiko-Masamune anti aldol were evaluated 
to install the stereocentres at C16 and C17. Most efficiently, the two stereocentres were 
constructed by employing Abiko-Masamune anti aldol reaction. The preparation procedure of 
the acid 113 was optimized and amenable to produce multigrams. Also a study of the direct 
displacement of the Abiko-Masamune auxiliary by phosphonate and Weinreb amide 
nucleophiles was successful using iPrMgCl for carbonyl activation. In total, subunit 142 was 
obtained in 10 steps with 54% overall yield in a well-scalable synthesis providing several 
grams of the required building block.  
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3.5 Connection of the C3-C13 and the C14-C19 Subunits 
3.5.1 HWE-Reactions between Phosphonate 118 and Aldehyde 143 
With phosphonate 118 in hand, HWE reactions with aldehyde 143 were carried out. At first, 
we selected the mild condition according to the Masamune-Roush protocol (LiCl, DBU, 
CH3CN, RT). In the presence of lithium chloride, the phosphonates 118 could be easily 
deprotonated with an amine, e.g. DBU or DIPEA, to generate reactive species under these 
simple, mild conditions. Here, Li+ most likely forms a tight complex 146 with the carbanion 
derived from phosphonate 118 as shown in Figure 18, thereby enhancing the acidity of 
phosphonate 118.115 
However, even under these mild conditions, no desired product was observed, and the 
aldehyde was isomerized. Stronger bases, for instance nBuLi, led to extensive decomposition. 
We therefore had to focus on an alternative strategy, an aldol disconnection. 
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Scheme 40 Unsuccessful HWE reactions between phosphonate 118 and aldehyde 143. 
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Figure 18 Li-activation of the β-ketone phosphonate. 
 
3.5.2 Aldol Condensation between Methyl Ketone and Aldehyde 
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Scheme 41 (a) (cHex)2BCl, Et2O, -78 °C, 1.5 h, 95%; (b) LiHMDS, THF, -78 °C, 1 h, 74%; 
(c) Ac2O, DMAP, THF, 0 °C then RT; 40 min; (d) DBU, THF, RT, 1 h, 93% 
over 2 steps. 
 
Accordingly, lithium and boron mediated aldol reactions were tried to assemble methyl 
ketone 142 and aldehyde 143. The boron mediated aldol reaction gave the better results and 
the respective aldol products 147 were obtained in 95% yield. Acylation of the free OH-group 
with Ac2O and DMAP, followed by elimination with DBU provided the product 144 in 93% 
yield. Therefore, the two northern fragments were successfully connected by using an aldol 
condensation reaction. 
The next step was the attachment of the thiazol fragment 83 to 144. 
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3.6 Connection of the C3-C19 and the C20-C1'' Subunits 
Deprotection of the PMB-group with DDQ and pH7-buffer in DCM, followed oxidation of 
the resulting primary alcohol under Swern conditions provided the aldehyde 149 in excellent 
yield. The intermolecular HWE reaction between aldehyde 149 and phosphonate 150116 with 
NaH as base led to the desired product 151, albeit in only poor yield (20%). Under 
Masamune-Roush conditions (LiCl, DBU, CH3CN, RT), the aldehyde 149 was isomerised 
and no desired product was isolated. With stronger base such as KHMDS, complete 
decomposition of the starting materials was observed. The Heck-Macrocyclisation reaction 
with PdCl2(PPh3)2, K2CO3 and nBuNCl at 80 °C gave no desired cyclisation product 152 and 
led to decomposition. 
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Scheme 42 (a) DDQ, pH7-buffer, DCM, RT, 30 min, 148 in 94%; (b) oxalyl chloride, 
DMSO, Et3N, 4Å MS, -78 °C, 1 h, 94%; (c) NaH, THF, RT, 5 h, 20%; (d) 
PdCl2(PPh3)2, K2CO3, nBu4NCl, 80 °C, 1 h. 
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3.7 Completion of the First Total Synthesis 
trans-Selective Heck Reaction and the HWE-Macrocyclisation – Sven Rudolph 
 
Therefore, the order of these reactions was changed. This sequence was pursured by Sven 
Rudolph in our group. Using more conventional protocols, 117  the inter-molecular Heck 
reaction between the iodide 148 and the terminal alkene 83 provided poor E/Z-selectivity and 
yield. Therefore, conditions for this coupling reaction were optimized. Finally, ideal 
conditions include PdCl2(PPh3)2 as catalyst, DMF, acetonitrile and water as solvents to give 
the desired product in good yield and very good selectivity. After esterification of the Heck-
product, followed by PMB deprotection and Swern oxidation provided the aldehyde 155, 
which was ready for the HWE-macrocyclisation. This was successfully carried out by use of 
NaH as base. Asymmetric reduction of the ketone function to alcohol with (S)-CBS and BH3, 
followed by desilylation with HF/pyridine provided archazolid A (4) (Scheme 43). 
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Scheme 43 Completion of the first total synthesis of archazolid A (4). 
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The spectroscopic data (1H NMR, 13C NMR, MS) and specific rotation ([α]D= -47 ° (c = 1.2 
mg/mL, MeOH)) of our synthetic material were in agreement with those of an authentic 
sample obtained from the Archangium gephyra myxobacterial source (Scheme 44). 
 
 
 
 
Scheme 44 1H NMR spectra comparing synthetic and natural Archazolid A (4). 
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3.8 Heck-Macrocyclisation: Towards Archazolid B 
After the total synthesis of archazolid A (4), we tried to synthesize archazolid B (5) by use of 
Heck-macrocyclisation strategy. At first, the intermolecular HWE reaction between the 
aldehyde 149 and phosphonate 157 118  was carried out using NaH as base. The Heck-
macrocyclisation with PdCl2(CH3CN)2/Et3N/HCOOH as catalytic system 119  provided the 
macrocycle 159 in good yield. 120  Final steps would involve our previously established 
protocols by the total synthesis of archazolid A (4). 
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Scheme 45 Towards the synthesis of archazolid B (5). 
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3.9 Conclusion 
An expedient first total synthesis of archazolid A could be accomplished. It proceeds in 20 
steps and 4% overall yield from 60 (longest linear sequence) and establishes unequivocally 
the relative and absolute configuration.121 Key transformations include highly enantio- and 
diastereoselective Abiko-Masamune and Paterson anti-aldol reactions and a crotylboration on 
an advanced intermediate to install the vicinal stereogenic centers at C7/C8, C15/C16 and 
C22/23 together with two highly Z-selective Still-Gennari-type HWE coupling to generate the 
9Z,11Z alkenes. Coupling of the three fragments was effectuated by an efficient aldol 
condensation reaction, a highly advantageous Heck-coupling and subsequent HWE-
macrocyclisation to construct the macroclactone. Importantly, this modular, convergent 
synthesis should be amenable to designed analogues of this novel V-ATPase inhibitor, 
enabling extensive exploration of its biological potential. 
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4 Studies Towards the Total Synthesis of Etnangien 
4.1 Retrosynthetic Analysis 
As outlined retrosynthetically in Scheme 46, our synthetic approach relies on a late-stage 
coupling between marceocycle 160 and side chain 161 using a Wittig (R1 = Bu3PCH, R2 = 
CHO), Stille (R1 = Bu3Sn, R2 = CHCHI) or Heck reactions (R1 = I, R2 = CHCH2). This 
retrosynthetic strategy calls for a late-stage introduction of the labile side chain. Notably, it 
allows for diversification to access various side chains to provide a range of structural 
derivatives to initiate structure-activity relationship studies. 
The core structure 160 would be constructed by using inter- or intra-molecular metal mediated 
coupling reactions like Stille (R3 = Bu3Sn, R4 = I), Heck (R3 = H, R4 = I), Suzuki (R3 = BX2, 
R4 = I) reactions and esterification or macrolactonation such as Yamaguchi (2,4,6-
trichlorobenzoyl chloride, DMAP, Et3N), Keck-Boden (DCC, DMAP), Mitsunobu (DEAD, 
Ph3P, Et3N) or Mukaiyama (2-chloro-1-methylpyridinium iodide) between two fragments 162 
and 163. As alternative strategies, ring closing metathesis (RCM, R3 = H, R4 = CHCH2) or 
relay ring closing metathesis (RRCM) could be employed for closing the macrocycle 160. 
In turn, the C34-C42 subunit 162 was planed to be accessible by a tin-mediated (1,4)-syn 
aldol reaction between aldehyde 164 and ethyl ketone 165, which should be prepared using an 
auxiliary-controlled diastereoseletive aldol reaction. The C15-C31 fragment 163 was 
envisioned to be derived by boron-mediated asymmetric aldol reaction between the C15-C23 
subunit 167 and the C24-C31 subunit 166. The stereocentre in the C24-C31 subunit 166 
should be constructed by employing asymmetric allylation reaction. Using an auxiliary-
controlled diastereoseletive aldol reaction, the two stereocentres in the C15-C23 subunit 167 
should be installed. 
In summary, the devised route would allow assembly of etnangien in a flexible, highly 
convergent and stereocontrolled manner. Key issues to be addressed include (i) two auxiliary-
controlled diastereoseletive aldol reactions; (ii) a boron-mediated asymmetric aldol reaction; 
(iii) a tin-mediated (1,4)-syn aldol reaction; (iv) a asymmetric allylation reaction; (v) inter- or 
intra-molecular metal mediated coupling reactions; and (vi) esterification or macrolactonation. 
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Scheme 46 Retrosynthetic analysis of etnangien. 
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4.2 Synthesis of the C34-C42 Subunit – Fatih Arikan 
The synthesis of the C34-C42 subunit 176 was realised by Fatih Arikan in our group. As 
shown in Scheme 47, it began with the preparation of PMB-protected aldehyde 169 in three 
steps fashion, PMP-acetal formation, DIBAL-H reduction and DMP oxidation. A 
dicyclohexylboron mediated Paterson anti-aldol reaction of lactate-derived ethyl ketone 20 
with the PMB-protected aldehyde 169 proceeded with excellent diasteroselectivity and yield 
(d.r. > 20:1, 88%). Reductive removal of the α-benzoate substituent in 170 by SmI2 gave the 
corresponding ethyl ketone 171. Then, the tin-mediated (1,2)- and (1,4)-syn aldol reaction of 
ethyl ketone 171 with Roche-ester 177 derived aldehyde 178 (TBS protection, DIBAL-H 
reduction and DMP oxidation) proceeded with useful selectivity (d.r. > 7:1) and yield 
(74%).122 The resulting β-hydroxy ketone 172 then underwent a 1,3-syn-selective reduction 
when treated with (cHex)2BCl and LiBH4 generating the respective diol (d.r. > 20:1),123 which 
was then protected as the cyclic acetal 173. After selective primary TBS cleavage with TBAF, 
tosylation with TosCl and DABCO 124  and triple bond formation with Na-acetylide, the 
resulting compound 174 was converted to acid 175 in three steps, DDQ deprotection, DMP 
oxidation and Pinnick oxidation.125 The C34-C42 subunit 176 was obtained after reduction of 
the triple bond in 175 using Lidlar-catalyst. In total, the desired C34-C42 fragment was 
obtained in a highly convergent and stereoselective route. This fragment was available in 16 
steps in 4% yield. Likewise, this route was well-scalable and allowed to obtain multi-gram 
quantities of the C34-C42 subunit 176. 
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Scheme 47 The synthesis of the C34-C42 subunit 176. 
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4.3 Synthesis of the C24-C31 Subunit – Pengfei Li 
The preparation of the C24-C31 subunit 184, as realised by Pengfei Li in our group is shown 
in Scheme 48. It starts with selective TBS protection of diol 179, followed by DMP oxidation 
of primary alcohol to provide aldehyde 180, which underwent a silicium-based asymmetric 
allylation reaction126 to allylic alcohol 181 in high selectivity and good yield. Methylation of 
the allylic alcohol 181 with MeI and NaH as base, followed by ozonolysis127 with O3 and 
PPh3 afforded aldehyde 182, which was converted to iodide 183 by use of a Stork-Zhao-Wittig 
olefination reaction.128 Finally, the synthesis of the C24-C31 subunit 184 was completed in 
two steps involving TBS cleavage with CSA and oxidation of the resulting primary alcohol 
with Parikh-Doering Oxidation.129 In summary, this route to the C24-C31 subunit 184 proved 
likewise well-scalable and multigram quantities of required building block were obtained 
from 179 in 8 steps and 30% overall yield. 
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Scheme 48 The synthesis of the C24-C31 subunit 184. 
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4.4 Synthesis of the C15-C23 Subunit 
Synthesis of the C15-C23 subunit was the focus of this thesis. 
The retrosynthetic analysis of the C15-C23 subunit 189 is outlined in Scheme 49. An 
auxiliary controlled anti aldol reaction would build the corresponding stereochemistry. The 
aldehyde 188 would be prepared from (Z)-ethyl 3-formylbut-2-enoate 187 by using Wittig 
olefination. The DMPM-protection group for the secondary alcohol was selected due to (i) 
PMB ethers and PMP acetals show high 1,5-anti induction by Boron mediated asymmetric 
aldol reactions130 which would be employed for connection of the C15-C23 subunit 189 and 
the C24-C31 subunit 184; (ii) the DMPM-protecting group is easier to cleave than the PMB-
group. 
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Scheme 49 Retrosynthetic analysis of the C5-C20 subunit. 
 
4.4.1 Synthesis of the Aldehyde Fragment – Wittig Reaction 
The Wittig reaction of 187 to give 191, as previously reported,131 was very slow in toluene 
and gave low yield. On the contrary, this reaction was faster in DCM and gave better yield. 
Optimum results were obtained in DCM with 1.5 eq. Wittig reagent and 1.0 eq. aldehyde 187 
at room temperature (Table 2, Entry 4). The side product of the Wittig reaction in DCM was 
the aldehyde 192, the amount of which may be reduced under the condition with excess of the 
aldehyde 187 (Table 2, Entry 7). The excess of the aldehyde 187 was recycled after silica gel 
chromatography. 
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Scheme 50 Wittig reaction with aldehyde 187 and ylide 190. 
 
 
Yield (%) 
Entry Solvent 
187 
(eq.) 
190 
(eq.) 
T 
(°C) 
Time 
(h) 192 191 187 
1 PhMe 1.0 1.1 110 24  57  
2 PhMe 1.0 1.1 RT 24 × 7 20 57 15 
3 DCM 1.0 1.1 RT 24 13 65 11 
4 DCM 1.0 1.5 RT 24 9 70 16 
5 DCM 1.0 2.0 RT 24 4 56 27 
6 DCM 2.0 1.0 RT 28  79 3.7 
7 DCM 3.0 1.0 RT 15  80 2.7 
 
Table 2 Results of the Wittig reaction with aldehyde 187 and ylide 190. 
 
 
The Wittig reaction of the aldehyde 187 (excess) with more sterically hindered ylide 193 give 
the aldehyde 194 in 62% yield after 24 h at room temperature. Although this type of the 
Wittig reaction with aldehyde 187 proceeded very well in DCM, no conversion of the reaction 
with the corresponding ketone 195 could be obtained. 
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Scheme 51 Wittig reaction with aldehyde 187 and ylide 193 and unsuccessful Wittig 
reaction with ketone 195 and ylide 190. 
 
Then, reduction of aldehyde 191 with NaBH4, followed by TBS-protection of the primary 
alcohol afforded the TBS ether 198 in 89% yield over two steps. The primary alcohol 197 was 
used directly for the next step after work up. Reduction of the ester functionality with 
DIBAL-H at 0 °C to the primary alcohol, followed by oxidation of allylic alcohol with MnO2 
and 4Å MS in Et2O gave the aldehyde 188132 in 95% yield over two steps, which was ready 
for the anti aldol reaction. 
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Scheme 52 (a) NaBH4, EtOH/H2O 1:1, 0 °C to RT, 20 min; (b) TBSCl, imidazole, DMF, 
RT, 30 min, 89% over 2 steps; (c) DIBAL-H, THF, 0 °C, 1 h, 97%; (d) MnO2, 
Et2O, 4Å MS, RT, 30 min, 95%. 
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4.4.2 Construction of the Stereocentre C20/C21 – anti Aldol Reactions 
4.4.2.1 The Abiko-Masamune anti Aldol Strategy 
With the good experience of the Abiko-Masamune anti Aldol reaction in course of our total 
synthesis of archazolid A, we wanted to construct the stereocentres at C20 and C21 in a 
similar fashion. Accordingly, the aldol adduct 199 should be directly converted to the 
corresponding Weinreb amide 200 using iPrMgCl activation of carbonyl by chelation, which 
was described in total synthesis of archazolid A. Then, conversion of the Weinreb amide 200 
to the methyl ketone 189 was planned to be carried out by standard conditions. 
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Scheme 53 Retrosynthetic analysis for Abiko-Masamune anti aldol stratgy. 
 
However, the Abiko-Masamude anti aldol reaction between the propionate ester 18 and the 
aldehyde 188 provided low selectivity and moderate yield (76%, d.r. > 5:1).101 The direct 
conversion of the aldol aduct 199 with iPrMgCl and O,N-dimethylhydroxylamine 
hydrochloride to the Weinreb amide 201 was not as good as in the total synthesis of 
archazolid A. The problem was elimination of the hydroxyl group. This byproduct 202 was 
obtained in 29%. The basic conditions and the formation of the conjugated system were the 
cause of the hydroxyl elimination. The protection of the Weinreb amide 201 with 4-
(bromomethyl)-1,2-dimethoxy benzene 204 and NaH in DMF also failed.133 
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Scheme 54 (a) (cHex)2BOTf, Et3N, DCM, -78 °C, 2 h, then 188, -78 °C, 1 h, 76%, d.r. > 
5:1; (b) iPrMgCl, O,N-dimethylhydroxylamine hydrochloride, -20 °C to 0 °C, 
3.5 h, 52%; (c) NaH, 4-(bromomethyl)-1,2-dimethoxybenzene 204, DMF, 0 °C. 
 
Direct protection of the aldol aduct 199 with 3,4-dimethoxybenzyl 2,2,2-trichloroacetimidate 
208 and PPTS as catalyst in DCM provided the DMPM ether134 only in 47% yield and the 
product 205 could not be separated from the starting material by silica gel chromatography. 
On the contrary, the TBS protection of 199 using TBSOTf and 2,6-lutidine in DCM provided 
the TBS ether 206 in 98% yield. However, the conversion of the TBS ether to corresponding 
Weinreb amide 207 was not successful. 
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Scheme 55 (a) 3,4-dimethoxybenzyl 2,2,2-trichloroacetimidate 208, PPTS, DCM, RT, 17 h, 
47%; (b) TBSOTf, 2,6-lutidine, DCM, -78 °C, 1 h, 98%; (c) iPrMgCl, O,N-
dimethylhydroxylamine hydrochloride, THF, -20 °C to RT. 
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In conclusion, the Abiko-Masamude anti aldol reaction afforded the aldol product 199 in low 
stereoslectivity and moderate yield. The direct conversion of the aldol product 199 to Weinreb 
amide 201 proceeded also not as smoothly as we had hoped. Due to theses unsatisfactory 
results, we turned our attention to a Paterson anti aldol reaction. 
 
4.4.2.2 The Paterson anti Aldol Strategy 
With Paterson anti aldol reaction, the stereocenters at C20 and C21 could be constructed. 
After DMPM protection of the aldol aduct 209, the ketone functionality could be removed by 
MeLi and the benzoyl could be cleaved concomitantly to provide the 1,2-diol 211,135 that 
could be converted to methyl ketone 189 by oxidative cleavage (Scheme 56). 
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Scheme 56 Paterson anti aldol reaction followed by DMPM protection. 
 
As shown in Scheme 57, the Paterson anti aldol reaction provided in this case high yield 
(97%) and selectivity (d.r. > 20:1),42 in contrast to the Abiko-Masamude anti aldol reaction. 
This reaction was also appropriate to large scale. But the problem was the DMPM protection 
of the secondary alcohol 209 after the aldol reaction. With various conditions, 136  the 
protection gave unsatisfactory results (Table 3). The best result was performed by using PPTS 
as catalyst. However, the product 210 could not be separated from the starting material by 
silica gel chromatography, in a similar fashion as was previously observed for the Abiko-
Masamune anti aldol product. 
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Scheme 57 (a) (cHex)2BCl, Me2NEt, Et2O, -78 °C then 0 °C, 2 h, then aldehyde 188, -78 
°C then -20 °C, 14 h, 97%, d.r. > 20:1; (b) Table 3. 
 
 
Catalyst 
Mol 
(%) 
T 
(°C) 
Yield 
(%) 
PPTS 50 RT 37 
CSA 15 RT 23 
BF3·Et2O 4 -78 to RT decomposition 
Sc(OTf)3 10 RT decomposition 
 
Table 3 Results of DMPM protection of Paterson anti aldol adduct 209. 
 
The methyl addition to the ketone functionality with concomitant benzoyl cleavage provided 
the 1,2-diol 211 only in 22% yield,135 which was then converted to the methyl ketone by 
oxidative cleavage with NaIO4 in THF/H2O. It was surprising that the oxidative cleavage with 
NaIO4 in THF/H2O gave different products. In the first case, NaIO4 (7.0 eq.) was added in 
three portions over a period of 3.5 h to give methyl ketone 212 with the TBS group. In the 
second case, NaIO4 (6.0 eq.) was added in one portion to give methyl ketone 213 without the 
TBS group. The second case showed that the TBS group was removed under this condition. 
This cleavage of the TBS group will be discussed below. 
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Scheme 58 (a) MeLi, Et2O, -78 °C to -20 °C, 4 h, 22%; (b) NaIO4 (7.0 eq.), THF/H2O (4 : 
1), RT, 6.5 h, 86%; (c) NaIO4 (6.0 eq.), THF/H2O (4 : 1), RT, 2 h, 93%. 
 
After the failure of the DMPM protection, we had to choose an alternative protection group. If 
β-hydroxyl methyl ketones were protected with TBS group, high levels of 1,5-anti induction 
have been obtained with Ipc-boron controlled enolates. This type of Ipc-boron controlled 1,5-
anti aldol reaction with a TBS-protected methyl ketone was used in the total synthesis of 
dolabelide D by Leighton.137 
The standard approach was envisioned following Paterson aldol reaction to prepare the 
methyl ketone 219: reduction of the ketone and ester functionalities, followed by oxidative 
cleavage of the resulting diol to give the aldehyde 217, which would then be converted to the 
methyl ketone 219. 
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Scheme 59 Paterson anti aldol reaction followed by TBS protection. 
 
As shown in Table 4, the protection of the aldol product 210 with TBSOTf and several 
organic bases was carried out. The best result was achieved with proton sponge® as base. The 
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reaction with 2,6-lutidine and 2,6-di-tert-butylpyridine proceeded not smoothly and gave 
lower yields. With 2,4,6-trimethyl pyridine or 2,3,5-collidine as base, elimination of water 
was observed as side reaction and better yields were obtained. It is know that proton sponge® 
is more basic than 2,4,6-trimethyl pyridine or 2,3,5-collidin. But the elimination of water as 
side reaction in this case was not found. On the other hand, proton sponge® is sterically more 
hindered as compared to these other bases. This suggests that this steric effect may be the 
cause of the elimination. The conversion of the TBS-protected aldol product 214 to diol 215 
by using methyl lithium led to decomposition. Perhaps, methyl lithium attacks the electron 
rich allylic TBS ethers moiety in ketone 214, which then leads to decomposition.138 
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Scheme 60 (a) Table 4; (b) MeLi, Et2O, -78 °C to -20 °C, decomposition. 
 
Base Reagent Solvent 
T 
(°C) 
Side 
Reaction 
Yield 
(%) 
N  
TBSOTf DCM -78 unknown 52 
N  
TBSOTf DCM -78 Elimination 81 
N  
TBSOTf DCM -78 Elimination 73 
N
 
TBSOTf DCM -78 unknown 60 
N N
 
TBSOTf DCM -78 unknown 87 
 
Table 4 Results of TBS protection of Paterson anti aldol adduct 210. 
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Then, we used the standard approach to prepare the methyl ketone. Using LiBH4 as reducing 
agent, the ketone and ester functionalities were reduced to the diol 216 in high yield. 
Oxidative cleavage of the diol 216 with NaIO4 however gave the aldehyde 217 in 68% yield 
only. This moderate yield was due to a side reaction, i.e. deprotection of the primary TBS 
ether under these conditions. This type of TBS-deprotection will be discussed below. The 
oxidative cleavage of the diol 216 with Pb(OAc)4 in toluene was very clean and fast, giving 
the aldehyde 217 in very high yield. The other benefit of this reaction was that the diol 216 
was used without purification after workup for the next step. The aldehyde 217 may be 
converted to the methyl ketone 219 by using two a two step procedure in 75% yield.  
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Scheme 61 (a) LiBH4, THF, -78 °C to RT, 24 h; (b) NaIO4, MeOH/H2O (2:1), RT, 4 h, 
62% over 2 steps; (c) Pb(OAc)4, PhMe, RT, 25 min, 90% over 2 steps; (d) 
MeLi, Et2O, -78 °C, 30 min, then -30 °C, 30 min; (e) DMP, NaHCO3, DCM, 
RT, 90 min, 75% over 2 steps. 
 
4.4.3 Conclusion 
During the synthesis of the C15-C23 subunit, two auxiliary-controlled anti selective aldol 
reactions involve Abiko-Masamune anti aldol and Paterson anti aldol were evaluated to 
construct the stereocentres at C20 and C21. Most efficiently, the two stereocentres were 
installed by using Paterson anti aldol reaction. The Wittig reaction of aldehyde 187 and ylide 
190 was optimized and amenable to produce multigrams. Under optimized conditions, the 
Wittig reaction of the aldehyde 187 (excess) with more sterically hindered ylide 193 give the 
aldehyde 194 in good yield. In addition, the TBS protection of the Paterson anti aldol adduct 
210 with different amine bases were studied. With proton sponge® as base, this type of 
protection give excellent yield. In total, subunit 219 was obtained in 11 steps with 37% yield 
from aldehyde 187 in a well-scalable providing several grams of the desired building block. 
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4.5 Connection of the C15-C23 and the C24-C31 Subunits 
With the methyl ketone 219 and the aldehyde 184 subunits in hand, the connection of this two 
subunits could be carried out according to our synthesis plan. Before the two subunits would 
be connected by using Ipc-boron aldol reaction, a model reaction with the aldehyde 221 and 
the methyl ketone 219 was carried out to check the selectivity of this asymmetric aldol 
reaction. 
4.5.1 The Model Ipc-Boron Aldol Reaction with Methyl Ketone 219 
As show in Scheme 62, the alcohol 220 was oxidized with DMP to aldehyde 221. The Ipc-
boron aldol reaction between the aldehyde 221 and the methyl ketone 219 provided moderate 
yield (50%) and good selectivity (d.r. > 12:1). The absolute configuration of the new 
stereocentre was deduced by Mosher-ester analysis of the bis-Mosher ester 223/224 of the 
alcohol 222.139 
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Scheme 62 (a) DMP, DCM, RT, 1 h, 94%; (b) (+)-DIPCl, Et3N, Et2O, 0 °C, 90 min; then 
aldehyde 221, -78 °C to RT, 18 h, 50%, d.r. > 12:1; (c) (R)-MTPA, DMAP, 
Et3N, 2,4,6-trichlorobenzoyl chloride, PhMe, RT, 20 min, 88%; (d) (S)-MTPA, 
DMAP, Et3N, 2,4,6-trichlorobenzoyl chloride, PhMe, RT, 20 min, 98%. 
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(R)
O
H
O(S)
Ph
MeO
F3C
(R)(R)
OOMe
OTBS
1
7911
5
15 Δδ > 0Δδ < 0
TBS  
H δ[ppm] 
S-Mosher ester 
δ[ppm] 
R-Mosher ester 
Δδ=δS-δR 
7 
8,9 
 
11a 
11b 
13 
Me-13 
2.61 
1.68 
 
2.88 
2.68 
2.53 
0.67 
2.54 
1.62 
 
2.93 
2.71 
2.59 
0.78 
+0.07 
+0.06 
 
-0.05 
-0.03 
-0.06 
-0.11 
 
Table 5 Mosher ester analysis of the model Ipc-boron aldol reaction. 
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4.5.2 The Ipc-Boron Aldol Reaction 
The connection of the methyl ketone 219 and the aldehyde 184 subunits was performed 
successful by using Ipc-boron aldol reaction in good yield and selectivity (Scheme 63). 
Enolization of methyl ketone 219 with (+)-DIPCl in conjunction with Et3N in Et2O at 0 °C led 
to the formation of the boron enolate, which was allowed to react with aldehyde 184 at -78 °C 
for 2 h and then at -20 °C for 14 h. The desired product 225 was obtained in 76% yield and 
good selectivity (d.r. > 14:1). The absolute configuration of C24 was deduced by Mosher-
ester analysis of the bis-Mosher ester 225a/225b of the alcohol 225.139 
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Scheme 63 (a) (+)-DIPCl, Et3N, Et2O, 0 °C, 1 h, then aldehyde 184, -78 °C, 2 h, then -20 
°C, 14 h, 76%, d.r. > 14:1; (b) (R)-MTPA, DMAP, Et3N, 2,4,6-
trichlorobenzoyl chloride, PhMe, RT, 20 min, 89%; (c) (S)-MTPA, DMAP, 
Et3N, 2,4,6-trichlorobenzoyl chloride, PhMe, RT, 20 min, 90%. 
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MeO
I
23
O
Me
OMe
OTBS
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(S)
O
Ph
MeO
F3C
18 Δδ>0Δδ<0
TBS  
H 
δ[ppm] 
S-Mosherester 
δ[ppm] 
R-Mosherester 
Δδ=δS-δR 
25 
26,27 
28 
Me-28 
29 
 
23a 
23b 
21 
Me-21 
20 
19 
Me-18 
1.676 
1.493 
3.255 
3.319 
2.328 
 
2.684 
2.904 
2.555 
0.674 
4.525 
5.210 
1.763 
1.612 
1.398 
3.187 
3.295 
2.296 
 
2.736 
2.950 
2.607 
0.779 
4.555 
5.226 
1.779 
+0.064 
+0.095 
+0.068 
+0.024 
+0.032 
 
-0.052 
-0.046 
-0.052 
-0.105 
-0.030 
-0.016 
-0.016 
 
Table 6 Mosher ester analysis of the Ipc-boron aldol reaction. 
 
As shown in Figure 19, it is postulated that the boron aldol reactions of β-hydroxy methyl 
ketone proceed via a boat transition state.140 For β-alkoxy methyl ketones, a stabilizing formyl 
hydrogen bond exists that leads to disfavouring of the 1,5-syn adduct by minimizing steric 
interactions between the β-alkyl group and one of the Ipc group on boron. Silyl protecting 
groups prevent formyl hydrogen bonding due to their large size and electron-deficient oxygen. 
So, the high levels of stereocontrol, which was achieved with TBS-protected β-hydroxy 
methyl ketones, may be realised through the reinforcing influence of an Ipc-boron enolate.141 
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Figure 19 Boat transition states of the Ipc-boron aldol reaction. 
 
4.5.3 Reduction of the Ketone 225 and Selective Protection of the Diol 227 
The reduction of the β-hydroxy ketone 225 to the diol with the desired new stereocenter could 
be carried out by using two asymmetric reduction methods, the Evans-Tishchenko 
reduction142 and the Saksena-Evans reduction.143 Using SmI2 and MeCHO in THF, the β-
hydroxy ketone 225 was reduced to the desired alcohol 226 in 93% yield, with complete 
diastereoselectivity and with concomitant protection of the hydroxyl group at C24 as acetate. 
However, cleavage of the acetyl group in competition to the macrolacton after the closing of 
the ring was envisioned to be problematic. Reduction of the β-hydroxy ketone 225 using 
tetramethylammoniumtriacetoxy-borohydride afforded the diol 227 in 92% yield and 
complete diastereoselectivity. 
In these cases, the anti stereoselectivity can be rationalized by intramolecular hydride transfer 
via cyclic transition state as shown in Figure 20. 
Using of TBSCl and imidazol in DCM at RT, the diol 227 could be selectively protected as 
TBS ether 228 at C24 in 63% (77%, based on rec. SM). As by-products, the TBS ether 229 at 
C22 and the bis-TBS ether (C22 and C24) 230 were isolated and also the diol 227 was 
recycled in 18% yield. The selective protection of hydroxyl group at C24 was also carried out 
with TBSOTf and 2,6-lutidine or proton sponge®, however giving lower selectivity. 
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Scheme 64 (a) SmI2, MeCHO, THF, -10 °C, 1 h, then -20 °C, 16 h, 93%; (b) 
Me4NBH(OAc)3, MeCN/AcOH (1:1), -40 then -22 °C, 40 h, 92%; (c) TBSCl, 
imidazole, DCM, RT, 30 min, 228: R1 = H, R2 = TBS, 63%; 229: R1 = TBS, R2 
= H, 9%; 230: R1 = R2 = TBS, 4%; 227: R1 = R2 = H, 18%. 
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Figure 20 Transition state of intra-molecular hydride transfer. 
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4.6 Connection of the C15-C31 and the C32-C42 Subunits 
Under standard Yamaguchi conditions144 (formation of the mixed anhydride by treatment with 
TCBC/Et3N, followed by DMAP promoted esterification) the esterification of the alcohol 
226/228 with acid 176 led to the desired product 231/232 in high yield. 
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Scheme 65 (a) 231: R = Ac, TCBC, DMAP, Et3N, PhMe, 0 °C, 30 min, 87%; (b) 232 R = 
TBS, TCBC, DMAP, Et3N, PhMe, 0 °C then RT, 30 min, 97%. 
 
The proposed catalytic cycle and the activated intermediates are shown in Scheme 66.145 
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Scheme 66 Proposed mechanism of the Yamaguchi esterification. 
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4.7 Completion of the Macrolide Moiety: Heck-Macrocyclization 
The intra-molecular Heck reaction for medium size rings is widely used in synthetic organic 
chemistry 146  and also examples have been described for macrocyclization in the total 
synthesis of natural products and their analogues.147 
In order to close the ring of etnangien, various coupling reactions were considered, for 
example Stille, Heck and Suzuki reactions, which could be applied for the macrocyclization. 
But the Heck reaction is the most direct because it does not require an activation of 
functionalization of the second double bond. In this case, various catalytic systems were 
tested as shown in Table 7. The catalytic systems PdCl2(MeCN)2 / Et3N / HOCO in MeCN or 
in DMF and Pd(PPh3)4 / Et3N / MeCN led to decomposition. The system PdCl2(PPh3)2 
/K2CO3 / Bu4NCl in DMF provided the desired product, but in very low yield. It was found 
that the system Pd(OAc)2 / K2CO3 / Bu4NCl in DMF 148  was the best for the Heck 
macrocyclization to close the ring of etnangien (Scheme 67). It is possible to obtain high 
levels of stereocontrol through the nature of the ring conformation and the nature of E-
selectivity of the Heck reaction, as demonstrated in our archazolids synthesis. 
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Scheme 67 (a) 233: R = Ac, Pd(OAc)2, K2CO3, Bu4NCl, DMF, 60 °C, 1 h, 34%; (b) 234: R 
= TBS, Pd(OAc)2, K2CO3, Bu4NCl, DMF, 70 °C, 1 h, 70%. 
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Catalyst Solvent 
Base 
Additive 
T 
(°C) 
Time 
(h) 
Yield 
R = TBS 
(%) 
PdCl2(MeCN)2 MeCN 
Et3N 
HOCO 
RT 22 decomposition 
PdCl2(MeCN)2 DMF 
Et3N 
HOCO 
RT 3 decomposition 
Pd(PPh3)4 MeCN Et3N 50 1 decomposition 
PdCl2(PPh3)2 DMF 
K2CO3 
Bu4NCl 
80 0.5 found 
Pd(OAc)2 DMF 
K2CO3 
Bu4NCl 
70 1 70 
 
Table 7 Heck macrocyclization with various catalytic systems. 
 
Following, deprotection of the primary allylic TBS ether with NH4F in MeOH149 at room 
temperature provided the primary allylic alcohol 235, which may then be oxidized with MnO2 
to the aldehyde for Wittig reaction with the side chain 161 (R1 = Bu3PCH) or extended by 
using Takai reaction for attachment of the side chain 161 (R1 = Bu3Sn) by Stille coupling, or 
using a Wittig olefination for Heck coupling with side chain 161 (R1 = I). 
 
36
38
40
O
22
24
O
20
OTBSOCH3
O
O
O
OTBS
OH
TBS
31
32
28
15
a)
234
235
 
 
Scheme 68 (a) NH4F, MeOH, RT, 18 h, 70%. 
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Scheme 69 presents a simplified scheme of the putative major mechanistic steps of the Heck 
catalytic cycle.150 Several elementary steps are discussed. (i) Preactivation, the reduction of 
Pd(II) complexes to Pd(0) and the generation of an active species through multiple ligand 
exchange equilibria. (ii) Oxidative addition: the oxidative addition proceeds as a concerted 
process in which C-X bond rupture is more or less synchronized with the formation of M-C 
and M-X bonds. (iii) Migratory insertion: the migratory insertion is the product-forming step 
of the Heck cycle, in which a new C-C bond is formed. It is this step which is most likely 
responsible for regio- and stereodiscrimination as well as substrate selectivity. (iv) Reductive 
elimination: after the migratory insertion comes the step in which palladium(0) is released and 
launches the next turn of the Heck cycle. (v) PdH elimination: after reductive elimination, 
PdH is coordinated to alkene and then scavenged fast by base, 
 
 
Pd(ΙΙ)
Pd(0)
R1
PdX
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X
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Pd
X
R2
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R2
Pd
X
R2 R1
Pd H
X
R2
R1
R2
R1
oxidative addition
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Scheme 69 Proposed catalytic cycle of Heck reaction. 
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4.8 Synthesis of Analogues of the Etnangien Macrolide Structure 
4.8.1 Heck Macrocyclization 
In the same fashion, the esterification of the acid 176 with the alcohol 229, which was a 
sideproduct by selective protection of diol 227, under standard Yamaguchi conditions led to 
the product 236, which underwent the Heck macrocyclization with Pd(OAc)2 / K2CO3 / 
Bu4NCl as catalytic system to the macrocycle 237. After global deprotection, biologic activity 
of the macrocycle may be tested for structure-activity relationship (SAR) studies. The primary 
TBS group was selectively removed with NaIO4 in THF/H2O to give the primary alcohol 238 
in high yield. This mild desilylation method will be discussed below. 
 
OCH3
OTBSI
O
O O
TBS TBS
O
O OTBS
O
OCH3
OR
O
O O
TBS TBS
O
O OTBS
O
OCH3
OTBSI
HO
O O
TBS TBS
OO OO
TBS
OH
Me Me Me
+
a)
b), c)
176 229
236
237/238
 
 
Scheme 70 (a) TCBC, DMAP, Et3N, PhMe, 0 °C then RT, 30 min, 92%. (b) 237: R = TBS, 
Pd(OAc)2, K2CO3, Bu4NCl, DMF, 70 °C, 1 h, 32%. (c) 238: R = H, NaIO4 (6.0 
eq.) THF/H2O (4:1), RT, 15 h, 84%. 
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4.8.2 Sonogashira Macrocyclization 
Under standard Yamaguchi conditions, the esterification of the acid 175 with the alcohol 
provided the product 239, which underwent Sonogashira macrocyclization with Pd(dba)3 / 
CuI / iPr2Net as catalytic system to the macrocycle 240.151 After global deprotection, biologic 
activity of the macrocycle may be tested for structure-activity relationship (SAR) studies. 
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Scheme 71 (a) TCBC, DMAP, Et3N, PhMe, 0 °C then RT, 30 min, 82%. (b) Pd(dba)3, CuI, 
iPr2NEt, RT, 70 min, 30%. 
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4.9 Conclusion  
The macrocycle 234 of etnangien (14) was successfully synthesized with three key building 
blocks (176, 184, 219) by employing highly enantio- and diastereoselective Ipc-boron-
mediated (1,5)-anti aldol reaction, highly efficient Yamaguchi esterification and highly E-
selective Heck macrocyclization. It proceeds in 18 steps and 27% overall yield from 168 
(longest linear sequence). Key transformations include two highly enantio- and 
diastereoselective Paterson anti aldol reactions, a tin-mediated (1,4)-syn aldol reaction, a 
silicium-based asymmetric allylation, a (1,3)-anti reduction reaction and a (1,3)-syn reduction 
reaction on an advanced intermediate to install the corresponding stereogenic centres at 
C20/C21, C39/C40, C36/C37, C28, C22 and C38 together with a optimized Wittig reaction to 
generate the 16E alkene. In addition, two analogues of the mcrocycle (238, 240) were 
synthesized using Heck macrocyclization and Sonogashira macrocyclization, respectively. 
The two analogues are envisioned for structure-activity relationship (SAR) studies. 
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5 Selective Deprotection of Silyl Ethers with NaIO4 
5.1 Introduction 
As synthetic targets such as natural products and their analogues have grown more complex, 
protection/deprotection methods have assumed prominent roles in synthetic organic 
chemistry.152,153,154 The ability to efficiently protect and then deprotect hydroxyl groups has 
become increasingly important due to the abundance of these groups in natural products. The 
transformation of alcohols to the corresponding silyl ethers is a very common way to protect 
hydroxyl groups. Selective deprotection of one silyl ether without affecting another silyl ether 
in the same molecule plays important roles and can be a crucial step in total synthesis of 
natural products and their analogues.155 Generally, silyl ethers may be deprotected under (i) 
acidic conditions; (ii) basic/nucleophilic conditions;156 and (iii) oxidative conditions.157 
Selective deprotection of primary TBS ethers in the presence of secondary TBS ethers is 
perhaps a most widely used strategy in total synthesis of natural products and their analogues. 
Reagents which are used in this strategy include HOAc/THF/H2O, 158  CSA, 159  PPTS, 160 
TsOH, 161  TFA, 162  HCl, 163  NH4F/MeOH/H2O, 164  DDQ/CH2Cl2, 165  quinolinium 
fluorochromate,166 Vilsmeier-Haack reagent (POCl3/DMF),167 ceric ammonium nitrate [CAN, 
(NH4)2Ce(NO3)6],168 CBr4 in alcohol solvents,169 LiBr with 18-crown-6 in acetone.170. 
The well-established methods of deprotection of primary TES or TBS ethers in the presence 
of primary TBDPS ethers include HOAc/THF/H2O,171 HCl,172 H2SO4,173 PPTS,174 CSA,175 
TsOH,176 TFA177 and AcCl/MeOH (generating dry HCl in situ).178 There are also many other 
methods to remove TBS groups from protected primary alcohols in the presence of primary 
TBDPS ethers such as LL-ALPS-SO3H (lowloading and alkylated polystyrene-supported 
sulfonic acid), 179  HF-pyridine, 180  Lewis acids [CeCl3.7H2O/NaI/MeCN, 181 
Ce(OTf)4/THF/MeOH,182 InCl3/MeCN,183 ZnBr2/H2O/CH2Cl2,184 Zn(BF4)2,185 CeCl.7H2O186], 
Verkade’s non-ionic base [P(MeNHCH2CH2)3N], 187  Br2, 188  I2, 189  IBr/CH2Cl2, 190 
TBAB/MeOH.191 
A frequently used method to cleave secondary TES ethers in the presence of secondary TBS 
or TBDPS ethers is acid-mediated deprotection. The acid reagents involve PPTS,192 TsOH,193 
TFA, 194  CSA, 195  AcOH, 196  HCl, 197  H2SO4. 198  A mumber of other examples of the 
deprotection of secondary TES ethers in the presence of secondary TBS ethers are reported 
like HF-pyridine in THF,199 aqueous HF in MeCN,200  HOAc-buffered TBAF in THF,201 
TBAF in THF,202 aqueous NaOH in DMPU.203 
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In this chapter we describe a new, selective, mild and facile deprotection method for silyl 
ethers. 
5.2 Result and Discussion 
By the execution of oxidative cleavage of diol 211 with NaIO4 in THF/H2O, the deprotected 
product 213 was obtained in high yield (Scheme 72).204 This indicated that the TBS group 
was removed under the oxidative cleavage conditions. 
 
HO
OH MeO
Me OTBS
DMPM
O MeO
Me OH
DMPM
NaIO4 (6.0 eq.)
THF/H2O (4:1)
RT, 2 h
93%
211 213  
 
Scheme 72 Oxidative cleavage of diol 211 with concomitant deprotection of TBS ether. 
 
Are only the primary allylic TBS ethers deprotected? To answer this question we have studied 
the cleavage of TBS groups under NaIO4 in THF/H2O conditions. The results are shown in 
Table 8 and illustrate that primary TBS ethers including allylic were selectively deprotected 
with NaIO4 in THF/H2O in presence of secondary TBS ethers including allylic, giving 
products in high yield. This cleavage method is mild and should enable applications to 
sensitive, acid- or base-labile or polyfunctional substrates (Entry 2, 5, 6, 7). 
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Entry Substrate 
T 
(h) 
Product 
Yield 
(%) 
1 I OTBS
241  
2 I OH
90  
90 
2 BzO
O MeO
Me
TBS
OTBS
214
3 BzO
O MeO
Me
TBS
OH
246
 
94 
3 
O
OTBS
242  
2 
O
OH
247  
92 
4 
OTBS243  
2 
OH
248  
92 
5 
O OTBS
MeO
244  
2.5 
O OH
MeO
249  
92 
6 TBSO I
OTBS
245  
10 HO I
OTBS
250  
90 
7 
O O O O OPMB
TBSTBS
173  
10 
OH O O O OPMB
TBS
251  
85 
 
Table 8 Selective deprotection of primary TBS ethers (0.1 M) with NaIO4 (6.0 eq.) in 
THF/H2O (4:1). 
 
After successful removal of TBS group, we have further investigated. TBDPS and TES 
groups are also extensively used protecting groups for alcohols and orthogonal to TBS group. 
Under NaIO4 in THF/H2O conditions the primary allylic TBDPS ether is stable and not 
deprotected (Scheme 73). 
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I OTBDPS I OH
NaIO4
THF/H2O (4:1)
RT, 72 h
252 90  
 
Scheme 73 Unsuccessful deprotection of TBDPS ether. 
 
On the contrary, the TES ethers were deprotected under these conditions as shown in Table 9. 
However, this mild cleavage method should enable applications to sensitive, acid- or base-
labile or polyfunctional TES protected substrates (Entry 3, 4, 5). Entry 5 indicated also that 
primary TBDPS ethers were not deprotected under NaIO4 in THF/H2O conditions. 
 
Entry Subsrate 
T 
(h) 
Product 
Yield
(%) 
1 I OTES
253  
1 I OH
90  
91 
2 OTES
254  
1 OH
248  
92 
3 EtO2C
OTES
255  
1 EtO2C
OH
258  
92 
4 O
Me
Ph
N
O
SO2MesBn
I
OTES
256  
18 
O
Me
Ph
N
O
SO2MesBn
I
OH
114
 
91 
5 
OPMBOO
TBS
OOR
TES
R = TBDPS
257  
10 
OPMBOO
TBS
OHOR
R = TBDPS
259
 
86 
 
Table 9 Deprotection of TES ethers (0.1 M) with NaIO4 (6.0 eq.) in THF/H2O (4:1). 
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5.3 Conclusion 
In summary, we have discovered a new, selective method to deprotect silyl ethers. These mild 
nonacidic and -basic conditions should enable applications to acid- or base-sensitive or 
complex substrates. Under these conditions, (1) primary TBS ethers were selectively 
deprotected in presence of secondary TBS ethers; (2) primary and secondary TES ethers were 
deprotected; (3) TBDPS ethers were stable; furthermore, (4) primary TBS ethers should be 
selectively deprotected in presence of primary TBDPS ethers; (5) secondary TES ethers 
should be selectively deprotected in presence of secondary TBS or TBDPS ethers. 
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5.4 Preparation of Silyl Ethers 
As shown in Table 10, TBS (241, 243, 242), TBDPS (252) and TES (253, 254, 256, 257) 
ethers were prepared under standard conditions. 
 
Entry Substrate Conditions Produtct 
Yield
(%) 
1 I OH
90  
a I OTBS
241  
91 
2 I OH
90  
b I OTBDPS
252  
94 
3 I OH
90  
c I OTES
253  
99 
4 OH
248  
a 
OTBS243  
99 
5 OH
248  
b OTES
254  
98 
6 
O
OH
247  
a 
O
OTBS
242  
93 
7 O
Me
Ph
N
O
SO2MesBn
I
OH
114  
d O
Me
Ph
N
O
SO2MesBn
I
OTES
256  
95 
8 
OPMBOO
TBS
OHOR
R = TBDPS
259
 
c 
OPMBOO
TBS
OOR
TES
R = TBDPS
257
 
93 
 
Table 10 (a) TBSOTf, 2,6-lutidine., DCM, -78 °C (b) TBDPSCl, imidazole, DCM, RT; 
(c) TESOTf, 2,6-lutidine, DCM, -78 °C; (d) TESCl, pyridine, DCM, RT. 
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TBS ether 244 was synthesized by cleavage of PMB ether 260 followed by TBS protection 
using TBSOTf and 2,6-lutidine as base at -78 °C (Scheme 74). 
 
O OPMB
MeO
O OH
MeO
a) b) O OTBS
MeO
260 261 244  
 
Scheme 74 (a) DDQ, DCM/buffer pH7, (10:1), RT, 80%; (b) TBSOTf, 2,6-lutidine, DCM, 
-78 °C, 90%. 
 
Treatment of aldol product 114 with BH3.SMe2 in THF at -20 °C afforded diol 262 in 78% 
yield, followed by diprotection of the diol 262 with TBSOT fand 2,6-lutidine in CH2Cl2 to 
give TBS ether 245 in high yield (Scheme 75). 
 
O
Me
Ph
N
O
SO2MesBn
I
OH
HO I
OH
TBSO I
OTBS
a) b)
114 262 245  
 
Scheme 75 (a) BH3.SMe2, THF, -20 °C, 78%, (b) TBSOTf, 2,6-lutidine, DCM, -78 °C, 
90%. 
 
The Grignard reaction of aldehyde 187 with vinylMgBr provided secondary alcohol 258,205 
which was converted to TES ether 255 by employing TESOTf and2,6-lutidine in CH2Cl2. 
 
EtO2C
OH
EtO2C
OTES
b)CHO
EtO2C
a)
187 258 255  
 
Scheme 76 (a) vinylMgBr, THF, -20 °C, 87%, (b) TESOTf, 2,6-lutidine, DCM, -78 °C, 
92% 
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6 Direct Reductive Amination 
Efficient One-Pot Synthesis of Hindered Tertiary Amines with Biological Activity 
6.1 Introduction 
The direct reductive amination of carbonylgroups, in which a mixture of a carbonyl 
compound and an amine is treated with a reductant in a “one-pot” fashion, is one of the most 
useful methods for the preparation of secondary or teriary amines.206-207 But application of 
these protocols to sensitive, acid-labile or polyfunctional substrates is limited. 
Living organisms employ organic NADH (nicotinamide adenine dinucleotide 264, Figure 21) 
in combination with enzyme catalysts for the direct reductive amination of ketones.208 A 
salient feature of this mediated amination is the activation of the imine 262 nitrogen by 
hydrogen bonds (Figure 21). To mimic key features of this biosynthetic pathway, assembly 
265/266 was selected as a surrogate. Thus, in a similar fashion, The “Hantzsch ester” 265 
would act as a reducing agent by hydride transfer and the imine 266 should be activated by 
intermolecular hydrogen bonding (Figure 21). 
 
R R
N
HR
H
N Lys
R R
N
HR Het
N
EtOOC COOEt
HH
H
N HH
H CONH2
HH
R
NADH Hantsch Ester
: hydrogen bond
262
264 265
266
 
 
Figure 21 Activation of the imine nitrogen by hydrogen bonds. 
 
Based on this innovative biomimetic approach, a direct reductive amination of ketones and 
aldehydes was recently developed in our group.209 This method uses the Hantzsch ester for 
transfer hydrogenation and proceeds in the presence of molecular sieves and catalytic 
amounts of thiourea for imine activation (Scheme 77). With this mild, acid- and metal-free 
procedure, various secondary amines were synthesized. 
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Scheme 77 Direct reductive amination of ketones and aldehydes with thiourea as catalyst. 
 
The proposed mechanism was showed in Figure 22. The first steps should involve an 
equilibrium of ketone 267 and amine 268 with ketimine 271, which might be rate determining. 
Imine 271 is not reduced under the reaction conditions. It is only after hydrogen bond 
activation by thiourea (269) to give intermediate 272 that the C=N moiety may be 
hydrogenated by the Hantzsch ester (265) to produce amine adduct 274. For the catalytic 
cycle to proceed, a transfer of thiourea from 274 to 271 is required to give again complex 262 
with concomitant liberation of the product amine 270. 
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Figure 22 Proposed mechanism of the hydrogen bond catalyzed direct reductive 
amination. 
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Tertiary amines are key structural elements in synthetic reagents, for example, in metal 
mediated asymmetric cataylsis as ligand 275,210 and numerous biologically active natural 
products like cocaine 276211 and pharmaceuticals like the clinically used antibiotic ciproflaxin 
(277) (Figure 23).212 
 
N
n PPh2 N
O O
OO
276: Cocaine
N
HN
COOH
O
F
277: Ciproflaxin275: Ligand  
 
Figure 23 Examples of tertiary amines with biologically activity. 
 
Tertiary amines of type 278 in general (Figure 24) could be theoretical accessed in a one-pot 
process with three components by using the reductive amination of carbonyls. Herein, three 
types of direct reductive amination procedure for the synthesis of sterically demanding 
tertiary amines under mild and operationally simple conditions are discussed. 
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Figure 24 One pot synthesis of tertiary amines. 
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6.2 One-Pot Synthesis of Hindered Tertiary Amines213 
6.2.1 Dialkylation of Amines with Ketone and Aldehyde 
As a first target we studied the access to para-anisidine by the reaction with ketone and 
aldehyde. A reaction mixture of para-anisidine 279-a (1.0 mmol), ketone (1.0 mmol) or 
aldehyde (1.0 mmol), Hantsch ester 265 (1.5 mmol), catalytic amounts of thiourea 269 (0.1 
mmol) and 5 Å molecular sieves in toluene was stirred at 60 °C. After 24 h, a second 
equivalent of ketone (1.0 mmol) or aldehyde (1.0 mmol), Hantsch ester 265 (1.5 mmol) and 
thiourea 269 (0.1 mmol) was added. The resulting mixture was stirred at the same temperature 
for 24-72 h. 
 
H2N
OMe
R R1
O
+
Toluene
5Å MS
265
269 (0.1 eq)
HN
R R1
OMe
N
R R1
R2
R
R
R2 O
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280
281
282 283
 
 
Scheme 78 Dialkylation of amine with ketone and aldehyde. 
 
The results (Table 11) showed that the reaction with two ketones (Entry 1) gave only the 
secondary amine (GCMS) and no desired tertiary amine 283-a. The reaction with 
acetophenone and isobutyraldehyde provided the desired tertiary amine 283-a in moderate 
yield (Entry 2). The best result was achieved with two aldehydes (Entry 3). Based on these 
results, the amination of two aldehydes with para-anisidine and the amination of two 
aldehydes with different amines were studied. 
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Entry 
Carbonyl 
280 
Carbonyl 
281 
Product 
283 (a-c) 
Yield 
(%) 
1 
O
 
O
 
N
OMe
 
0 
2 
O
 
H
O
 
N
OMe
 
56 
3 H
O
 
H
O
 
N
OMe
 
67 
 
Table 11 Results of dialkylation of amine with ketone and aldehyde. 
 
6.2.2 Dialkylation of para-Anisidine with two Aldehydes 
Treatment of para-anisidine (1.0 mmol), a first aldehyde 284 (1.0 mmol), Hantsch ester 265 
(1.5 mmol), and 5 Å molecular sieves with catalytic amounts of thiourea 269 (0.1 mmol) in 
toluene at 60 °C for 24 h produced a secondary amines as intermediate which was then treated 
with a second aldehyde 286 (1.0 mmol), Hantzsch ester 265 (1.5 mmol) and thiourea 269 (0.1 
mmol) at the same temperature for 24 h. 
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Scheme 79 Dialkylation of para-anisidine with two aldehydes. 
 
Direct Reductive Amination 98
Indeed, this procedure was successful. Table 12 showed the results of this procedure. Mostly, 
the desired trisubstituted amines 287 were obtained in good yield (Entries 1-5). Both aliphatic 
and aromatic aldehydes were accepted as substrates and variations in the electronic and steric 
properties were tolerated. 
 
Entry 
Carbonyl 
284 
Carbonyl 
286 
Product 
287 (a-f) 
Yield 
(%) 
1 
O2N
H
O
 
H
O
N
OMe
O2N
 
86 
2 
O2N
H
O
 
H
O
 
N
OMe
O2N
 
82 
3 H
OOMe
 
H
O
N
OMe
OMe
 
79 
4 H
OOMe
 
H
O
 
N
OMe
OMe
 
75 
5 H
O
 
H
O
 
N
OMe
 
67 
6 
O2N
H
O
 MeO
H
O
N
OMe
O2N
MeO  
30 
 
Table 12 Results of dialkylation of para-anisidine with two aldehydes. 
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The amination with 4-nitrobenzaldehyde and 2-methoxybenzaldehyde (Entry 6) provided the 
tertiary amine 287-f in poor yield. This could be explained by steric aspect because the 
product 287-f was more hindered. 
 
6.2.3 Dialkylation of Different Amines with Isobutyraldehyde and 
Benzaldehyde 
In order to study the dialkylation of different amines with isobutyraldehyde and benzaldehyde, 
a suspension of isobutyraldehyde (1.0 mmol), Hantzsch ester 265 (1.5 mmol), catalytic 
amounts of thiourea 269 (0.1 mmol) and 5 Å molecular sieves in toluene were treated with 
amine 279 (b-f) at 60 °C for 24 h. Benzaldehyde (1.0 mmol), Hantsch ester 265 (1.5 mmol) 
and thiourea 269 (0.1 mmol) were added. The mixture was stirred at the same temperature for 
another 24 h. 
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Scheme 80 Dialkylation of different amines with isobutyraldehyde and benzaldehyde. 
 
As shown in Table 13, this procedure was not successful and no desired tertiary amines were 
obtained. GC-MS analysis showed that the reaction stops after the first step. A further 
aminiation with benzaldehyde did not occur. 
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Entry 
Amine 
279 
Product 
289 (a-e) 
Yield 
(%) 
1 
H2N  
N
 
0 
2 
H2N
Cl
 
N
Cl
 
0 
3 
H2N
O
 
N
O
 
0 
4 
H2N
OH
O
N
OH
O
 
0 
5 
H2N
N
 
N
N
 
0 
 
Table 13 Unsuccessful dialkylation of different amines with isobutyraldehyde and 
benzaldehyde. 
 
To our surprise, if the order of isobutyraldehyde and benzaldehyde (Table 13, Entry 1) was 
changed, the desired tertiatry amin 289-f was obtained (Scheme 81). This could be explained 
by following aspects: 
1) para-anisidine is more electrophilic than para-toluidine; 
2) isobutyraldehyde is more nucleophilic than benzaldehyde; 
3) the second amination is more difficult than the first one (also due to steric aspect). 
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Scheme 81 Dialkylation of para-toluidine with isobutyraldehyde and benzaldehyde. 
 
6.3 Biological activity 
In view of the cytotoxic activity of simple aromatic amines,214 it appeared rewarding to 
likewise test these tertiatry amines in whole cell-based assays. Consequently, the inhibitory 
effect on the murine connective tissue cell line L-929 was analyzed. 215 As shown in Table 14, 
various representatives showed potent cytotoxicity with IC50 values in the low micromolar 
range. These results demonstrate that the biological function of such tertiary amines is quite 
versatile. 
To get further hints about the mode of action, the tertiary amine 289-f and the secondary 
amine 290 as exemplary representatives of this compound class were checked for effects on 
the morphology of PtK2 potoroo cells by Florenz Sasse at our Institute. The cultured cells 
were stained by labeling the nuclei and a marker protein of the endoplasmatic reticulum, and 
inspected by fluorescence microscopy. As shown in Figure 25, treated cells showed striking 
alterations of the inner membrane structure of the cytoplasm. They displayed big vacuoles 
near the nucleus or a cushion-like pattern, the first being more pronounced in the 290 treated 
cells. Compound 289-f seems to be less effective in vacuolization, rather leading to cell 
enlargement. The effect of 290 is very similar to the corallidicyals, sesquiterpene 
hydroquinones from the Caribbean Sponge Aka coralliphagum, 216  which suggests that a 
similar mode of action might be involved. Possibly, redox processes might be associated. The 
notion that the tertiary amine 289-f is less effective in vacuolization as compared to 290, 
might be related to the fact that the central nitrogen is sterically much more hindered and thus 
less accessible to oxidation–reduction processes. Significantly, tertiary amines are more 
potent in the cell culture assays in comparison to primary or secondary amines, which might 
suggest that also other effects may be involved for these more encumbered nitrogen-
containing structures. 
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Compound 
Growth inhibition  
L-929 IC50 
µg/mL (µM) 
N
OMe
 
10 (37) 
N
OMe
O2N
> 40 
N
OMe
O2N
MeO
> 40 
N
 
5 (20) 
N
OMe
OMe
 
15 (50) 
N
OMe
OMe
 
> 40 
N
OMe
O2N
> 40 
 
Table 14 Inhibitory effects of tertiary aromatic amines on the growth of mammalian 
murine connective tissue cell line. 
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                     control 
                                                       
H
N
HO
NO2
290            
N
289-f  
 
Figure 25 Changes in the morphology of cultivated PtK2 potoroo cells upon treatment 
with the tertiary amine 289-f (right side) and the secondary amine 290 (middle) 
in comparison to control cells (left side). Cells were incubated with 50 µg/mL 
for 18 h and stained for nuclei (blue) and ER structure (green). 
6.4 Conclusion 
We have developed an efficient procedure for the synthesis of structurally diverse tertiary 
amines, including aromatic and sterically demanding amines. The operationally simple 
procedure uses the Hantzsch ester for transfer hydrogenation and proceeds in the presence of 
molecular sieves and thiourea. The mild conditions and chemoselectivity of this protocol 
should enable applications also to complex and/or acid-sensitive substrates. It is expected, that 
this method opens the venue for further exploring sterically hindered tertiary amines as 
synthons for preparative and medicinal chemistry. 
Indeed, these tertiary amines exhibited pronounced inhibitory effects on the growth of the 
murine connective tissue cell line L-929 in the low micromolar range. Two exemplary was 
shown to cause alterations of the inner membrane structure of the cytoplasm by microscopy-
based studies. 
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7 Summary 
7.1 Total Synthesis of Archazolid A 
Archazolid A (4) is a potent V-ATPase inhibitor from the myxobacerium Archangium 
gephzra. An expedient first total synthesis of archazolid A could be accomplished by coupling 
of the three main building blocks (143, 118, 83). The total synthesis of archazolid A proceeds 
in 20 steps and 4% overall yield from 60 (longest linear sequence) and establishes 
unequivocally the relative and absolute configuration. 
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HO
OH
MeO
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4
O
HO
P(OEt)2
O O
154
 
 
 
Firstly, this thesis describes the synthesis of the C14-C19 subunit 118. This was accomplished 
in 10 steps with 54% overall yield in a well-scalable route providing several grams of the 
required building block. Key features of the synthesis include an optimized procedure to 
prepare the vinyliodide 113 and a highly enantio- and diastereoselective Abiko-Masamune 
anti aldol reaction to construction C16 and C17 stereocentres. 
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I O
1. NaH
    CHI3
2. KOH
(cHex)2BOTf
18, Et3N
Ag2O, MeI
90%
(2 steps)
Me CO2Et
CO2Et
CO2H
I
77%
1. LiAlH4
2. MnO2
H
LiAlH4
O
Me
Ph
N
O
SO2MesBn
I
OH
I OH
OMe
I
OMe O
O
Me
Ph
N
O
SO2MesBn
I
OMe
91%
97%
1. DMP
2. MeMgBr
3. DMP
92%
96%
(d.r. > 20:1)
111 113 91
114115
133 142  
 
Additionally, an efficient method for the direct displacement of the Abiko-Masamune 
auxiliary by using metallated phosphonates and Weinreb amides was developed which uses 
iPrMgCl for carbonyl activation. The resulting intermediates, such as β-ketone phosphonate 
119 and Weinreb amide 139 are generally very useful in the total synthesis of natural products. 
 
MeO
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Finally, for completion of the total synthesis, fragment 118 was connected with 143 by using 
an aldol condensation reaction, followed by a highly advantageous Heck-coupling and 
subsequent HWE macrocyclisation to construct the macroclactone. Alternatively, the 
macrocyclic core of the archazolids was also constructed by an inter-molecular HWE reaction 
between 143 and 154 and a subsequent Heck-macrocyclisation. 
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7.2 Studies Towards the Total Synthesis of Etnangien 
Etnangien (14) is a macrolide isolated from culture broths of various strains of the 
myxobacterium Sorangium cellulosum and shows antibiotic activity against various gram-
positive bacteria (IC50: ~100 nM) by inhibition of RNA-polymerase. Notably, it shows no 
cross-resistance to rifampicin, a clinically-valued RNA-polymerase inhibitor. This thesis 
describes the synthesis of the C15-C23 subunit and the preparation of the macrocyclic core of 
etnangien. 
The macrocycle 160 of etnangien was successfully synthesized from three main building 
blocks (176, 184, 219). For their fusion, a highly asymmetric Ipc-boron-mediated aldol 
reaction, an efficient Yamaguchi esterification and an E-selective Heck macrocyclization 
(Pd(OAc)2 / K2CO3 / Bu4NCl in DMF) were used. In total, this route proceeds in 18 steps and 
27% overall yield from 168 (longest linear sequence). 
 
 
Heck reaction
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O
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The C15-C23 subunit 219 was synthesized in 11 steps with 37% yield from aldehyde 187 in a 
well-scalable process providing several grams of the desired building block. Key 
transformations include a highly enantio- and diastereoselective Paterson anti-aldol reaction 
to install the stereocentre C20/C21, an optimized Wittig reaction procedure to prepare the 
aldehyde 191, a TBS protection reaction with proton sponge® as base and a highly efficient 
oxidative cleavage of diol 216 with Pb(OAc)4. 
 
CHO
EtO2C
CHO
EtO2C
Ph3P
O
DCM, RT, 80%
OTBS
O
82% 
(4 steps)
(c-Hex)2BCl
Me2NEt, XX
O
Me
OH Me
OTBS
BzO
1. MeLi
2. DMP
1. TBSOTf
2. LiBH4
3. Pb(OAc)4
H
OTBS
O MeO
Me
TBS
OTBS
O MeO
Me
TBS
75%
(2 steps)
1. NaBH4
2. TBSCl
3. DiBAL
4. MnO2
97%
d.r. > 20:1
78%
(3 steps)
H
187
190
191
188210
217 219  
 
7.3 Selective Deprotection of Silyl Ethers with NaIO4 
During the course of this thesis, a new and selective method to cleave silyl ethers has been 
developed. The mild nonacidic and -basic conditions enable applications to acid- or base-
sensitive or complex substrates. Under the conditions, which involve the use of NaIO4 (1) 
primary TBS ethers were selectively deprotected in presence of secondary TBS ethers; (2) 
TES ethers were unstable; (3) TBDPS ethers were stable; furthermore, (4) primary TBS/TES 
ethers may be selectively deprotected in presence of primary TBDPS ethers; (5) secondary 
TES ethers may be selectively deprotected in presence of secondary TBS/TBDPS ethers. 
Notably, this method was successfully used for deprotection of the primary TBS ether of the 
highly complex substrate 237, giving 238 with excellent yield. 
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7.4 Direct Reductive Amination 
We have developed an efficient procedure for the synthesis of structurally diverse tertiary 
amines, including aromatic and sterically demanding amines. The operationally simple 
procedure uses the Hantzsch ester for transfer hydrogenation and proceeds in the presence of 
molecular sieves and thiourea. The mild conditions and chemoselectivity of this protocol 
should enable applications also to complex and/or acid-sensitive substrates. It is expected, that 
this method opens the venue for further exploring sterically hindered tertiary amines as 
synthons for preparative and medicinal chemistry. 
Indeed, these tertiary amines exhibited pronounced inhibitory effects on the growth of the 
murine connective tissue cell line L-929 in the low micromolar range. Two substances were 
analysed in more detail and were shown to cause alterations of the inner membrane structure 
of the cytoplasm. 
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8 Experimental Section 
8.1 General Methods 
All non-aqueous reactions were performed using oven-dried (100 °C) or flamedried glassware 
under a positive pressure of dry argon (Ar) unless otherwise noted. 
Tetrahydrofuran and diethyl ether were freshly dried under reflux and an atmosphere of Ar 
over sodium (Na) and benzophenone as indicator and purified by disitillation. Methylene 
chloride was dried under reflux and an atmosphere of Ar over calciumhydride (CaH2) and 
purified by distillation. Other dry solvents were obtained commercially. All reagents were 
obtained commercially as reagent grade and, unless otherwise noted, used without further 
purification. The organic extracts were dried over anhydrous magnesium sulfate (MgSO4) or 
sodium sulfate (Na2SO4). The column chromatographic purifications were performed on silica 
gel (230-400 mesh). 
Analytical TLC: Thin-layer chromatography was performed on precoated silica gel 60 F254 
(Merck) analytical plates and visualized by fluorescence quenching under UV light. In 
addition, TLC plates were stained using cerium(IV)sulfate- phosphomolybdic acid in sulfuric 
acid followed by charring. 
Melting points: measured on a Büchi 510 apparatus. All melting points were measured in 
open capillaries and are uncorrected. 
Optical rotations: Optical rotations were measured on a Perkin-Elmer 241 instrument 
operating at the sodium D line with a 100 mm path length cell, and are reported as follows: 
[α]TD, concentration (g/100 ml), and solvent. 
NMR spectra: NMR spectra were recorded in CD3OD and CDCl3 on a Bruker AM 300, AM 
400 and DMX-600 spectrometer. Chemical shifts are reported in parts per million (ppm, δ) 
with the residual non-deuterated solvent as an internal standard. In reporting spectral data, the 
following abbreviations were used: s = singlet, d = doublet, t = triplet, q = quartet, quin = 
quintuplet, m = multiplet, dd = doublet doublet, dt = doublet triplet. 
Mass spectra: EI and DCI mass spectra (reactant gas ammonia) were obtained on a Finnigan 
MAT 95 spectrometer, high resolution data were aquired using peak matching (M/DM = 
10000). 
Chemical names: generated with ChemOffice 2005 (CambridgeSoft®). 
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8.2 Preparation of Reagents 
A Stock Solution of Dicyclohexylboron Triflate [(C6H11)2BOTf] in Hexane 
An oven-dried 250-mL round-bottom flask capped with a rubber septum was charged with 
cyclohexene (14.2 mL, 140 mmol) and dry diethyl ether (50 mL), and kept at 0 °C under 
argon Borane-dimethyl sulfide complex (6.64 mL, 70.0 mmol) was added dropwise during 30 
min with stirring, and then the whole reaction mixture was stirred for 3 h at 0 °C, when the 
solid was settled without stirring. The supernatant organic solution was removed as much as 
possible by syringe, and the residual solid was washed with dry diethyl ether (2 × 50 mL) and 
dried in vacuo to give dicyclohexylborane (11.3 g, 63.4 mmol), which was used for the 
preparation of the triflate without further purification. The solid was suspended in 50 mL of 
dry n-hexane and trifluoromethanesulfonic acid (10.0 g, 66.6 mmol) was added dropwise via 
syringe during 30 min with constant stirring, during which time vigorous gas evolution 
occurred and the solid gradually disappeared. Stirring continued at room temperature for 1 h. 
The solvent was reduced to ca. 5 mL and removed by syringe. The residual solid was washed 
with dry diethyl ether (3 × 5 mL) and dried in vacuo to give dicyclohexylboron triflate (16.6 g, 
50.9 mmol), which was dissolved in 45 mL dry n-hexane (ca. 1M).1 
 
Dicyclohexylboron Chloride [(C6H11)2BCl] 
To a solution of dried cyclohexene (21.2 mL, 210 mmol) in anhydrous diethyl ether (90 mL) 
under an argon atmosphere at 0 °C was slowly added monochloroborane dimethyl sulphide 
(11.6, mL, 100 mmol). The mixture was stirred at 0 °C for 2 h and then the solvent was 
removed by distillation. The resulting crude product was distilled under reduced pressure 
(104-105 °C / 0.5 mmHg) to afford the dicyclohexylboron chloride as a colorless oil.2 
 
                                                 
1 Inoue, T.; Liu, J.-F.; Buske, D. C.; Abiko, A. J. Org. Chem. 2002, 67, 5250-5256. 
2 Cowden, C, J.; Paterson, I. Org. React. 1997, 51, 1. 
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(1R,2S)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl propionate 18 
 
OH
N
Ph
Me
SO2Mes
Bn
OH
NH2
Ph
Me
OH
NH
Ph
Me
SO2Mes
O
Me
Ph
N
O
SO2MesBn
C28H33NO4S
Exact Mass: 479,213
Mol. Wt.: 479,6309  
 
To a stirred solution of (-)-Norephedrin (5.22 g, 34.5 mmol, 1 eq) and Et3N (5.77 ml, 41.4 
mmol, 1.2 eq) in CH2Cl2 (60mL) was added mesitylenesulfonyl chloride (7.55 g, 34.5 mmol, 
1 eq) at 0 °C. The reaction mixture was stirred at 0 °C for 2 h and diluted with Et2O (120 mL). 
The mixture was washed with 20 ml each of H2O, 1 M aqueous HCl, H2O, saturated aqueous 
Na2CO3 and saturated aqueous NaCl and dried over Na2SO4. The organic solution was 
concentrated to give an oily residue, which was dissolved in CH2Cl2 (8 mL). Hexane (16 mL) 
was added in the solution to give the crystalline (11.5 g, 34.5 mmol, 100%). 
mp 120 °C; [α]20D = -15.5 (c = 1.06, CHCl3); 1H-NMR (300 MHz, CDCl3) δ ppm 0.85 (d, 
J=7.0 Hz, 3 H), 2.29 (s, 3 H), 2.64 (s, 6 H), 2.68 (s, 1 H), 3.44 - 3.55 (m, 1 H), 4.76 (d, J=3.0 
Hz, 1 H), 4.98 (d, J=8.5 Hz, 1 H), 6.94 (s, 2 H), 7.20 - 7.32 (m, 5 H); 13C-NMR (75 MHz, 
CDCl3) δ ppm 14.6, 20.9, 23.0, 54.7, 75.7, 126.0, 127.7, 128.4, 132.0, 134.4, 139.0, 140.4, 
142.3. 
To a stirred solution of N-((1R,2S)-1-hydroxy-1-phenylpropan-2-yl)-2,4,6-trimethyl 
benzenesulfonamide (4.20 g, 12.6 mmol, 1 eq) in DMF (50 mL) was added t-BuOK (1.41 g, 
12.6 mmol, 1 eq) at room temperature. After 20 min, benzyl bromide (1.50mL, 12.6 mmol, 1 
eq) was added. The reaction mixture was stirred at room temperature for 3 h and water (170 
mL) was added. The mixture was extracted with CH2Cl2 (5x50 mL). The combined organic 
layers were dried over Na2SO4 and concentrated in vacuum. The residue was purified by 
column chromatography on silica gel (hexanes / EtOAc = 4:1) to give the alcohol (5.07 g, 
12.0 mmol, 95%) as a white solid. 
Rf = 0.47 (hexanes / EtOAc = 4:1); m.p. 125 °C; [α]20D = -7.9 (c = 0.81, CHCl3); 1H-NMR 
(300 MHz, CDCl3) ppm 1.03 (d, J=7.0 Hz, 3H), 2.16 (d, J=2.8 Hz, 1H), 2.28 (s, 3H), 2.64 (s, 
6H), 3.84 (dq, J=1.9 Hz, J=5.3 Hz, 1H), 4.55 (A of ABq, JAB=16.0, 1H), 4.77 (B of ABq, 
JAB=16.2, 1H), 4.99 (s, 1H), 6.93 (s, 2H), 7.03 - 7.10 (m, 2H), 7.15 - 7.36 (m, 8H); 13C-NMR 
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(75 MHz, CDCl3) δ ppm 10.0, 20.9, 23.0, 49.2, 59.8, 76.7, 125.6, 127.3, 127.4, 127.8, 128.2, 
128.6, 132.2, 133.6, 138.7, 140.2, 142.2, 142.6. 
To a solution of N-benzyl-N-((1R,2S)-1-hydroxy-1-phenylpropan-2-yl)-2,4,6-trimethyl 
benzenesulfonamide (4.56 g, 10.8 mmol, 1 eq) and pyridine (1.13 mL, 14.0 mmol, 1.3 eq) in 
CH2Cl2 (60 mL) was added propionyl chloride (1.14 mL, 13.0 mmol, 1.2 eq) at 0 °C. The 
reaction was stirred at room temperature for 15 h and diluted with diethyl ether (100 mL). The 
mixture was washed with 30 mL each of water, 1 M HCl, water, saturated aqueous Na2CO3 
and saturated aqueous NaCl and dried over Na2SO4. The organic solution was concentrated to 
give a crystalline, which was purified by column chromatography on silica gel (hexanes / 
EtOAc = 10:1) to give the ester (5.16 g, 10.8 mmol, ~100%) as a white solid. 
Rf = 0.31 (hexanes / EtOAc = 10:1); m.p. 143 °C; [α]20D = +9.0 (c = 1.10, CHCl3); 1H-NMR 
(300 MHz, CDCl3) ppm 1.02 (t, J= 7.5 Hz, 3H), 1.13 (d, J= 7.0 Hz, 3H), 2.14 (m, 2H), 2.27 (s, 
3H), 2.52 (s, 6H), 4.06 (dq, J= 4.1, 6.9 Hz, 1H), 4.60 (A of ABq, JAB=16.8, 1H), 4.72 (B of 
ABq, JAB=16.6, 1H), 5.85 (d, , J= 4.0 Hz, 1H), 6.87 (s, 2H), 6.90-6.94 (m, 2H), 7.14-7.34 (m, 
8H); 13C-NMR (75 MHz, CDCl3) δ ppm 8.8, 12.8, 20.9, 23.0, 27.5, 48.2, 56.8, 78.0, 126.0, 
127.1, 127.4, 127.8, 128.4, 132.2, 133.5, 138.7, 140.2, 142.5, 172.6; HRMS calculated for 
C30H36N2O4SNa [M+CH3CN+Na]+: 543.2293, found: 543.2300. The spectroscopic data were 
in agreement to those previously reported.3 
 
Dess-Martin periodinane 136 
 
I
CO2H
O
I
HO O
O
O
I
O
OAc
AcO OAc..
C13H13IO8
Exact Mass: 423,9655
Mol. Wt.: 424,142  
 
2-Iodobenzoic acid (100 g, 0.403 mol, 1.0 eq.) was added to a suspesion of Oxone (362 g, 
0.589 mol, 1.4 eq.) in water (1.3 L) in a 2 L flask. The reaction mixture was warmed to 70 °C 
and stirred at this temperature for 3 h. The suspension was then cooled to 5 °C and left at this 
temperature for 2 h with slow stirring. The mixture was filtered through a medium porosity 
sintered-glass funnel, and the solid was repeatedly rinsed with water (7 × 150 mL) and 
                                                 
3 Inoue, T.; Liu, J.-F.; Buske, D. C.; Abiko, A. J. Org. Chem. 2002, 67, 5250-5256. 
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acetone (2 × 150 mL). The white, crystalline solid was left to dry at rt for 16 h and weighed 
98.7 g (87%).4 
l-Hydroxy-1,2-benziodoxol-3(lH)-one (98.7 g, 0.352 mol, 1.0 eq.) was added to a 1 L flask 
containing Ac2O (399 mL, 4.22 mol, 12 eq.) and TsOH.H2O (536 mg, 2.82 mmol, .008 eq.). 
The reaction mixture was warmed to 80 °C and stirred at this temperature for 2 h and then 
cooled in an ice-water bath. The cold mixture was filtered through a fritted glass funnel 
followed by rinsing with anhydrous ether (5 × 50 mL). The resulting white, crystalline solid 
(127 g, 85%) was dried in vacuo.5 
1H NMR (300 MHz, CDCl3) δ = 1.98 (s, 6H), 2.31 (s, 3H), 7.89 (m, 1H), 8.06 (m, 1H), 8.28 
(m, 2H); 13C NMR (75 MHz, CDCl3) δ = 20.3, 20.4, 126.0, 126.5, 131.8, 133.8, 135.7, 142.3, 
166.1, 174.0, 175.7. The spectroscopic data were in agreement to those previously reported.6 
 
3,4-dimethoxybenzyl 2,2,2-trichloroacetimidate 208 
 
O CCl3
NH
OMe
OMe
C11H12Cl3NO3
Exact Mass: 310,9883
Mol. Wt.: 312,5769  
 
A solution of 3,4-dimethoxybenzyl alcohol (5.00 g, 29.7 mmol, 1.0 eq.) in tetrahydrofuran 
(6.0 mL) was slowly added to a suspension of sodium hydride (60% dispersion in oil) (238 
mg, 6.00 mol, 0.2 eq.) in tetrahydrofuran (6.0 mL). The solution was then cooled to 0 °C and 
trichloroacetonitrile (3.50 mL, 35.0 mmol, 1.2 eq.) was added dropwise. The mixture was 
stirred for 1 h at 0 °C and 2 h at room temperature. Pentane (10 mL) containing methanol (0.2 
mL) was added followed by activated carbon. The mixture was stirred for 1 h before being 
filtered through celite. The celite was then washed with pentane. The organic phase was 
concentrated under reduced pressure affording the trichloroacetimidate, which was used 
without further purification (6.57 g, 21.0 mmol, 71%). 
                                                 
4 Frigerio, M.; Santagostino, M.; Sputore, S. J. Org. Chem. 1999, 64, 4537-4538. 
5 Ireland, R. E.; Liu, L. J. Org. Chem. 1993, 58, 2899-2899. 
6 Dess, D. B.; Martin, J. C. J. Am. Chem. Soc. 1991, 113, 7277. 
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Rf = 0.48 (hexanes / EtOAc = 6:1); 1H NMR (300 MHz, CDCl3) δ = 3.87 (s, 6H), 5.27 (s, 2H), 
6.85 (d, J = 7.9 Hz, 1H), 6.98 (m, 2H), 8.36 (s, 1H); 13C NMR (75 MHz, CDCl3) δ = 55.9, 
70.8, 111.0, 111.3, 120.7, 127.9, 194.0, 194.1, 162.5. The spectroscopic data were in 
agreement to those previously reported.7 
 
4-(bromomethyl)-1,2-dimethoxybenzene 204 
 
OMe
OMe
Br
C9H11BrO2
Exact Mass: 229,9942
Mol. Wt.: 231,0864  
 
To a solution of 3,4-dimethoxybenzyl alcohol (5.00 g, 29.8 mmol) in CH2Cl2 (125 mL) was 
added PPh3 (9.40 g, 35.7 mmol) and N-bromosuccinimide (5.80 g, 32.7 mmol), and the 
resulting mixture was stirred for 1 h at room temperature. The reaction volume was then 
reduced by evaporation and directly passed through a silica gel column (eluent, CH2Cl2) to 
afford bromide (5.30 g, 22.9 mmol, 77%) as white crystals. 
1H NMR (300 MHz, CDCl3) δ = 3.86 (s, 3H), 3.88 (s, 3H), 4.49 (s, 2H), 6.79 (d, J = 8.1 Hz, 
1H), 6.92 (m, 2H); 13C NMR (75 MHz, CDCl3) δ = 34.4, 55.9, 111.1, 112.1, 121.6, 130.3, 
149.1, 149.3. The spectroscopic data were in agreement to those previously reported.8 
 
                                                 
7 Gea, A.; Farcy, N.; Roqué i Rossell, N.; Martins, J. C.; De Clercq, P. J.; Madder, A. Eur. J. 
Org. Chem. 2006, 4135–4146. 
8 (a) Charlton, J. L.; Alauddin, M. M. J. Org. Chem. 1986, 51, 3490-3493. (b) Torrado, A.; 
Imperiali, B. J. Org. Chem. 1996, 61, 8940-8948. 
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(S)-2-Benzoyloxypentan-3-one 20 
 
OEt
HO
O
N
HO
O
Me
OMe BzO
O
C12H14O3
Exact Mass: 206,0943
Mol. Wt.: 206,2378  
 
To a cooled (-20 °C) mixture of ethyl (S)-lactate (20.0 g, 0.169 mol, 1.0 eq.) and 
MeON(Me)H·HCl (41.0 g, 0.420 mol, 2.5 eq.) in THF (150 mL), was added a 2 M solution of 
i-PrMgCl in Et2O (0.420 L, 0.84 mol, 4.9 eq.) dropwise over 30 min. The reaction mixture 
was stirred at –20 °C for 30 min and at 0 °C for a further 30 min before satd aq NH4Cl 
solution (300 mL) was added. The mixture was extracted with Et2O (4 × 50 mL), followed by 
CH2Cl2 (4 × 50 mL). The combined organic extracts were dried (MgSO4), concentrated in 
vacuo, and the residue purified by by distillation to give the amide (19.1 g, 0.144 mol, 85%) 
as a colourless oil. 
To a cooled (0 °C) solution of amide XX (10.0 g, 75.0 mmol, 1.0 eq.) in THF (100 mL) was 
added a 3 M solution of EtMgBr in Et2O (80 mL, 240 mmol, 3.2 eq.) and the reaction mixture 
was allowed to warm to r.t. After 1 h, satd aq NH4Cl solution (100 mL) was added and the 
mixture was extracted with Et2O (80 mL) followed by CH2Cl2 (3 × 20 mL). The combined 
organic extracts were dried (MgSO4) and concentrated to ca. 50 mL. To this solution was 
added Bz2O (25.5 g, 113 mmol, 1.5 eq.), DMAP (1.0 g, 8.2 mmol, 0.1 eq.) and i-Pr2NEt (25 
mL, 143 mmol, 144 mmol, 1.9 eq.). After stirring for 14 h, excess Bz2O was removed by 
addition of ethylenediamine (5.00 g, 83.0 mmol, 1.1 eq.). H2O (120 mL) was added, the 
mixture extracted with Et2O (4 × 30 mL), then the organic extracts were dried (MgSO4) and 
concentrated to an oil. Column chromatography (hexanes / EtOAc = 4:1) afforded the ethyl 
ketone (11.8 g, 76%) as a colourless oil. 
[α]20D = +25.1 (c = 4.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ = 1.08 (t, J = 7.2 Hz, 3H), 
1.52 (d, J = 7.0 Hz, 3H), 2.58 (m, 2H), 5.34 (q, J = 7.0 Hz, 1H), 7.44 (m, 2H), 7.57 (m, 1H), 
8.07 (m, 2H); 13C NMR (75 MHz, CDCl3) δ = 7.2, 16.5, 31.5, 75.1, 128.5, 129.5, 129.8, 133.4, 
165.9, 208.5. The spectroscopic data were in agreement to those previously reported.9 
 
                                                 
9 Paterson, I.; Wallace, D. J.; Cowden, C. J. Synthesis 1998, 639-652. 
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8.3 Total Synthesis of Archazolids 
8.3.1 Synthesis of alcohol 64a for the C3-C13 subunit 
4-(4-methoxybenzyloxy)butan-2-one 61 
 
O
OPMB
C12H16O3
Exact Mass: 208,1099
Mol. Wt.: 208,2536  
 
A solution of CSA (5.53 g, 25.6 mmol, 0.06 eq.) in CH2Cl2 (360 ml) was treated with 
acetone-aldol (4-hydroxybutan-2-on (35.1 g, 398 mmol, 1.0 eq.) in CH2Cl2 (100 ml). At 0 °C, 
a solution of 4-methoxybenzyl-2,2,2-trichloroacetimidat (112 g, 397 mmol, 1.o eq.) in CH2Cl2 
(100 ml) was added and the resulting yellow solution was stirred over night. The solution was 
washed with sat. aqueous NaHCO3 (700 mL) and the aqueous phase was extracted with Et2O 
(2 × 600 ml). The combined organic phases were washed with sat. aqueous NaHCO3 (350 mL) 
and with brine (350 mL). The organic phase was dried (MgSO4) and the solvent evaporated in 
vacuo. The yellow residue was suspended in petroleum ether (50 mL) and the white 
precipitate was removed by filtration. Removal of the solvent in vacuo and silica gel 
chromatography (PE/EtOAc = 3:1) afforded the PMB-protected ketone (63.9 g, 77%) as a 
colorless oil.  
Rf = 0.44 (hexanes / EtOAc = 7:3); 1H NMR (400 MHz, CDCl3) δ = 2.18 (s, 3H), 2.70 (t, J = 
6.3 Hz, 2H), 3.72 (t, J = 6.3 Hz, 2H), 3.81 (s, 3H), 4.45 (s, 2H), 6.88 (d, J = 8.7 Hz, 2H), 7.25 
(d, J = 8.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ = 30.4, 43.8, 55.3, 65.0, 72.9, 113.8, 
129.3, 130.1, 159.3, 207.2. The spectroscopic data were in agreement to those previously 
reported.10 
 
 
 
 
 
                                                 
10 Rai, N. A.; Basu, A. Tetrahedron Lett. 2003, 44, 2267-2270. 
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(E)-methyl 5-(4-methoxybenzyloxy)-3-methylpent-2-enoate 63 
 
O OPMB
MeO
C15H20O4
Exact Mass: 264,1362
Mol. Wt.: 264,3169  
 
To a cooled (0 °C), stirred solution of the trimethyl phosphonoacetate (9.11 g, 50.0 mmol, 
1.25 eq.) in THF (100 mL) was added potassium bis(trimethylsilyl)amide solution (~0.5 M in 
toluene, 100 mL, 50.0 mmol, 1.25 eq) in a period of 15 min. The mixture was stirred for 
20 min at 0  °C, 30 min at ambient temperature and a solution of 4-(4-methoxybenzyloxy)-
butan-2-one (8.33 g, 40.0 mmol, 1.0 eq.) in THF (25 mL) was added. After stirring for 19 h at 
ambient temperature, the reaction mixture was quenched with saturated aqueous NaCl (600 
mL). The organic layer was separated and the aqueous layer was extracted with CH2Cl2 (3 × 
100 mL). The combined organic layers were dried over MgSO4, filtered and concentrated in 
vacuo. The residue was purified by column chromatography on silica gel (hexanes / Et2O = 
7:3) to give 6.52 g (24.7 mmol, 62%) of the desired ester (E/Z = 2:1) as a colourless oil.  
Rf = 0.57 (hexanes / Et2O = 7:3); 1H NMR (300 MHz, CDCl3) δ = 2.16 (s, 3H), 2.42 d(t, J = 
6.6, 1.1 Hz, 2H), 3.56 (t, J = 6.6 Hz, 2H), 3.67 (s, 3H), 3.79 (s, 3H), 4.43 (s, 2H), 5.71 (m, 
1H), 6.86 (m, 2H), 7.23 (m, 2H); 13C NMR (75 MHz, CDCl3) δ = 19.0, 40.8, 50.8, 55.3, 67.5, 
72.7, 113.9, 116.6, 129.3, 130.3, 157.0, 159.3, 167.0. 
 
(E)-5-(4-methoxybenzyloxy)-3-methylpent-2-en-1-ol 64a 
 
OPMB
HO
C14H20O3
Exact Mass: 236,1412
Mol. Wt.: 236,3068  
 
To a stirred solution (-78 °C) of the respective ester (10.8 g, 40.9 mmol, 1.0 eq.) in CH2Cl2 
(160 mL) was added DIBAL-H (122.4 mL, 1M in n-hexane, 122.4 mmol, 3.0 eq.). After 1 h, 
Et2O (160 mL) was added and the mixture was allowed to warm to room temperature. 
Dropwise addition of water (16 mL) led to the formation of a colourless gel. Upon addition of 
aqueous 2N NaOH (26 mL) and additional water (16 mL), a white solid precipitates. The 
resulting suspension was dried with MgSO4. The mixture was filtered and the solvent was 
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evaporated in vacuo to afford the alcohol as a E/Z mixture (2:1) (8.85 g, 37.5 mmol, 96%). 
The mixture was separated by column chromatography on silica gel (CH2Cl2 / Et2O = 8:3) to 
give the E configurated alcohol (5.17 g, 21.9 mmol, 54%) as a colourless oil.  
Rf = 0.45 (CH2Cl2 / Et2O = 8:3); 1H NMR (300 MHz, CDCl3) δ = 1.67 (s, 3H), 2.32 (t, J = 
6.8 Hz, 2H), 3.53 (t, J = 6.9 Hz, 2H), 3.79 (s, 3H), 4.13 (d, J = 6.8 Hz, 2H), 4.43 (s, 2H), 5.44 
(m, 1H), 6.86 (d, J = 8.7 Hz, 2H), 7.24 (d, J = 8.9 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ = 
16.5, 39.5, 55.3, 59.3, 68.3, 72.5, 113.8, 125.1, 129.3, 130.5, 136.7, 159.2; MS (EI) calculated 
for C14H20O3: 236.1, found: 236.2. The spectroscopic data were in agreement to those 
previously reported.11 
(Z)-5-(4-methoxybenzyloxy)-3-methylpent-2-en-1-ol: Rf = 0.58 (CH2Cl2 / Et2O = 8:3); 1H 
NMR (300 MHz, CDCl3) δ = 1.72 (s, 3H), 2.37 (t, J = 6.2 Hz, 2H), 3.49 (t, J = 6.0 Hz, 2H), 
3.78 (s, 3H), 3.98 (d, J = 7.5 Hz, 2H), 4.43 (s, 2H), 5.68 (t, J = 7.6 Hz, 1H), 6.86 (d, 
J = 8.8 Hz, 2H), 7.22 (d, J = 8.7 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ = 16.5, 39.5, 55.3, 
59.3, 68.3, 72.5, 113.8, 125.1, 129.3, 130.5, 136.7, 159.2. 
 
8.3.2 Synthesis of the C14-C19 Subunit 
8.3.2.1 Plan 1: Evans anti Aldol Reaction 
(E)-3-iodo-2-methylprop-2-en-1-ol 90 
 
I OH
C4H7IO
Exact Mass: 197,9542
Mol. Wt.: 198,0023  
 
A suspension of Cp2ZrCl2 (4.25 g, 14.5 mmol, 1.0 eq.) in CH2Cl2 (60 mL) was treated at 0 °C 
with trimethylaluminum (2.0 M in toluene, 21.8 mL, 43.5 mmol, 3.0 eq) followed by addition 
of a solution of prop-2-yn-1-ol (815 mg, 14.5 mmol, 1.0 eq.) in CH2Cl2 (5 mL). The reaction 
mixture was stirred at room temperature for 24 h and then cooled down to -30 °C. A solution 
of I2 (4.77 g, 18.8 mmol, 1.3 eq) in THF (40 mL) was added, and the mixture was stirred for 
30 min at -30 °C and then allowed to warm to -10 °C. the reaction mixture was quenched by 
                                                 
11 Nagano, H.; Nakanishi, E.; Takajo, S.; Sakuma, M.; Kudo, K. Tetrahedron. 1999, 55, 2591-
2608. 
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addition of saturated aqueous NaHCO3 (100 mL) at -30 °C. The layers were separated, and 
the aqueous layer was extracted with Et2O (3 × 20 mL). The combined extract was dried over 
MgSO4 and concentrated in vacuo. The residue was purified by column chromatography on 
silica gel (pentane / Et2O = 4:1) to give the alcohol (618 mg, 3.12 mmol, 22%) as a light 
yellow oil. Rf = 0.18 (pentane / Et2O 4:1); 1H NMR (300 MHz, CDCl3) δ = 1.81 (s, 1H), 1.83 
(s, 3H), 4.10 (d, J = 1.3 Hz, 2H), 6.26 (m, 1H); 13C NMR (75 MHz, CDCl3) δ = 21.3, 67.2, 
77.3, 147.2. The spectroscopic data were identical to those previously reported.12 
 
tert-butyldimethyl(prop-2-ynyloxy)silane 84 
 
OTBDMS
C9H18OSi
Exact Mass: 170,1127
Mol. Wt.: 170,3241  
 
To a solution of the alcohol (1.43 g, 25.5 mmol, 1.0 eq.) in abs. THF (50 mL) was added 
TBSCl (9.61 g, 63.8 mmol, 2.5 eq.), imidazol (6.07 g, 89.3 mmol, 3.5 eq.) and DMAP (318 
mg, 2.60 mmol, 0.1 eq). The reaction mixture was stirred at RT for 120 min. Sat. aq. NaHCO3 
(50 mL) were added, the organic phase separated, and the aq. phase thoroughly extracted with 
DCM (3 x 20 mL). The combined organic extracts were dried over MgSO4 and concentrated 
in vacuo. After flash chromatography (hexanes / Et2O = 30:1) the TBS-ether (3.55 g, 20.8 
mmol, 82%) was obtained as colourless oil. 
Rf = 0.71 (hexanes / Et2O = 30:1); 1H NMR (300 MHz, CDCl3) δ = 0.12 (s, 6H), 0.90 (s, 9H), 
2.37 (t, J = 2.4 Hz, 1H), 4.30 (d, J = 2.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ = -5.2, 18.3, 
25.8, 51.5, 72.8, 82.5. 
 
tert-butyldiphenyl(prop-2-ynyloxy)silane 85 
 
OTBDPS
C19H22OSi
Exact Mass: 294,144
Mol. Wt.: 294,4629  
 
                                                 
12 White,J. D.; Blakemore, P. R.; Green, N. J.; Hauser, E. B.; Holoboski, M. A.; Keown, L. E.; 
Nylund Kolz, C. S.; Phillips, B. W. J. Org. Chem. 2002, 67, 7750-7760. 
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To a solution of the alcohol (561 mg, 10.0 mmol, 1.0 eq.) and imidazol (886 mg, 13.0 mmol, 
1.3 eq.) in abs. DCM (10 mL) was added TBDPSCl (2.76 g, 10.0 mmol, 1.0 eq.) at 0 °C. The 
reaction mixture was warmed to RT and stirred for 30 min. Sat. aq. NaHCO3 (20 mL) were 
added, the organic phase separated, and the aq. phase thoroughly extracted with DCM (3 x 15 
mL). The combined organic extracts were dried over MgSO4 and concentrated in vacuo. After 
flash chromatography (hexanes / Et2O = 30:1) the TBS-ether (2.95 g, 10.0 mmol, 100%) was 
obtained as colourless oil. 
Rf = 0.61 (hexanes / Et2O = 30:1); 1H NMR (300 MHz, CDCl3) δ = 1.07 (s, 9H), 2.37 (t, J = 
2.4 Hz, 1H), 4.31 (d, J = 2.4 Hz, 3H), 7.41 (m, 6H), 7.71 (m, 4H); 13C NMR (75 MHz, CDCl3) 
δ = 19.2, 26.7, 52.5, 73.0, 82.1, 127.8, 129.9, 133.0, 135.6. 
 
(R)-4-benzyl-3-((2S,3R,E)-3-hydroxy-5-iodo-2,4-dimethylpent-4-enoyl)oxazolidin-2-one 
92 
 
NO
O O
Bn
I
OH
C17H20INO4
Exact Mass: 429,0437
Mol. Wt.: 429,2495  
 
To a stirred solution of (E)-3-iodo-2-methylprop-2-en-1-ol (216 mg, 1.09 mmol, 1.0 eq.) in 
Et2O (5 mL) was added MnO2 (1.42 g, 16.3 mmol, 15 eq.) at room temperature. The resulting 
suspension was stirred for 3 h. Then the suspension was filtered and the solvent of the filtrate 
was removed at 40 °C, to give XX in quantitative yield (214 mg, 1.09 mmol), which was used 
without further purification, due to it’s volatility. 
The aldehyde (98.0 mg, 0.500 mmol, 1.0 eq.) was dissolved in EtOAc (2 mL) and added to 
neat propionyl oxazolidinone (175 mg, 7.50 mmol, 1.5 eq.). The reaction mixture was then 
treated at rt with anhydrous MgCl2 (48.0 mg, 0.504 mmol, 1.0 eq.), Et3N (174 μL, 1.25 mmol, 
2.5 eq.), and TMSCl (128 μL, 1.00 mmol, 2.0 eq.). After stirring for 52 h, the reaction mixture 
was filtered through a silica plug (Et2O) and the filtrate was concentrated under reduced 
pressure. The residual oil was dissolved in MeOH (3 mL), treated with TFA (1 drop) and 
stirred for 10 min. Toluene (3 mL) was added and the reaction mixture was concentrated 
under reduced pressure. Purification of the crude product by column chromatography on silica 
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gel (hexanes / EtOAc, gradient elution, 9:1 to 4:1) afforded aldol product (62.0 mg, 0.144 
mmol, 29%) as a white solid.  
Rf = 0.28 (hexanes / EtOAc = 4:1); [α]20D = -37.0 (c = 1.41, CHCl3); 1H-NMR (300 MHz, 
CDCl3) δ = 1.11 (d, J = 7.0 Hz, 3H), 1.88 (s, 3H), 2.77 (dd, J = 13.5, 9.4 Hz, 1H), 3.05 (d, J = 
7.1 Hz, 1H), 3.27 (dd, J = 13.5, 3.3 Hz, 1H), 4.18 (m, 3H), 4.33 (t, J = 7.9 Hz, 1H), 6.48 (m, 
1H), 6.39 (s, 3H), 7.22 (m, 2H), 7.28 (m, 1H), 7.33 (m, 2H); 13C-NMR (75 MHz, CDCl3) δ = 
14.7, 19.4, 37.8, 40.4, 55.5, 66.2, 79.8, 80.8, 127.4, 129.0, 129.5, 135.1, 147.5, 153.7, 176.0; 
HRMS calculated for C17H19INO4 [M]-: 428.0359, found: 428.0360. 
 
8.3.2.2 Plan 2: Noyori’s asymmetric transfer hydrogenation 
(R)-methyl 3-(tert-butyldimethylsilyloxy)-2-methylpropanoate 99 
 
MeO OTBS
O
C11H24O3Si
Exact Mass: 232,1495
Mol. Wt.: 232,392  
 
To a solution of (R)-methyl 3-hydroxy-2-methylpropanoate (510 mg, 4.32 mmol, 1.0 eq.) in 
THF (30 mL) was added TBS-Cl (1.63 g, 10.8 mmol, 2.5 eq.), imidazole (1.47 g, 21.6 mmol, 
5.0 eq.) and DMAP (50.0 mg, 0.41 mmol, 0.1 eq.). The reaction mixture was stirred at room 
temperature for 1.5 h. Sat. aq. NaHCO3 (30 mL) were added, the organic phase separated, and 
the aq. phase thoroughly extracted with Et2O (3 × 20 mL). The combined organic extracts 
were dried over MgSO4 and concentrated in vacuo. Flash chromatography (hexanes / EtOAc 
= 10:1) gave the TBS-ether (888 mg, 3.82 mmol, 88%) as colourless oil. 
Rf = 0.71 (hexanes / EtOAc = 10:1); 1H NMR (300 MHz, CDCl3) δ = 0.02 (s, 6H), 0.86 (s, 
9H), 1.13 (d, J = 7.2 Hz, 3H), 2.63 (m, 1H), 3.64 (dd, J = 9.7, 6.9 Hz, 1H), 3.66 (dd, J = 9.6, 
6.0 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ = -5.5, 13.5, 18.2, 25.8, 42.6, 51.5, 65.3, 175.5; 
The spectroscopic data were in agreement to those previously reported.13 
 
 
 
                                                 
13 Mori, K.; Koseki, K. Tetrahedron 1988, 44, 6013-6020. 
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(R)-methyl 3-(tert-butyldiphenylsilyloxy)-2-methylpropanoate 100 
 
MeO
O
OTBDPS
C21H28O3Si
Exact Mass: 356,1808
Mol. Wt.: 356,5307  
 
To a solution of (R)-methyl 3-hydroxy-2-methylpropanoate (1.75 g, 14.8 mmol, 1.0 eq.) and 
imidazole (1.31 g, 19.2 mmol, 1.3 eq.) in DCM (15 mL) was added TBSCl (4.08 g, 14.8 
mmol, 1.0 eq.) at 0 °C. The reaction mixture was warmed up to r.t. and stirred for 30 min. Sat. 
aq. NaHCO3 (40 mL) were added, the organic phase separated, and the aq. phase thoroughly 
extracted with DCM (3 × 20 mL). The combined organic extracts were dried over MgSO4 and 
concentrated in vacuo. Flash chromatography (hexanes / EtOAc = 20:1) gave the TBS-ether 
(5.16 g, 14.5 mmol, 98%) as colourless oil. 
Rf = 0.47 (hexanes / EtOAc = 20:1); 1H NMR (400 MHz, CDCl3) δ = 1.03 (s, 9H), 1.15 (d, J 
= 7.1 Hz, 3H), 2.71 (m, 1H), 3.67 (s, 3H), 3.72 (dd, J = 9.7, 5.6 Hz, 1H), 3.83 (dd, J = 9.7, 5.7 
Hz, 1H), 7.40 (m, 6H), 7.64 (m, 4H); 13C NMR (100 MHz, CDCl3) δ = 13.5, 19.3, 26.8, 42.5, 
51.5, 66.0, 127.7, 129.7, 133.6, 133.7, 135.6, 175.3; MS (EI) calculated for C21H28O3Si: 
356.2, found: 356.2. The spectroscopic data were in agreement to those previously reported.14 
 
(R)-3-(tert-butyldimethylsilyloxy)-N-methoxy-N,2-dimethylpropanamide 101 
 
N OTBS
O
MeO
C12H27NO3Si
Exact Mass: 261,176
Mol. Wt.: 261,4332  
 
Ester (620 mg, 2.67 mmol, 1.0 eq.) and N,O-Dimethylhydroxylamine hydrochloride (390 mg, 
4.00 mmol, 1.5 eq.) were suspended in THF (10 mL), cooled to -20 °C and treated with 
iPrMgCl (~2 M in Et2O, 4.0 mL, 8.0 mmol, 3.0 eq.) over 5 min to create a homogeneous 
                                                 
14 Smith III, A. B.; Condon, S. M.; McCauley, J. A.; Leahy, J. W.; Leazer, Jr.,J. L.; Maleczka, 
Jr., R. E. Tetrahedron Lett. 1994, 35, 4907-4910. 
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reaction mixture. After stirring at -10 °C for additional 15 min, the reaction was quenched by 
addition of sat. aq. NH4Cl (20 mL). The poducte was extracted into DCM (3 × 10mL), and the 
combined organic layers were dried over MgSO4, concentrated to afford amide (627 mg, 2.40 
mmol, 90%).  
Rf = 0.23 (hexanes / EtOAc = 10:1); 1H NMR (400 MHz, CDCl3) δ = 0.02 (s, 3H), 0.03 (s, 
3H), 0.86 (s, 9H), 1.06 (d, J = 7.1 Hz, 3H), 3.13 (m, 1H), 3.12 (s, 3H), 3.51 (dd, J = 9.7, 6.1 
Hz, 1H), 3.70 (s, 3H), 3.82 (dd, J = 9.7, 8.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = -5.4, 
13.8, 18.3, 25.9, 32.2, 38.2, 61.5, 65.8, 175.2. 
 
(R)-3-(tert-butyldiphenylsilyloxy)-N-methoxy-N,2-dimethylpropanamide 102 
 
N
O
OTBDPS
MeO
C22H31NO3Si
Exact Mass: 385,2073
Mol.r Wt.: 385,5719  
 
Ester (3.65 g, 10.2 mmol, 1.0 eq.) and N,O-Dimethylhydroxylamine hydrochloride (1.47 g, 
15.1 mmol, 1.5 eq.) were suspended in THF (40 mL), cooled to -20 °C and treated with 
iPrMgCl (~2 M in Et2O, 15.0 mL, 30.0 mmol, 3.0 eq.) over 15 min to create a homogeneous 
reaction mixture. After stirring at -10 °C for additional 15 min, the reaction was quenched by 
addition of sat. aq. NH4Cl (100 mL). The producte was extracted into DCM (3 × 10 mL), and 
the combined organic layers were dried over MgSO4, concentrated in vacuo. Flash 
chromatography (hexanes / EtOAc = 4:1) gave the amide (3.66 g, 9.49 mmol, 93%) as white 
solid. 
Rf = 0.37 (hexanes / EtOAc = 4:1); ); 1H NMR (300 MHz, CDCl3) δ = 1.03 (s, 9H), 1.08 (d, J 
= 7.1 Hz, 3H), 3.19 (m, 1H), 3.19 (s, 3H), 3.59 (dd, J = 9.6, 6.2 Hz, 1H), 3.65 (s, 3H), 3.93 
(dd, J = 9.5, 8.0 Hz, 1H), 7.39 (m, 6H), 7.66 (m, 4H); 13C NMR (75 MHz, CDCl3) δ = 13.8, 
19.2, 26.8, 32.2, 38.1, 61.5, 66.3, 127.6, 129.6, 133.6, 133.8, 135.6, 176.0; HRMS calculated 
for C22H31NO3SiNa [M+Na]+: 408.1971, found: 408.1973. 
 
 
 
 
(R)-5-(tert-butyldiphenylsilyloxy)-4-methylpent-1-yn-3-one 105 
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O
H
OTBDPS
C22H26O2Si
Exact Mass: 350,1702
Mol. Wt.: 350,5261  
 
To a solution of amide (426 mg, 1.10 mmol, 1.0 eq.) in THF (10 mL) was added Lithium 
acetylide ethylenediamine complex (254 mg, 2.76 mmol, 2.5 eq.) at 0 °C. The reaction 
mixture was stirred for 60 min at room temperature. H2O (10 mL) were added, the organic 
phase separated, and the aq. phase thoroughly extracted with DCM (3 × 10 mL). The 
combined organic extracts were dried over MgSO4 and concentrated in vacuo. Flash 
chromatography (hexanes / Et2O = 30:1) gave ketone (100 mg, 0.285 mmol, 26%) as 
colourless oil. 
Rf = 0.29 (hexanes / Et2O = 20:1); ); 1H NMR (300 MHz, CDCl3) δ = 1.03 (s, 9H), 1.18 (d, J = 
7.0 Hz, 3H), 2.83 (m, 1H), 3.16 (s, 1H), 3.89 (m, 2 H), 7.39 (m, 6H), 7.65 (m, 4H); 13C NMR 
(75 MHz, CDCl3) δ = 12.7, 19.7, 27.1, 51.4, 65.5, 79.5, 81.1, 128.1, 130.1, 133.6, 136.0, 
189.9. 
 
(6R,11R)-2,2,6,11,15,15-hexamethyl-3,3,14,14-tetraphenyl-4,13-dioxa-3,14-isilahexadec-
8-yne-7,10-dione 104 
 
O
TBDPS
OTBDPS
C38H44O2Si2
Exact Mass: 588,288
Mol. Wt.: 588,9258  
 
Ketone 104 (66.8 mg, 0.113 mmol, 10%) was as colourless oil. 
Rf = 0.39 (hexanes / Et2O = 20:1); 1H NMR (300 MHz, CDCl3) δ = 1.02 (s, 9H), 1.11 (s, 9H), 
1.24 (d, J = 7.0 Hz, 3H), 2.91 (m, 1H), 3.90 (m, 1H), 4.01 (m, 1 H), 7.37 (m, 12H), 7.64 (dd, J 
= 7.9, 1.5 Hz, 4H), 7.74 (dd, J = 7.8, 16 Hz, 4H); 13C NMR (75 MHz, CDCl3) δ = 12.8, 18.7, 
19.3, 26.8, 27.0, 51.3, 65.4, 94.2, 104.6, 127.7, 128.0, 129.7, 130.0, 131.5, 133.3, 135.6, 189.5; 
HRMS calculated for C38H48NO2Si2 [M+NH4]+: 606.3224, found: 606.3214. 
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(R)-5-(tert-butyldiphenylsilyloxy)-4-methyl-1-(trimethylsilyl)pent-1-yn-3-one 106 
 
O
TMS
OTBDPS
C25H34O2Si2
Exact Mass: 422,2097
Mol. Wt.: 422,7073  
 
To a stirred solution of trimethylsilylacetylene (0.17 mL, 1.2 mmol, 1.2 eq) in anhydrous THF 
(4 mL) at -78 °C, a solution of nBuLi in hexanes (0.94 mL, 1.5 mmol, 1.5 eq) were added 
dropwise. After stirring for 30 min, a solution of amide (386 mg, 1.00 mmol, 1.0 eq) in 
anhydrous THF (5 mL) was dropwise added and the mixture was allowed to warm to room 
temperature. After 3 h, pH 7 phosphate buffer (10 mL) was slowly added via cannula and the 
mixture was partitioned with diethyl ether (3 × 10 mL). The organic layer was dried over 
MgSO4, filtered and carefully concentrated in vacuo. The crude which was purified by a short 
flash chromatography (hexanes / Et2O = 20:1) to yield 165 mg (0.390 mmol, 39%) of (R)-5-
(tert-butyldiphenylsilyloxy)-4-methyl-1-(trimethylsilyl)pent-1-yn-3-one as a colourless oil. 
Rf = 0.52 (hexanes / Et2O = 20:1); 1H NMR (400 MHz, CDCl3) δ = 0.22 (s, 9H), 1.03 (s, 9H), 
1.17 (d, J = 6.6 Hz, 3H), 2.82 (m, 1H), 3.88 (m, 2H), 7.40 (m, 6H), 7.65 (m, 4H); 13C NMR 
(100 MHz, CDCl3) δ = -0.7, 12.6, 19.4, 26.8, 50.8, 65.5, 98.7, 101.4, 127.7, 129.7, 133.4, 
135.6, 190.1. 
 
8.3.2.3 Plan 3: Abiko-Masamune anti Aldol Reaction 
(E)-3-Iodo-2-methylacrylic acid 113 
 
CO2H
I
Me
C4H5IO2
Exact Mass: 211,9334
Mol. Wt.: 211,9858  
 
A solution of diethyl methylmalonate (33.2 g, 0.190 mol, 1.0 eq) in Et2O (60 mL) was added 
to NaH (55-65% in mineral oil, 9.21 g, 0.230 mol, 1.2 eq) in Et2O (120 mL) during 40 min 
with vigorous stirring and the resulting mixture was refluxed for 3 h. After being cooled to 
ambient temperature, CHI3 (75.0 g, 0.190 mol, 1 eq) was added during 30 min and the 
Experimental Section 126
mixture was refluxed for 32 h. At 0 °C 10% aqueous HCl (100 mL) was added and the 
mixture stirred for 20 min. The organic layer was separated and the aqueous layer was 
extracted with Et2O (3 × 30 mL). The combined organic layers were dried over MgSO4 and 
concentrated in vacuum. The residue was dissolved in EtOH/H2O (3:1, 520 mL) and KOH 
(28.1 g, 0.500 mol) was added. The mixture was refluxed for 24 h. After being cooled to 
ambient temperature, the mixture was concentrated in vacuum. The residue was redissolved in 
10% aqueous K2CO3 (300 mL) and the precipitated CHI3 was removed by filtration. The 
filtrate was washed with CH2Cl2 (2 × 50 mL) and acidified with 12 M HCl (pH < 1, 130 mL) 
and extracted with CH2Cl2 (8 × 50 mL). The combined organic layers were dried over MgSO4 
and concentrated in vacuum. The residue was purified by column chromatography on silica 
gel (hexanes / EtOAc = 10:1, 0.5% AcOH) to give of the carboxylic acid (31.1 g, 0.147 mol, 
77%, over two steps) as a white solid. 
Rf  = 0.25 (hexanes / EtOAc = 10:1, 0.5% AcOH); mp. 58 °; 1H NMR (300 MHz, CDCl3) δ = 
2.05 (s, 3H), 8.03 (s, 1H), 12.08 (s, 1H); 13C NMR (75 MHz, CDCl3) δ = 19.8, 102.0, 139.0, 
169.2. HRMS calculated for C4H4IO2 [M-H]: 210.9256, found: 210.9254. The spectroscopic 
data were identical to those previously reported.15 
 
(E)-3-iodo-2-methylprop-2-en-1-ol 90 
 
I OH
C4H7IO
Exact Mass: 197,9542
Mol. Wt.: 198,0023  
 
To a cooled (0 °C), stirred solution of the carboxylic acid (5.30 g, 25.0 mmol, 1.0 eq) in Et2O 
(50 mL) was added LiAiH4 (0.950 g, 25.0 mmol, 1.0 eq).in a period of 10 min. The mixture 
was stirred for 4 h at ambient temperature and additional LiAH4 (95.0 mg, 2.50 mmol, 0.1 eq) 
was added and the mixture was stirred for 30 min. The reaction mixture was cooled to 0 °C 
and quenched with saturated aqueous Na2SO4 (1.5 mL). Et2O (30 mL) and 2 M aqueous 
H2SO4 (50 mL) were added. The organic layer was separated and the aqueous layer was 
extracted with CH2Cl2 (3 × 15 mL). The combined organic layers were concentrated in 
vacuum and the remaining oil dissolved in CH2Cl2 (30 mL) and washed with 10% aqueous 
K2CO3 (20 mL). The aqueous layer was extracted with CH2Cl2 (3 × 15 mL). The combined 
                                                 
15 Baker, R.; Castro, J. L. J.Chem. Soc., Perkin Trans. 1 1990, 47. 
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organic layers were dried over MgSO4 and concentrated in vacuum. The residue was purified 
by column chromatography on silica gel (pentane / Et2O = 4:1) to give the alcohol (4.45 g, 
22.5 mmol, 85%) as a light yellow oil. Rf = 0.18 (pentane / Et2O 4:1); 1H NMR (300 MHz, 
CDCl3) δ = 1.81 (s, 1H), 1.83 (s, 3H), 4.10 (d, J = 1.3 Hz, 2H), 6.26 (m, 1H); 13C NMR (75 
MHz, CDCl3) δ = 21.3, 67.2, 77.3, 147.2. spectroscopic data were identical to those 
previously reported.15 
 
(2R,3S,E)-((1R,2S)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl)-3-
hydroxy-5-iodo-2,4-dimethylpent-4-enoate 114 
 
O
Me
Ph
N
O
SO2MesBn
I
OH
 C32H38INO5S
Exact Mass: 675,1515
Mol. Wt.: 675,6173  
 
To a stirred solution of (E)-3-iodo-2-methylprop-2-en-1-ol (4.53 g, 22.9 mmol, 1.0 eq.) in 
CH2Cl2 (50 mL) was added MnO2 (5.92 g, 68.1 mmol, 20 eq.) at room temperature. The 
resulting suspension was stirred for 1 h. Then the suspension was filtered and the solvent of 
the filtrate was removed at 40 °C, to give the aldehyde in quantitative yield (4.49 g, 22.9 
mmol), which was used without further purification, due to it’s volatility. 
In the next step a solution of (1R,2S)-2-(N-benzyl-2,4,6-trimethylphenyl-sulfonamido)-1-
phenylpropyl propionate XX (5.00 g, 10.4 mmol, 1.0 eq.) and NEt3 (3.60 mL, 26.0 mmol, 2.5 
eq.) in CH2Cl2 (80 mL) under argon atmosphere was cooled down to -78 °C. Then 
dicyclohexyl-(trifluoromethylsulfonyloxy)borane (26.0 mL, 1M in n-Hexane, 26.0 mmol, 2.5 
eq.) was added slowly. The resulting mixture was stirred for 5h at -78 °C, before a solution of 
the aldehyde (4.49 g, 22.9 mmol, 2.2 eq.) in 15 mL CH2Cl2  (dried with 3Å molecular siever) 
was added slowly. After further 60 min the reaction mixture was warmed up to room 
temperature (ca. 2h), quenched with pH 7 buffer (50 mL), diluted with MeOH (200 mL) and 
charged with 26 mL of a H2O2-solution, before the mixture was stirred overnight. After that, 
the solvent was removed in vacuo and the residue was dissolved in CH2Cl2 (250 mL). The 
organic layer was washed with H2O, separated and the aqueous phase was reextracted with 
CH2Cl2 (3 × 100 mL). The combined organic layer was dried over Na2SO4, filtered and the 
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solvent was removed in vacuo. The residue was purificated by column chromatography 
(hexanes / EtOAc = 8:1) to give the aldol product as white crystals (6.74 g, 9.98 mmol, 96%). 
Rf = 0.43 (hexanes / EtOAc = 8:1); mp. 72 °C; [α]20D = +38.9 (c = 0.97, CHCl3); 1H NMR 
(300 MHz, CDCl3) δ = 0.95 (d, J = 7.2 Hz, 3H), 1.17 (d, J = 7.0 Hz, 3H), 1.81 (d, J = 1.1 Hz, 
3H), 2.27 (s, 3H), 2.50 (s, 6H), 2.54-2.65 (m, 1H), 2.77 (d, J = 3.8 Hz, 1H, OH), 4.10 (dq, J = 
4.1, 7.0 Hz, 1H), 4.24 (dd, J = 3.4 Hz, 1H), 4.56 (A of ABq, JAB=16.6, 1H), 4.74 (B of ABq, 
JAB=16.6, 1H), 5.85 (d, J = 4.1 Hz, 1H), 6.29 (s, 1H), 6.82-6.85 (m, 2H), 6.87 (s, 2H), 7.13-
7.35 (m, 8H); 13C NMR (75 MHz, CDCl3) δ = 13.4, 14.1, 18.9, 20.9, 23.0, 43.3, 48.3, 56.8, 
78.6, 78.7, 81.2, 125.9, 127.2, 127.6, 128.0, 128.4 128.5, 132.2, 133.4, 138.1, 138.6, 140.3, 
142.6, 146.9, 174.1; HRMS calculated for C32H38INNaO5S: 698.1413, found: 698.1409.  
 
(2R,3S,E)-((1R,2S)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 5-
iodo-3-methoxy-2,4-dimethylpent-4-enoate 115 
 
O
Me
Ph
N
O
SO2MesBn
I
OMe
C33H40INO5S
Exact Mass: 689,1672
Mol. Wt.: 689,6439  
 
To a solution of the alcohol (3.92 g, 5.80 mmol, 1 eq.) in Et2O (40 mL) under argon 
atmosphere were added molecular sieves 3Å (13 g), Ag2O (5.37 mg, 23.2 mmol, 4 eq.) and 
CH3I (4.34 mL, 70.0 mmol, 12 eq.) subsequently. The resulting mixture was stirred for 48 h at 
ambient temperature and filtered through cotton afterwards. The solvent was evaporated and 
the crude product was purificated by column chromatography on silica gel (hexanes / EtOAc 
= 10:1) to receive the desired methyl ether (3.75 g, 5.44 mmol, 94%) as white crystals. 
Rf = 0.36 (hexanes / EtOAc = 15:1); m.p. 76 °C; [α]20D = +44.8 (c = 0.96, CHCl3); 1H NMR 
(300 MHz, CDCl3) δ = 0.88 (d, J= 7.2 Hz, 3H), 1.10 (d, J= 7.0 Hz, 3H), 1.77 (d, J= 0.94 Hz, 
3H), 2.30 (s, 3H), 2.53 (s, 6H), 2.69-2.80 (m, 1H), 3.09 (s, 3H), 3.81 (d, J= 10.2 Hz, 1H,), 
4.02 (dq, J= 4.0, 7.0 Hz, 1H), 4.39 (A of ABq, JAB=16.8, 1H), 4.96 (B of ABq, JAB=16.6, 1H), 
5.70 (d, J= 3.8 Hz, 1H), 6.32 (s, 1H), 6.68-6.73 (m, 2H), 6.93 (s, 2H), 7.11-7.28 (m, 6H); 
7.38-7.41 (m, 2H); 13C NMR (75 MHz, CDCl3) δ = 13.5, 13.8, 18.0, 20.9, 22.9, 43.2, 48.2, 
56.3, 56.8, 78.1, 81.9, 88.5, 125.8, 126.2, 127.0, 127.8, 128.3, 128.4, 132.2, 133.8, 138.4, 
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139.4, 140.4, 142.6, 144.9, 173.6; HRMS calculated for C33H40INNaO5S: 712.1570, found: 
712.1567. 
 
Dimethyl (3E,5E)-6-iodo-3,5-dimethyl-2-oxohexa-3,5-dienylphosphonate 135 
 
P
O
IMeO
O
MeO
C10H16IO4P
Exact Mass: 357,9831
Mol. Wt.: 358,1099  
 
Dimethyl methylphosphonate (30.0 μL, 0.281 mmol, 2.0 eq.) in THF (3 mL) at –78 °C was 
treated with nBuLi (1.6M in hexane, 130 μL, 0.208 mmol, 1.5 eq.). After stirring at -50 °C for 
1.5 h, the mixture was recooled to -78 °C and a solution of the ester (100 mg, 0.145 mmol, 1.0 
eq.) in THF (3 mL) was added. The reaction mixture was stirred at -78 °C for 60 min, and 
then treated with saturated aqueous NH4Cl solution. The organic layer was separated and the 
aqueous layer was extracted with EtOAc (4 × 10 mL). The combined organic layers were 
dried (MgSO4) and concentrated under reduced pressure. Purification by flash 
chromatography (hexanes / EtOAc = 1:1) gave the respective phosphonate (20.8 mg, 55.6 
µmol, 38%). 
Rf = 0.19 (hexanes / EtOAc = 1:1); 1H-NMR (400 MHz, CDCl3) δ = 1.90 (s, 3H), 2.04 (s, 3H), 
3.36 (d, J = 22.4 Hz, 2H), 3.75 (s, 3H), 3.78 (s, 3H), 6.54 (s, 1H), 6.97 (s, 1H); 13C-NMR (75 
MHz, CDCl3) δ = 13.1, 17.9, 42.2, 43.9, 48.5, 53.0, 56.4, 81.7, 89.3, 145.1, 205.; HRMS 
calculated for C10H16IO4PNa [M+Na]+: 380.9729, found: 380.9727. 
 
(2S,3S,E)-5-iodo-3-methoxy-2,4-dimethylpent-4-en-1-ol 133 
 
I OH
OMe
C8H15IO2
Exact Mass: 270,0117
Mol. Wt.: 270,108  
 
A solution of the prepared methyl ether (3.70 g, 5.37 mmol, 1.0 eq.) in Et2O (30 mL) was 
cooled down to 0 °C. Then the solution was treated with LiAlH4 (204 mg, 5.37 mmol, 1.0 eq.) 
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and stirred for 2 h at this temperature, before it was warmed up to room temperature. Then the 
mixture was quenched by addition of a saturated aqueous Na2SO4 solution (20 mL). After this 
the solution was acidified to pH = 2 by addition of 2M H2SO4 (12 mL). The organic layer was 
separated and the aqueous layer was extracted with Et2O (3 × 40 mL). The combined organic 
layer was washed with saturated, aqueous NaHCO3 solution and brine, dried over MgSO4, 
filtered and the solvent was removes under reduced pressure. The residue was purificated by 
flash chromatography on silica gel (pentane / Et2O = 3:1) to give 1.39 g (5.15 mmol, 97%) of 
the desired alcohol as light yellow oil. 
Rf = 0.16 (pentane / Et2O = 3:1); [α]20D = -28.7 (c = 1.48, CHCl3); 1H NMR δ = (400 MHz, 
CDCl3) ppm 0.70 (d, J = 6.6 Hz, 3H), 1.74 (s, 3H), 1.87-1.97 (m, 1H), 3.00 (br s, 1H, OH), 
3.19 (s, 3H), 3.51 (d, J = 9.7 Hz, 1H,), 3.60 (d, J = 5.6 Hz, 2H), 6.21 (s, 1H); 13C-NMR (100 
MHz, CDCl3) δ = 13.6, 18.4, 37.6, 56.4, 67.8, 80.5, 92.6, 146.4; HRMS calculated for 
C8H15IO5: 270.0117, found: 270.0117. 
 
Dimethyl (3R,4S,E)-6-iodo-4-methoxy-3,5-dimethyl-2-oxohex-5-enylphosphonate 118 
 
P(OMe)2
I
O O
MeO
C11H20IO5P
Exact Mass: 390,0093
Mol. Wt.: 390,1517  
 
To a solution of primary alcohol (55.0 mg, 0.204 mmol, 1.0 eq.) in CH2Cl2 (3 mL) at 0 °C was 
added Dess-Martin periodinane (94.0 mg, 0.222 mmol, 1.1 eq.). After stirring for 2 h, the 
reaction mixture was treated with saturated aqueous Na2S2O3 solution and saturated aqueous 
NaHCO3 solution. The organic layer was separated and the aqueous layer was extracted with 
CH2Cl2 (3 × 5 mL). The combined organic layers were dried (MgSO4) and concentrated under 
reduced pressure. 
In a separate flask, dimethyl methylphosphonate (218 μL, 2.04 mmol, 10 eq.) in THF (250 μL) 
at –78 °C was treated with n-BuLi (2.5M in hexane, 816 μL, 2.04 mmol, 10 eq.). After 
stirring for 1 h, the crude aldehyde obtained from the Dess-Martin oxidation was dissolved in 
THF (200 μL) and added to the mixture. The reaction mixture was warmed to 0 °C, stirred for 
15 min, and then treated with saturated aqueous NH4Cl solution. The organic layer was 
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separated and the aqueous layer was extracted with EtOAc (4 × 5 mL). The combined organic 
layers were dried (MgSO4) and concentrated under reduced pressure. Purification by flash 
chromatography (hexanes / EtOAc = 1:2 to 0:1) gave the respective secondary alcohol (42.4 
mg, 108 µmol, 53%, two steps), which was used in the next step. 
The secondary alcohol (14.0 mg, 36.0 μmol, 1.0 eq.) was dissolved in CH2Cl2 (2 mL), and 
Dess-Martin periodinane (17.0 mg, 39.0 µmol, 1.1 eq.) was added at r.t. After stirring for 30 
min, the reaction mixture was treated with saturated aqueous Na2S2O3 solution and saturated 
aqueous NaHCO3 solution. The organic layer was separated and the aqueous layer was 
extracted with CH2Cl2 (1 × 5 mL) and EtOAc (3 × 5 mL). The combined organic layers were 
dried (MgSO4) and concentrated under reduced pressure. Purification of the crude product by 
flash chromatography (hexanes / EtOAc 1:2) afforded phosphonate (12.0 mg, 30.7 µmol, 86%) 
as a colorless oil. 
Rf = 0.43 (hexanes / EtOAc = 1:2); [α]22D = -24.5 (c = 0.2, CHCl3); 1H-NMR (300 MHz, 
CDCl3) δ = 0.86 (d, J = 6.8 Hz, 3H), 1.74 (d, J = 1.1 Hz, 3H), 3.00 - 3.09 (m, 1H), 3.07 (s, 
3H), 3.08 (dd, J = 22.5, 14.0 Hz, 1H), 3.36 (dd, J = 22.5, 14.0 Hz, 1H), 3.67 (d, J = 9.9 Hz, 
1H), 3.75 (s, 3H), 3.79 (s, 3H), 6.27 (d, J = 1.1 Hz, 1H); 13C-NMR (75 MHz, CDCl3) δ = 13.1, 
17.9, 42.2, 43.9, 48.5, 53.0, 56.4, 81.7, 89.3, 145.1, 205.2; HRMS calculated for 
C11H20IO5PNa [M+Na]+: 412.9991, found: 412.9991. 
 
Dimethyl (1E,3S,4S,5E)-6-iodo-4-methoxy-3,5-dimethylhexa-1,5-dienylphosphonate 134 
 
P
I
OMe
MeO
O
MeO
C11H20IO4P
Exact Mass: 374,0144
Mol. Wt.: 374,1523  
 
To a solution of primary alcohol (207 mg, 0.766 mmol, 1.0 eq.) in CH2Cl2 (10 mL) at 0 °C 
was added Dess-Martin periodinane (358 mg, 0.843 mmol, 1.1 eq.). After stirring for 90 min, 
additional Dess-Martin periodinane (75.0 mg, 0.177 mmol, 0.2 eq.) was added. After stirring 
for further 30 min, the reaction mixture was treated with saturated aqueous Na2S2O3 solution 
(10 mL) and saturated aqueous NaHCO3 solution (10 mL). The organic layer was separated 
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and the aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The combined organic layers 
were dried (MgSO4) and concentrated. The crude aldehyde was used in the next step. 
In a separate flask, dimethyl methylphosphonate (0.82 mL, 7.66 mmol, 10 eq.) in THF (8 mL) 
at -50 °C was treated with n-BuLi (2.5M in hexane, 2.75 mL, 6.89 mmol, 9.0 eq.). After 
stirring at -20 °C for 1 h, the mixture was recooled to -78 °C and a solution of the crude 
aldehyde obtained from the Dess-Martin oxidation in THF (1 mL) was added. The reaction 
mixture was warmed up to 0 °C (c.a. 3 h), and then treated with saturated aqueous NH4Cl 
solution (10 mL). The organic layer was separated and the aqueous layer was extracted with 
EtOAc (4 × 10 mL). The combined organic layers were dried over MgSO4 and concentrated 
under reduced pressure. The crude alcohol was used in the next step. 
The crude alcohol was dissolved in CH2Cl2 (10 mL), and Dess-Martin periodinane (358 mg, 
0.843 mmol, 1.1 eq.) was added at r.t. After stirring for 1 h, the reaction mixture was treated 
with saturated aqueous Na2S2O3 solution (10 mL) and saturated aqueous NaHCO3 solution (10 
mL). The organic layer was separated and the aqueous layer was extracted with CH2Cl2 (1 × 
10 mL) and EtOAc (3 × 10 mL). The combined organic layers were dried over MgSO4 and 
concentrated under reduced pressure. Purification of the crude product by FC (hexanes / 
EtOAc = 1:1) afforded the phosphonate (128 mg, 0.342 mmol, 45%, three steps) as a 
yellowish oil.  
Rf = 0.26 (hexanes / EtOAc = 1:2); [α]22D = +2.48 (c = 1.05, CHCl3); 1H-NMR (300 MHz, 
CDCl3) δ = 0.89 (d, J = 7.0 Hz, 3H), 1.72 (d, J = 1.1 Hz, 3H), 2.49 (m, 1H), 3.14 (s, 3H), 3.39 
(d, J = 8.7 Hz, 1H), 3.68 (d, J = 0.9 Hz, 3H), 3.71 (d, J = 0.9 Hz, 3H), 5.61 (m, 1H), 6.20 (s, 
1H), 6.78 (m, 1H); 13C-NMR (75 MHz, CDCl3) δ = 15.8, 18.7, 40.8, 41.1, 52.3, 56.7, 80.5, 
89.6, 114.3, 116.8, 146.0, 156.3; HRMS calculated for C13H23INO4PNa [M+CH3CN+Na]+: 
438.0307, found: 438.0309. 
 
Dimethyl (3R,4S)-4-hydroxy-3,5-dimethyl-2-oxohex-5-enylphosphonate 137 
 
P
O OH
MeO
O
MeO
C10H19O5P
Exact Mass: 250,097
Mol. Wt.: 250,2286  
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To a cold solution (-78 °C) of dimethyl methylphosphonate (80 μL, 740 μmol, 10 eq) in THF 
(1 mL) were added nBuLi (2.5 M in hexane, 300 μL, 10 eq) and the resulting suspension was 
stirred at -20 °C for 2 h. To a cold solution (-78 °C) of the ester (50.0 mg, 74.0 μmol, 1.0 eq) 
in THF (0.5 mL) was added iPrMgCl (2.0 M in Et2O, 80 μL, 150 μmol, 2.0 eq). After 20 min 
the mixture from on high was added via cannula. The reaction mixture was warmed to room 
temperature and stirred 14 h. Sat. aq. NH4Cl (1 mL) and H2 O (1 mL) were added, the organic 
phase separated, and the aq. phase thoroughly extracted with CH2Cl2 (4 × 6 mL). The 
combined organic phases were dried over MgSO4 and concentrated under reduced pressure. 
Silica gel chromatography (hexanes / EtOAc = 1:2) afforded the phosphonate (16.0 mg, 63.9 
μmol, 86%) as a colorless oil.  
Rf = 0.10 (hexanes / EtOAc = 1:2); [α]20D = -34.9 (c = 0.97, CHCl3); 1H NMR (300 MHz, 
CDCl3) δ = 0.96 (d, J = 7.0 Hz, 3H), 1.73 (s, 3H), 2.77 (d, J = 4.7 Hz, 1H), 3.02 (m, 1H), 3.23 
(m, 2H), 3.76 (s, 3H), 3.80 (s, 3H), 4.12 (dd, J = 9.1, 4.2 Hz, 1H), 4.92 (m, 2H); 13C NMR (75 
MHz, CDCl3) δ = 13.7, 16.4, 41.1, 42.8, 50.1, 53.1, 79.0, 114.5, 144.4, 206.2; HRMS 
calculated for C10H19O5Na [M+Na]+: 273.0868, found: 273.0868. 
 
Dimethyl (3R,4S,E)-4-hydroxy-6-iodo-3,5-dimethyl-2-oxohex-5-enylphosphonate 119 
 
P
O
I
OH
MeO
O
MeO
C10H18IO5P
Exact Mass: 375,9937
Mol. Wt.: 376,1252  
 
To a cold solution (-78 °C) of dimethyl methylphosphonate (156 mL, 2.93 mmol, 11 eq) in 
THF (1 mL) were added KHMDS (0.5 M in toloene, 2.66 mL, 1.33 mmol, 10 eq) and the 
resulting suspension was stirred at -20 °C for 2 h. To a cold solution (-78 °C) of the ester 
(92.1 mg, 0.136 mmol, 1.0 eq) in THF (1 mL) was added iPrMgCl (2.0 M in Et2O, 204 μL, 
0.409 mmol, 3.0 eq). After 20 min the mixture from above was added via cannula. The 
reaction mixture was warmed to -20 °C for ca. 1.5 h and stirred at -20 °C for 0.5 h. Sat. aq. 
NH4Cl (6 mL) and H2O (6 mL) were added, the organic phase separated, and the aq. phase 
thoroughly extracted with EtOAc (4 × 6 mL). The combined organic phases were dried over 
MgSO4 and concentrated under reduced pressure. Silica gel chromatography (hexanes / 
EtOAc = 1:2) afforded the phosphonate (40.9 mg, 0.109 μmol, 80%) as a colorless oil.  
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Rf = 0.15 (hexanes / EtOAc = 1:2); 1H NMR (300 MHz, CDCl3) δ = 0.93 (d, J = 7.0 Hz, 3H), 
1.82 (s, 3H), 3.06 (m, 1H), 3.17 (d, J = 5.1 Hz, 1H), 3.25 (d, J = 4.9 Hz, 1H), 3.76 (s, 3H), 
3.80 (s, 3H), 4.25 (d, J = 9.2 Hz, 1H), 6.30 (s, 1H); 13C NMR (75 MHz, CDCl3) δ = 13.7, 18.7, 
41.2, 42.9, 50.2, 53.2, 53.3, 79.2, 80.9, 147.4, 205.4, 205.5. 
 
(E)-(3R,4S)-6-Iodo-4-methoxy-3,5-dimethyl-hex-5-en-2-one 142 
 
I
OMe O
C9H15IO2
Exact Mass: 282,0117
Mol. Wt.: 282,1187  
 
To a cold solution (0 °C) of (E)-(2S,3S)-5-Iodo-3-methoxy-2,4-dimethyl-pent-4-en-1-ol (1.39 
g, 5.14 mmol, 1eq) in CH2Cl2 (50 mL) were added NaHCO3 (864 mg, 2 eq) and Dess-Martin 
periodinan (5.02 g, 11.8 mmol, 2.3 eq) and the resulting solution was stirred 4 h at room 
temperature. Sat. aq. Na2SO3 (55 mL) and sat. aq. NaHCO3 (55 mL) were added, the organic 
phase separated, and the aq. phase thoroughly extracted with CH2Cl2. The combined organic 
phases were dried (MgSO4). Evaporation of the solvent under ambient pressure afforded 
crude aldehyde (1.37 g, 5.11 mmol), which was used for the next steps without further 
purification. 
To a cold (-78 °C) stirred, solution of crude aldehyde (1.37 g, 5.11 mmol, 1 eq) was added 
MeMgBr (3.43 mL, 3 M in Et2O, 10.3 mmol, 2 eq). After 30 min, the reaction mixture was 
cannulated into cold (0 °C) sat. aq. NH4Cl (60 mL). The organic phase was separated, and the 
aq. phase thoroughly extracted with Et2O. Drying of the combined organic extracts (MgSO4), 
evaporation of the solvent gave the respective secondary alcohol (1.45 g, 5.11 mmol), which 
was directly used in the next step. 
To a cold solution (0 °C) of the above prepared secondary alcohol in CH2Cl2 (50 mL) were 
added NaHCO3 (1.08 g, 12.8 mmol, 2.5 eq) and Dess-Martin periodinan (3.27 g, 7.71 mmol, 
1.5 eq) and the resulting solution was stirred 90 min at room temperature. Sat. aq. Na2SO3 (50 
mL) and sat. aq. NaHCO3 (50 mL) were added, the organic phase separated, and the aq. phase 
thoroughly extracted with DCM (3 × 10 mL). The combined organic phases were dried over 
MgSO4. Evaporation of the solvent in vacuo and flash chromatography (pentane / Et2O = 20:1 
to 4:1) afforded the methyl ketone (1.33 g, 4.71 mmol, 92%, over three steps) as a white solid. 
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Rf = 0.17 (pentane / Et2O = 4:1); [α]20D = +5.9 (c = 0.102, CHCl3); 1H NMR (300 MHz, 
CDCl3) δ = 0.82 (d, J = 7.0 Hz, 3H), 1.73 (d, J = 1.1 Hz, 3H), 2.19 (s, 3H), 2.76 (dq, J = 10.0, 
7.2 Hz, 1H), 3.10 (s, 3H), 3.75 (d, J = 10.0 Hz, 1H), 6.27 (d, J = 1.1 Hz, 1H); 13C NMR (75 
MHz, CDCl3) δ = 13.4, 18.1, 30.5, 48.6, 56.5, 81.2, 88.5, 145.5, 211.1. 
 
(2R,3S,E)-3-hydroxy-5-iodo-N-methoxy-N,2,4-trimethylpent-4-enamide 139 
 
MeO
N
O
I
OH
Me
C9H16INO3
Exact Mass: 313,0175
Mol.  Wt.: 313,1327  
 
To a solution of ester (231 mg, 0.342 mmol, 1.0 eq) in THF (1 mL) was added iPrMgCl (~2 
M in THF, 0.17 mL, 0.34 mmol, 1.0 eq.), after 10 min, a suspension of magnesium chloride 
methoxy(methyl)amide complex, which was prepared by addition of iPrMgCl (~2 M in THF, 
3.42 mL, 6.84 mmol, 20 eq.) to a suspension of N,O-dimethylhydroxylamine hydrochloride 
(334 mg, 3.42 mmol, 10 eq.) in THF (3 mL) at -20 °C was added. The reaction mixture was 
stirred at -20 °C for 2 h and warmed up to -10 °C (1 h). The reaction was quenched by 
addition of sat. aq. NH4Cl (5 mL). The product was extracted into EtOAc (3 × 20 mL), and 
the combined organic layers were dried over MgSO4, concentrated in vacuo. Purification by 
flash chromatography (hexanes / EtOAc = 2:1 to 1:1) gave the amide (77.0 mg, 0.246 mmol, 
72%) as white solid. 
Rf = 0.15 (hexanes / EtOAc = 2:1); ); [α]20D = -13.2 (c = 1.94, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ = 1.09 (d, J = 7.1 Hz, 3H), 1.81 (d, J = 1.0 Hz, 3H), 3.15 (m, 1H), 3.17 (s, 3H), 3.58 
(d, J = 6.1 Hz, 1H), 3.69 (s, 3H), 4.26 (t, J = 6.4 Hz, 1H), 6.30 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ = 15.1, 20.1, 32.2, 38.2, 61.8, 79.0, 80.1, 148.1, 176.3; HRMS calculated for 
C11H19IN2O3Na [M+CH3CN+Na]+: 377.0338, found: 377.0356. 
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(2R,3S,E)-5-iodo-N,3-dimethoxy-N,2,4-trimethylpent-4-enamide 140 
 
MeO
N
O
I
OMe
Me
C10H18INO3
Exact Mass: 327,0331
Mol. Wt.: 327,1593  
 
To a solution of the alcohol (41.0 mg, 0.131 mmol, 1.0 eq.) in Et2O (0.50 mL) under argon 
atmosphere were added molecular sieves 4Å (100 mg), Ag2O (150 mg, 0.647 mmol, 5.0 eq.) 
and CH3I (0.20 mL, 3.14 mmol, 24 eq.) subsequently. The resulting mixture was stirred for 72 
h at ambient temperature and filtered through cotton afterwards. The solvent was evaporated 
and the crude product was purified by a short column chromatography on silica gel (hexanes / 
EtOAc = 2:1) to receive the desired methyl ether (34.2 mg, 0.105 mmol, 80%) as a colorless 
oil.  
Rf = 0.37 (hexanes / EtOAc = 2:1); [α]20D = -21.4 (c = 0.08, CHCl3); 1H NMR (300 MHz, 
CDCl3) δ = 0.88 (d, J = 7.0 Hz, 3H), 1.74 (d, J = 1.1 Hz, 3H), 3.12 (m, 1H), 3.12 (s, 3H), 3.20 
(s, 3H), 3.71 (s, 3H), 3.87 (d, J = 10.2 Hz, 1H), 6.29 (s, 1H); 13C NMR (75 MHz, CDCl3) δ = 
14.1, 18.2, 32.1, 37.5, 56.6, 61.5, 81.3, 88.0, 145.7, 175.5; HRMS calculated for 
C12H21IN2O3Na [M+CH3CN+Na]+: 391.0495, found: 391.0490. 
 
8.3.3 Connection of the C3-C13 and the C14-C19 Subunits 
(2Z,4Z,6S,7S,8E)-7-(tert-butyldimethylsilyloxy)-11-(4-methoxybenzyloxy)-2,4,6,9-
tetramethylundeca-2,4,8-trienal 143 
 
O
O OPMBH
TBS
C29H46O4Si
Exact Mass: 486,3165
Mol. Wt.: 486,7586  
 
A solution of the alcohol (161 mg, 0.329 mmol, 1.0 eq.) in CH2Cl2 (8 mL) under argon 
atmosphere was cooled down to 0 °C, before Dess-Martin Periodinane ( 170 mg, 0.400 mmol, 
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1.2 eq.) was added. The resulting solution was stirred for 60 min at this temperature and 
quenched by addition of saturated aqueous Na2SO3 solution (5 mL) and saturated aqueous 
NaHCO3 solution afterwards. The organic layer was separated and the aqueous phase 
reextracted with CH2Cl2 (3 × 15 mL). The combined organic layer was dried (MgSO4), 
filtered and the solvent was evaporated. The residue was purified by column chromatography 
on silica gel (hexanes / EtOAc = 5:1) to give the aldehyde 3 (152 mg, 0.312 mmol, 95%) as 
colourless liquid. 
Rf = 0.81 (hexanes / EtOAc = 5:1); [α]D20 = +33.3 (c = 0.94, CHCl3); 1H NMR (400 MHz, 
CDCl3): δ = -0.06 (s, 3H), -0.03 (s, 3H), 0.83 (d, J = 6.8 Hz, 3H), 0.84 (s, 9H), 1.59 (s, 3H), 
1.81 (s, 3H), 1.86 (s, 3H), 2.27 (t, J = 7.1 Hz, 2H), 2.33 (m, 1H), 3.50 (t, J = 7.0 Hz, 2H), 3.79 
(s, 3H), 4.08 (dd, J = 8.9 Hz, J = 6.2 Hz, 1H), 4.42 (s, 2H), 5.08 (d, J = 9.0 Hz, 1H), 5.38 (d, J 
= 10.2 Hz, 1H), 6.86 (d, J = 8.5 Hz, 2H), 6.90 (s, 1H), 7.24 (d, J = 8.7 Hz, 2H), 9.88 (s, 1H); 
13C NMR (100 MHz, CDCl3): δ = -4.9, -4.2, 15.9, 16.3, 17.2, 18.1, 25.0, 25.8, 39.6, 40.8, 55.3, 
68.8, 72.6, 73.1, 113.8, 129.1, 129.3, 130.6, 133.0, 136.0, 136.3, 147.0, 159.2, 193.4; HRMS 
calculated for C29H46NaO4NaSi: 509.3063, found: 509.3070. 
 
(2E,4Z,8E)-(6S,7S)-7-(tert-Butyl-dimethyl-silanyloxy)-11-(4-methoxy-benzyloxy)-2,4,6,9-
tetramethyl-undeca-2,4,8-trienal 145 
OTBS OPMB
CHO
C29H46O4Si
Exact Mass: 486,3165
Mol. Wt.: 486,7586  
 
To a solution of phosphonate (10.0 mg, 25.6 μmol) in MeCN (1 mL) at RT was added 
anhydrous LiCl (1.3 mg, 31 μmol) and DBU (4.3 μL, 29 μmol). After stirring for 10 min, a 
solution of aldehyde (15.0 mg, 30.8 μmol) in MeCN (1 mL) was added. After stirring for 24 h, 
the reaction mixture was treated with saturated aqueous NH4Cl solution and diluted with 
EtOAc. The organic layer was separated and the aqueous layer was extracted with EtOAc (3 × 
2 mL). The combined organic layers were dried (MgSO4) and concentrated under reduced 
pressure. Purification of the crude product by column chromatography (hexanes / EtO2Ac 9:1) 
afforded aldehyde as a colorless oil. 
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Rf = 0.43 (hexanes / EtOAc 6:1); [α]22D = +25 (c = 1.0, CHCl3); 1H-NMR (300 MHz, CDCl3) 
δ ppm = -0.06 (s, 3H), -0.03 (s, 3H), 0.82 (s, 9H), 0.89 (d, J = 7.1 Hz, 3H), 1.62 (d, J = 1.0 Hz, 
3H), 1.86 (d, J = 1.5 Hz, 3H), 1.98 (d, J = 1.5 Hz, 3H), 2.27 (td, J = 6.7, 2.8 Hz, 2H), 2.42-
2.53 (dqd, J = 10.2, 7.1, 6.6 Hz, 1H), 3.50 (t, J = 6.9 Hz, 2H), 3.8 (s, 3H), 4.11 (dd, J = 8.9, 
6.4 Hz, 1H), 4.41 (s, 2H), 5.12 (d, J = 9.2 Hz, 1H), 5.45 (d, J = 10.2 Hz, 1H), 6.85 (d, J = 8.7 
Hz, 2H), 7.02 (s, 1H), 7.23 (d, J = 8.7 Hz, 2H), 9.43 (s, 1H); 13C-NMR (75 MHz, CDCl3) δ 
ppm = -4.9, -4.2, 10.8, 16.4, 17.2, 18.1, 23.2, 25.8, 39.6, 40.7, 55.3, 68.8, 72.6, 73.1, 113.8, 
129.0, 129.2, 130.6, 131.1, 133.2, 137.6, 140.5, 149.6, 159.2, 196.1; HRMS calculated for 
C29H46O4NaSi: 509.3063, found: 509.3063. 
 
(1E,6E,8Z,10Z,14E)-(3S,4R,12S,13S)-13-(tert-Butyl-dimethyl-silanyloxy)-1-iodo-3-
methoxy-17-(4-methoxy-benzyloxy)-2,4,8,10,12,15-hexamethyl-heptadeca-1,6,8,10,14-
pentaen-5-one 144 
 
O
TBS
O
I
MeO
PMBO
C38H59IO5Si
Exact Mass: 750,3176
Mol. Wt.: 750,862  
 
To a cold (0 °C), stirred solution of the methyl ketone (137 mg, 0.487 mmol, 1.0 eq.) in Et2O 
(2 mL), that had stirred over powdered 4 Å MS for 30 min, was added NEt3 (167 µl, 1.19 
mmol, 2.4 eq.) followed by (cHex)2BCl (213 µl, 1,17 mmol, 2.0 eq). After stirring at 0 °C for 
1 h, the reaction mixture was cooled to -78 °C, treated with a solution of the aldehyde (396 
mg, 0.814 mmol, 1.7 eq) that had been pre-stirred over 4 Å MS for 1 h. After stirring for 1.5 h, 
the reaction mixture was warmed to -30 °C, and stirred at this temperature for 15 min. 
Following this, the reaction mixture was warmed to 0 °C, and treated sequentially with pH7 
buffer (8 mL), MeOH (3 mL), and aq. hydrogen peroxide (1.5 mL). After stirring for an 
additional 1 h, the reaction mixture was treated with brine (20 mL), the organic phase 
separated, and the aq. phase thoroughly extracted with Et2O (3 × 10 mL). The combined 
organic extracts were dried (MgSO4), and concentrated in vacuo. Purification by flash 
chromatography (pentane / Et2O = 100:0 to 40:10 to 10:10) gave the respective aldol adduct 
(354 mg, 0.460 mmol, 95%), which was used in the next step. 
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A solution of the aldol adduct (100 mg, 0.130 mmol, 1.0 eq.) in THF (2 mL), that had pre-
stirred over molecular sieves 4Å for 40 min, was treated at RT with Ac2O (120 µL, 1.30 
mmol, 10 eq.) and DMAP (143 mg, 1.17 mmol, 9.0 eq.) and stirred at room temperature for 
60 min. DBU (192 µL, 1.30 mmol, 10 eq.) was added. The mixture was stirred for an 
additional 2 h, then it was diluted with Et2O and poured into brine. The aqueous layer was 
separated and extracted with Et2O (3 × 10 mL). The combined organic extracts were washed 
with 0.5 N HCl, brine, and dried over MgSO4. Removal of the solvent in vacuo gave an oily 
residue, which was purified by flash chromatography (petroleum ether/Et2O = 100:0 to 40:10) 
to give trienone (91.2 mg, 0.121 µmol, 93%, over 2 steps) as a colourless oil. 
Rf = 0.43 (hexanes / EtOAc = 6:1); [α]22D = +68 (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) 
δ = -0.08 (s, 3H), -0.05 (s, 3H). 0.82 (s, 9H), 0.84 (d, J = 6.6 Hz, 6H), 1.60 (d, J = 1.0 Hz, 3H), 
1.75 (d, J = 1.0 Hz, 3H), 1.82 (s, 3H), 1.90 (d, J = 1.5 Hz, 3H), 2.20-2.33 (m, 3H), 3.00 (dq, J 
= 9.7, 7.1 Hz, 1H), 3.07 (s, 3H), 3.49 (t, J = 7.1 Hz, 2H), 3.79 (s, 3H), 3.87 (d, J = 10.2 Hz, 
1H), 4.1 (dd, J = 8.9, 5.9 Hz, 1H), 4.41 (s, 2H), 5.09 (d, J = 10.2 Hz, 1H), 5.21 (d, J = 10.2 Hz, 
1H), 6.20 (d, J = 16.3 Hz, 1H), 6.24 (s, 1H), 6.28 (s, 1H), 6.85 (d, J = 8.7 Hz, 2H), 7.23 (d, J 
= 8.7 Hz, 2H), 7.57 (d, J = 15.8 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ = -4.9, -4.3, 14.1, 
15.7, 17.2, 18.2, 18.2, 19.9, 24.6, 25.9, 29.7, 39.7, 40.7, 46.1, 55.3, 56.6, 69.0, 72.6, 73.0, 81.0, 
88.5, 113.8, 126.4, 128.9, 129.2, 130.7, 131.6, 131.8, 132.7, 134.9, 139.3, 141.5, 145.8, 159.2, 
202.4; HRMS calculated for C38H59IO5NaSiI: 773.3074, found: 773.3074. 
 
8.3.4 Connection of the C3-C19 and the C20-C1'' Subunits 
(1E,3S,4R,6E,8Z,10Z,12S,13S,14E)-13-(tert-butyldimethylsilyloxy)-17-hydroxy-1-iodo-3-
methoxy-2,4,8,10,12,15-hexamethylheptadeca-1,6,8,10,14-pentaen-5-one 148 
 
O
TBS
O
I
MeO
HO
C30H51IO4Si
Exact Mass: 630,2601
Mol. Wt.: 630,7135  
 
The PMB ether (83.0 mg, 11.0 μmol, 1.0 eq.) was dissolved in CH2Cl2 / aq. pH 7 buffer (10:1, 
1.1 mL) under argon atmosphere. Then DDQ (75.0 mg, 33.0 μmol, 3.0 eq.) was added fast 
Experimental Section 140
and the resulting suspension was stirred for 30 min at ambient temperature. The reaction 
mixture was quenched by addition of 7 mL saturated, aqueous NaHCO3 solution. The organic 
layer was separated and the aqueous phase was extracted with CH2Cl2 (3 × 5 mL). Then the 
combined organic layer was washed with brine (10 mL), dried over MgSO4, filtered and the 
solvent was removed under reduced pressure, before the crude product was purified by flash 
chromatography on silica gel (hexanes / EtOAc = 9:1 to 4:1) to give the desired primary 
alcohol (65.0 mg, 10.0 μmol, 95%). 
Rf = 0.10 (hexanes / EtOAc = 9:1); [α]D20 = +54.3 (c = 1.1, CHCl3); 1H NMR (400 MHz, 
CDCl3): δ = -0.06(s, 3H), -0.03(s, 3H), 0.84 (s, 9H), 0.85 (d, J = 6.6 Hz, 3 H), 0.87 (d, J = 6.6 
Hz, 3H), 1.61 (d, J = 1.0 Hz, 3H), 1.76 (d, J = 1.0 Hz, 3H), 1.83 (s, 3H), 1.91 (d, J = 1.0 Hz, 
3H), 2.22 (t, J = 6.3 Hz, 2H), 2.25 - 2.35 (m, 1H), 2.95 - 3.06 (m, 1H), 3.08 (s, 3 H), 3.65 (t, J 
= 5.1 Hz, 2H), 3.88 (d, J =9.6 Hz, 1H), 4.10 (dd, J = 8.6, 5.6 Hz, 1H), 5.16 (d, J = 9.2 Hz, 1H), 
5.24 (d, J = 10.1 Hz, 1H), 6.21 (d, J = 15.7 Hz, 1H), 6.24 (s, 1H), 6.28 (s, 1H), 7.56 (d, J = 
15.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = -4.8, -4.3, 14.1, 15.9, 16.7, 18.1, 18.2, 19.8, 
24.6, 25.8, 40.6, 42.7, 46.2, 56.6, 60.5, 72.8, 81.1, 88.4, 126.4, 130.4, 131.7, 131.9, 132.0, 
134.2, 139.1, 141.3, 145.8, 202.3; HRMS calculated for C30H51IO4NaSi: 653.2499, found: 
653.2499. 
 
(3E,5S,6S,7Z,9Z,11E,14R,15S,16E)-5-(tert-butyldimethylsilyloxy)-17-iodo-15-methoxy-
3,6,8,10,14,16-hexamethyl-13-oxoheptadeca-3,7,9,11,16-pentaenal 149 
 
O
TBS
O
I
MeO
O
C30H49IO4Si
Exact Mass: 628,2445
Mol. Wt.: 628,6976  
 
To a solution of oxalyl chloride (19.0 μL, 219 μmol, 7.4 eq.) in DCM (500 μL) mit 4Å MS 
was added DMSO (30.0 μL, 438 μmol, 15 eq.) at -78 °C. After 20 min stirring of the resulting 
mixture at the same temperature, a solution of the primary alcohol (18.7 mg, 29.6 μmol, 1.0 
eq., pre-stirred over 4Å MS for 0.5 h at RT) in DCM (500 μL) was added slowly. The 
resulting mixture was stirred for 1 h at -78 °C and Et3N (39.0 μL, 292 μmol, 10 eq.) was 
added. After 20 min stirring at -78 °C, the reaction mixture was quenched by addition of 6 mL 
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saturated, aqueous NH4Cl solution at -10 °C. The organic layer was separated and the aqueous 
phase was extracted with Et2O (3 × 5 mL). Then the combined organic layer was washed with 
brine (5 mL), dried over MgSO4, filtered and the solvent was removed under reduced pressure. 
The crude product was purified by flash chromatography on silica gel (hexanes / Et2OAc = 
4:1) to give the desired aldehyde (17.5 mg, 27.8 mmol, 94%). 
Rf = 0.36 (hexanes / EtOAc = 9:1); 1H NMR (300 MHz, CDCl3): δ = -0.06(s, 3H), -0.03(s, 
3H), 0.84 (s, 9H), 0.85, (d, J = 7.0 Hz, 3 H), 0.88 (d, J = 6.8 Hz, 3H), 1.65 (d, J = 1.3 Hz, 3H), 
1.75 (d, J = 1.1 Hz, 3H), 1.83 (s, 3H), 1.91 (d, J = 1.3 Hz, 3H), 2.30 (m, 1H), 3.01 (m, 3H), 
3.08 (s, 3 H), 3.87 (d, J =9.8 Hz, 1H), 4.11 (dd, J = 8.8, 5.6 Hz, 1H), 5.24 (m, 2H), 6.21 (d, J 
= 15.3 Hz, 1H), 6.23 (s, 1H), 6.28 (s, 1H), 7.55 (d, J = 15.4 Hz, 1H), 9.58 (t, J = 2.4 Hz, 1H),; 
13C NMR (75 MHz, CDCl3) δ = -4.5, -4.0, 14.4, 16.1, 18.1, 18.6, 20.2, 24.9, 26.1, 40.9, 46.7, 
54.6, 57.0, 73.1, 81.4, 88.8, 126.8, 127.1, 132.4, 133.8, 134.2, 139.4, 141.6, 146.1, 200.1, 
202.6; HRMS calculated for C30H49IO4NaSi: 651.2343, found: 651.2349. 
 
(2E,5E,7S,8S,9Z,11Z,13E,16R,17S,18E)-((1S,2S)-2-methyl-1-(2-((S)-3-methyl-1-
(methylcarbamoyloxy)butyl)thiazol-4-yl)but-3-enyl) 7-(tert-butyldimethylsilyloxy)-19-
iodo-17-methoxy-2,5,8,10,12,16,18-heptamethyl-15-oxononadeca-2,5,9,11,13,18-
hexaenoate 151 
 
O
O
MeO
N
S
O
H
N
O
O O
I
TBS
C48H75IN2O7SSi
Exact Mass: 978,4109
Mol. Wt.: 979,1733  
 
To NaH (55-65% in mineral oil, 1.2 mg, 30.0 μmol, 1.1 eq.) was added a solution of the 
phosphonate (18.4 mg, 36.5 μmol, 1.3 eq.) in THF (200 μL) at 0 °C. After 30 min stirring at 0 
°C, the resulting suspension was cooled at -20 °C and a solution of the aldehyde (17.5 mg, 
27.8 μmol, 1.0 eq.) in THF (200 μL) was added. The reaction mixture was warmed to room 
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temperature, stirred for 4 h and quenched by addition of 2 mL saturated, aqueous NH4Cl 
solution. The organic layer was separated and the aqueous phase was extracted with EtOAc (4 
× 5 mL). Then the combined organic layer was dried over MgSO4, filtered and the solvent 
was removed under reduced pressure. The crude product was purificated by flash 
chromatography on silica gel (hexanes / Et2OAc = 4:1) to give the desired ester (5.5 mg, 5.6 
μmol, 20%). 
Rf = 0.22 (hexanes / EtOAc = 6:1); [α]D20 = +49.7 (c = 0.27, CHCl3); 1H NMR (600 MHz, 
CDCl3): δ = -0.05(s, 3H), -0.03(s, 3H), 0.89 (s, 9H), 0.90 (d, J = 7.1 Hz, 3 H), 0.92 (d, J = 7.0 
Hz, 3H), 1.00 (d, J = 6.6 Hz, 3H), 1.01 (d, J = 7.0 Hz, 3H), 1.02 (d, J = 7.3 Hz, 3H), 1.70 (s, 
3H), 1.78 (m, 1H), 1.79 (s, 3H), 1.85 (s, 3H), 1.90 (m, 2H),1.90 (s, 3H), 1.97 (s, 3H), 2.34 (m, 
1H), 2.75 (s, 3H), 2.93 (t, J = 7.5 Hz, 2H), 3.00 (m, 1H), 3.07 (m, 1H), 3.11 (s, 3H), 3.93 (d, J 
=9.9 Hz, 1H), 4.22 (dd, J = 8.8, 5.5 Hz, 1H), 5.05 (m, 2H), 5.16 (d, J = 8.8 Hz, 1H), 5.30 (d, J 
= 10.3 Hz, 1H), 5.81 (m, 1H), 5.86 (d, J = 7.0 Hz, 1H), 6.03 (m, 1H), 6.30 (s, 1H), 6.40 (d, J = 
15.4 Hz, 1H), 6.50 (s, 1H), 6.90 (t, J = 7.7 Hz, 1H), 7.33 (s, 1H), 7.60 (d, J = 15.8 Hz, 1H); 
13C NMR (75 MHz, CDCl3) δ = -4.5, -4.0, 12.6, 14.2, 16.0, 17.0, 17.7, 18.5, 19.0, 19.8, 22.4, 
23.4, 24.7, 25.8, 26.4, 27.5, 39.3, 42.0, 43.5, 45.9, 47.9, 56.8, 73.3, 74.2, 76.6, 82.1, 89.7, 
116.4, 117.8, 127.2, 128.1, 129.9, 133.3, 133.5, 134.2, 134.8, 140.6, 141.5, 142.5, 146.7, 
155.5, 158.2, 168.4, 173.8, 204.5; HRMS calculated for C48H76IN2O7SSi: 979.4187, found: 
979.4167. 
 
8.3.5 Heck-Macrocyclisation: Towards Archazolid B 
(2E,5E,7S,8S,9Z,11Z,13E,16R,17S,18E)-((1S,2S)-2-methyl-1-(2-((S)-3-methyl-1-(methyl 
carbamoyloxy)butyl)thiazol-4-yl)but-3-enyl) 7-(tert-butyldimethylsilyloxy)-19-iodo-17-
methoxy-5,8,10,12,16,18-hexamethyl-15-oxononadeca-2,5,9,11,13,18-hexaenoate 158 
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O
O
MeO
N
S
O
H
N
O
O O
TBS
I
C47H73IN2O7SSi
Exact Mass: 964,3952
Mol. Wt.: 965,1467  
 
To NaH (55-65% in mineral oil, 1.4 mg, 35.5 μmol, 1.3 eq.) was added a solution of the 
phosphonate (13.7 mg, 27.9 μmol, 1.0 eq.) in THF (200 μL) at 0 °C. After 30 min stirring at 0 
°C, the resulting suspension was cooled at -20 °C and a solution of the aldehyde (26.7 mg, 
42.5 μmol, 1.5 eq.) in THF (200 μL) was added. The reaction mixture was stirred at -20 °C 
for 30 min and quenched by addition of 2 mL saturated, aqueous NH4Cl solution. The organic 
layer was separated and the aqueous phase was extracted with EtOAc (4 × 5 mL). Then the 
combined organic layer was dried over MgSO4, filtered and the solvent was removed under 
reduced pressure. The crude product was purified by flash chromatography on silica gel 
(hexanes / Et2OAc = 4:1) to give the desired este (17.8 mg, 18.4 μmol, 66%). 
Rf = 0.32 (hexanes / EtOAc = 6:1); [α]D20 = +22.3 (c = 0.35, CHCl3); 1H NMR (600 MHz, 
CDCl3): δ = 0.008 (s, 3H), 0.04(s, 3H), 0.89 (d, J = 7.0 Hz, 3 H), 0.90 (s, 9H), 0.94 (d, J = 7.0 
Hz, 3H), 0.98 (d, J = 6.6 Hz, 3H), 1.01 (d, J = 7.0 Hz, 3H), 1.02 (d, J = 7.0 Hz, 3H), 1.68 (s, 
3H), 1.78 (m, 1H), 1.80 (s, 3H), 1.85 (s, 3H), 1.92 (m, 2H), 1.97 (s, 3H), 2.34 (m, 1H), 2.75 (s, 
3H), 2.92 (t, J = 7.0 Hz, 2H), 2.98 (m, 1H), 3.07 (m, 1H), 3.11 (s, 3H), 3.93 (d, J =9.9 Hz, 
1H), 4.22 (dd, J = 9.0, 5.3 Hz, 1H), 5.05 (m, 2H), 5.20 (dd, J = 8.8, 1.1 Hz, 1H), 5.30 (d, J = 
9.9 Hz, 1H), 5.80 (m, 1H), 5.86 (d, J = 7.3 Hz, 1H), 5.93 (d, J = 15.8 Hz, 1H); 6.03 (dd, J = 
9.2, 4.8 Hz, 1H); 6.32 (s, 1H), 6.39 (d, J = 15.8 Hz, 1H), 6.50 (s, 1H), 7.01 (m, 1H), 7.36 (s, 
1H), 7.60 (d, J = 15.8 Hz, 1H); 13C NMR (600 MHz, CDCl3) δ = -4.5, -4.0, 14.2, 16.0, 16.8, 
17.4, 18.5, 19.0, 19.7, 22.4, 23.4, 24.7, 25.8, 26.4, 27.5, 41.9, 43.0, 43.4, 45.9, 47.9, 56.8, 73.3, 
74.2, 76.2, 82.1, 89.7, 116.4, 118.0, 123.1, 127.2, 131.1, 133.4, 133.5, 133.6, 134.6, 140.6, 
142.5, 146.7, 149.0, 155.5, 158.3, 167.0, 173.9, 204.5; HRMS calculated for 
C47H73IN2O7NaSSi: 987.3850, found: 987.3857. 
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8.4 Studies Towards the Total Synthesis of Etnangien 
8.4.1 Synthesis of the C15-C23 Subunit 
8.4.1.1 Synthesis of the Aldehyde Fragment – Wittig Reaction 
(2E,4E)-ethyl 3-methyl-6-oxohexa-2,4-dienoate 191 
 
EtO2C O
C9H12O3
Exact Mass: 168,0786
Mol. Wt.: 168,1898  
 
1. (E)-Ehyl 3-methyl-4-oxobut-2-enoate (1.0 g, 7.03 mmol, 1.0 eq.) was added to a 
suspension of Ph3PCHCHO (3.20 g, 10.5 mmol, 1.5 eq.) in dry CH2Cl2 (4 mL). The reaction 
mixture was stirred for 24 h at room temperature and purified direct by flash chromatography 
(hexanes / Et2O = 6:1 to 2:1) to give the aldehyde (831 mg, 4.94 mmol, 70%) as white needle 
crystals. 
2. A flask containing Ph3PCHCHO (146 mg, 0.481 mmol, 1.0 eq.) was added a solution of 
(E)-Ehyl 3-methyl-4-oxobut-2-enoate (207 μL, 1.52 mmol, 3.0 eq.) in abs. DCM (100 μl). 
The reaction mixture was stirred for 15 h at room temperature and purified direct by flash 
chromatography (hexanes / Et2O = 6:1 to 1:1) to give the aldehyde (64.6 mg, 0.384 mmol, 
80%) as white needle crystals. 
 
Rf = 0.37 (hexanes / EtOAc = 9:1); 1H NMR (300 MHz, CDCl3) δ = 1.29 (t, J = 7.2 Hz, 3H), 
2.29 (s, 3H), 4.20 (q, J = 7.2 Hz, 2H), 6.11 (s, 1H), 6.43 (dd, J = 15.6, 7.4 Hz, 1H), 7.08 (d, J 
= 15.6 Hz, 1H), 9.65 (d, J = 7.5 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ = 13.8, 14.2, 60.5, 
127.0, 132.7, 148.6, 154.2, 165.8, 193.3.  
 
Byproduct: (2E,4E,6E)-ethyl 3-methyl-8-oxoocta-2,4,6-trienoate 192 
 
EtO2C O
C11H14O3
Exact Mass: 194,0943
Mol. Wt.: 194,2271  
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Rf = 0.37 (hexanes / EtOAc = 9:1); 1H NMR (300 MHz, CDCl3) δ = 1.28 (t, J = 7.2 Hz, 3H), 
2.31 (s, 3H), 4.18 (q, J = 7.0 Hz, 2H), 6.94 (s, 1H), 6.26 (dd, J = 15.3, 7.7 Hz, 1H), 6.65 (d, J 
= 15.4, 1H), 6.74 (dd, J = 15.3, 10.4 Hz, 1H), 7.16 (dd, J = 15.3, 10.4 Hz, 1H), 9.60 (d, J = 
7.9 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ = 13.6, 14.3, 60.2, 123.9, 131.1, 133.5, 144.8, 
150.0, 150.4, 166.4, 193.3. 
 
(2E,4E)-ethyl 3,5-dimethyl-6-oxohexa-2,4-dienoate 194 
 
EtO2C O
C10H14O3
Exact Mass: 182,0943
Mol Wt.: 182,2164  
 
A flask containing Ph3PC(CH3)CHO (50.0 mg, 0.157 mmol, 1.0 eq.) was added a solution of 
(E)-Ehyl 3-methyl-4-oxobut-2-enoate (64.0 μL, 0.471 mmol, 3.0 eq.) in abs. DCM (40 μl). 
The reaction mixture was stirred for 28 h at room temperature and purified direct by flash 
chromatography (hexanes / Et2O = 9:1 to 4:1) to give aldehyde (17.8 mg, 97.7 μmol, 62%) as 
yellow crystals. 
Rf = 0.24 (hexanes / Et2O = 9:1); 1H NMR (400 MHz, CDCl3) δ = 1.29 (t, J = 7.1 Hz, 3H), 
1.94 (s, 3H), 2.37 (d, J = 1.5 Hz, 3H), 4.19 (q, J = 7.1 Hz, 2H), 5.94 (s, 1H), 6.73 (s, 1H), 9.46 
(s, 1H); 13C NMR (75 MHz, CDCl3) δ = 11.1, 14.2, 18.4, 60.3, 123.0, 140.4, 150.1, 150.9, 
166.0, 195.1. 
 
(2E,4E)-ethyl 6-hydroxy-3-methylhexa-2,4-dienoate 197 
 
EtO2C OH
C9H14O3
Exact Mass: 170,0943
Mol. Wt.: 170,2057  
 
A solution of sodium borohydride (242 mg, 6.4 mmol, 0.5 eq.) in EtOH/H2O (1:1, 3 mL) was 
added to a solution of (2E,4E)-ethyl 3-methyl-6-oxohexa-2,4-dienoate (2.15 g, 12.8 mmol) in 
EtOH/H2O (1:1, 2 mL) at 0 °C. The reaction mixture was stirred at RT for 20 min, saturated 
with NaCl and extracted with Et2O (5 x 20 mL). The combined organic extracts were dried 
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over MgSO4. Evaporation of the solvent in vacuo afforded crude alcohol (3.12 g), which was 
used for the next steps without further purification.  
Rf = 0.41 (hexanes / EtOAc = 2:1); 1H NMR (400 MHz, CDCl3) δ = 1.27 (t, J = 7.1 Hz, 3H), 
2.26 (s, 3H), 4.15 (q, J = 7.1 Hz, 2H), 4.28 (t, J = 4.8, 2H), 5.76 (s, 1H), 6.20 (dt, J = 15.8, 5.1 
Hz, 1H), 6.31 (d, J = 15.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = 13.4, 14.3, 59.8, 63.1, 
119.7, 133.7, 134.5, 151.4, 167.1.  
 
(2E,4E)-Ethyl 6-(tert-butyldimethylsilyloxy)-3-methylhexa-2,4-dienoate 198 
 
EtO2C OTBS
C15H28O3Si
Exact Mass: 284,1808
Mol. Wt.: 284,4665  
 
To a solution of the crude alcohol (3.12 g) and imidazol (1.13 g, 16.6 mmol, 1.3 eq.) in abs. 
DMF (2 mL) was added slowly a solution of TBSCl (2.51 g, 16.6 mmol, 1.3 eq.) in abs. DMF 
(5ml). The reaction mixture was stirred at RT for 30 min. Sat. aq. NaHCO3 (25 mL) were 
added, the organic phase separated, and the aq. phase thoroughly extracted with Et2O (4 × 40 
mL). The combined organic extracts were dried over MgSO4 and concentrated in vacuo. 
Purified by flash chromatography (hexanes / Et2O = 9:1) gave TBS-ether (3.25 g, 11.4 mmol, 
89%, two steps) as colourless oil. 
Rf = 0.43 (hexanes / Et2O = 9:1); 1H NMR (300 MHz, CDCl3) δ = 0.07 (s, 6H), 0.91 (s, 9H), 
1.27 (t, J = 7.2 Hz, 3H), 2.27 (d, J = 1.5 Hz, 3H), 4.15 (q, J = 7.1 Hz, 2H), 4.30 (dd, J = 4.6, 
1.5 Hz, 2H), 5.75 (s, 1H), 6.14 (dt, J = 15.8, 4.6 Hz, 1H), 6.31 (d, J = 15.8 Hz, 1H); 13C NMR 
(75 MHz, CDCl3) δ = -5.2, 13.9, 14.3, 18.4, 25.9, 59.7, 63.3, 119.0, 132.4, 135.2, 151.8, 167.1; 
LC-MS (ESI) calculated for C15H28O3Si: 284.1808, found: 284.0. 
 
(2E,4E)-6-(tert-butyldimethylsilyloxy)-3-methylhexa-2,4-dien-1-ol 
 
OTBS
HO
C13H26O2Si
Exact Mass: 242,1702
Mol. Wt.: 242,4298  
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To a cooled (0 °C) solution of the ester (3.44 g, 12.1 mmol, 1.0 eq.) in THF (50 mL) was 
added slowly DIBAL-H (1.0 M in hexane, 36.3 mL, 36.3 mmol, 3.0 eq.) in a period of 15 min. 
The reaction mixture was stirred at 0 °C for 1 h and 200 mL H2O were added. The organic 
phase was separated, and the aq. phase extracted with Et2O (6 × 40 mL). The combined 
organics were dried over MgSO4, filtered and evaporated in vacuo. Silica gel chromatography 
(hexanes / Et2O, gradient elution, 1:1 to 1:2) afforded alcohol (2.85 g, 11.8 mmol, 97%) as a 
colorless oil.  
Rf = 0.29 (hexanes / Et2O = 6:1); 1H NMR (300 MHz, CDCl3) δ = 0.06 (s, 6H), 0.90 (s, 9H), 
1.78 (s, 3H), 4.24 (d, J = 4.7 Hz, 4H), 5.62 (t, J = 6.6 Hz, 1H), 5.75 (dt, J = 15.6, 5.1 Hz, 1H), 
6.24 (d, J = 15.6 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ = -5.2, 12.6, 18.4, 26.0, 59.4, 63.8, 
128.6, 129.6, 133.7, 135.8. 
 
(2E,4E)-6-(tert-butyldimethylsilyloxy)-3-methylhexa-2,4-dienal 188 
 
OTBS
Me
O
C13H24O2Si
Exact Mass: 240,1546
Mol. Wt.: 240,414  
 
To a stirred solution of the alcohol (2.80 g, 11.5 mmol, 1.0 eq.) in Et2O (10 mL) was added 4 
Å MS (7 g) and MnO2 (15.1 g, 173 mmol, 15 eq.) in portions at 0 °C. The resulting 
suspension was stirred at room temperature for 30 min. Then the suspension was filtered 
through Celite and Silica gel which were washed with Et2O (10 × 50 mL). The solvent of the 
filtrate was removed to give aldehyde in 95% yield (2.63 g, 10.9 mmol) as yellow oil, which 
was used for the next step without further purification. 
Rf = 0.51 (hexanes / EtOAc = 6:1); 1H NMR (300 MHz, CDCl3) δ = 0.07 (s, 6H), 0.90 (s, 9H), 
2.24 (s, 3H), 4.32 (dd, J = 4.0, 1.4 Hz, 2H), 5.92 (d, J = 8.1 Hz, 1H), 6.30 (dt, J = 15.6, 4.1 Hz, 
1H), 6.42 (d, J = 15.6 Hz, 1H), 10.09 (d, J = 8.1 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ = -
5.3, 13.2, 18.4, 25.9, 63.2, 129.4, 131.9, 137.2, 154.0, 191.4. 
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8.4.1.2 Construction of the Stereocentres at C20 and C21 
(2R,3R,4E,6E)-((1R,2S)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 
8-(tert-butyldimethylsilyloxy)-3-hydroxy-2,5-dimethylocta-4,6-dienoate 199 
 
O
O
Me
OH Me
OTBSN
Bn SO2Mes
Ph
Me
C41H57NO6SSi
Exact Mass: 719,3676
Mol. Wt.: 720,0449  
 
A solution of (1R,2S)-2-(N-benzyl-2,4,6-trimethylphenyl-sulfonamido)-1-phenylpropyl 
propionate (356 mg, 0.742 mmol, 1eq.) and Et3N (0.260 mL, 1.86 mmol, 2.5 eq.) in CH2Cl2 
(2.5 mL) under argon atmosphere was cooled down to -78 °C. Then dicyclohexyl-
(trifluoromethylsulfonyloxy)borane (1.63 mL, 1M in n-Hexane, 1.63 mmol, 2.2 eq.) was 
added slowly. The resulting mixture was stirred for 2h at -78 °C, before a solution of aldehyde 
(360 mg, 1.48 mmol, 2.0 eq.) in 6 mL CH2Cl2 (dried with 4Å molecular sieves) was added 
slowly. After further 1h the reaction mixture was warmed up to -40 °C (1h), quenched with 
pH7 buffer (3.5 mL), diluted with MeOH (14 mL) and charged with 2 mL of a 30% H2O2 
solution, before the mixture was stirred at r.t. overnight. Afterwards, the solvent was removed 
in vacuo and the residue was dissolved in CH2Cl2 (15 mL). The organic layer was washed 
with H2O, separated and the aqueous phase was reextracted with CH2Cl2 (3 × 10 mL). The 
combined organic layer was dried over Na2SO4, filtered and the solvent was removed in 
vacuo. The residue was purified by column chromatography (hexanes / EtOAc = 8:1) to give 
ester as white crystals (408 mg, 0.567 mmol, 76%, d.r. > 5:1). 
Rf = 0.31 (hexanes / EtOAc = 6:1); [α]20D = +41.6 (c = 0.88, CHCl3); 1H NMR (300 MHz, 
CDCl3) δ = 0.07 (s, 6H), 0.91 (s, 9H), 1.03 (d, J = 7.2 Hz, 3H), 1.16 (d, J = 7.0 Hz, 3H), 1.78 
(s, 3H), 2.27 (s, 3H), 2.43 (m, 1H), 2.50 (s, 6H), 4.09 (m, 1H), 4.24 (dd, J = 5.1, 0.9 Hz, 2H), 
4.57 (dd, J = 8.5, 4.0 Hz, 1H), 4.57 (A of ABq, JAB=16.5, 1H), 4.78 (B of ABq, JAB=16.5, 1H), 
5.36 (d, J = 9.2 Hz, 1H), 5.76 (dt, J = 15.2, 5.1 Hz, 1H), 5.84 (d, J = 4.0 Hz, 1H), 6.24 (d, J = 
15.4 Hz, 1H), 6.85 (m, 4H), 7.19 (m, 6H), 7.30 (m, 2H); 13C NMR (75 MHz, CDCl3) δ = -5.2, 
13.3, 13.8, 18.4, 20.9, 22.9, 26.0, 46.3, 48.3, 56.9, 63.7, 70.2, 78.3, 125.9, 126.1, 127.1, 127.5, 
127.6, 127.9, 128.3, 128.4, 129.3, 130.4, 132.1, 133.4, 133.5, 137.0, 138.3, 138.7, 140.3, 
142.5, 174.3; HRMS calculated for C41H57NO6SSiNa [M+Na]+: 742.3574, found: 742.3574. 
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(2R,3R,4E,6E)-8-(tert-butyldimethylsilyloxy)-3-hydroxy-N-methoxy-N,2,5-trimethylocta 
-4,6-dienamide 201 
 
MeO
N
O
Me
OH Me
OTBSMe
C18H35NO4Si
Exact Mass: 357,2335
Mol. Wt.: 357,5603  
 
To a stirred suspension (-20 °C) of O,N-dimethylhydroxylamine hydrochloride (55.8 mg, 
572 μmol, 20.0 eq.) in THF (100 μL) was added iPrMgCl (~2 M in THF, 587 μL, 1173 μmol, 
41.0 eq). The mixture was stirred at - 20 °C for 20 min and then a solution of ester (20.6 mg, 
28.6 μmol, 1.0 eq.) in THF (100 μL + 2 × 100 μL washings) was added. The reaction mixture 
was warmed to -10 °C for 2.5 h and stirred at 0 °C for 2 h, quenching with sat. aq. NH4Cl (5 
mL). The organic layer was separated and the aqueous layer was extracted with CH2Cl2 (3 × 
10 mL) and the combined organic extracts washed with brine (20 mL), dried (MgSO4) and 
concentrated in vacuo. Silica gel chromatography (hexanes / EtOAc, gradient elution, 9:1 to 
1:1) afforded amide (5.30 mg, 14.8 μmol, 52%) as a colorless oil.  
Rf = 0.12 (hexanes / EtOAc = 1:1); [α]20D = -13.0 (c = 0.83, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ = 0.06 (s, 6H), 0.90 (s, 9H), 1.11 (d, J = 7.1, 3H), 1.82 (s, 3H), 2.94 (m, 1H), 3.04 (d, 
J = 5.6, 1H), 3.20 (s, 3H), 3.68 (s, 3H), 4.24 (d, J = 5.1, 2H), 4.60 (dd, J = 7.6, 7.2, 1H), 5.43 
(d, J = 9.2, 1H), 5.75 (dt, J = 15.3, 5.1, 1H), 6.24 (d, J = 15.3, 1H); 13C NMR (100 MHz, 
CDCl3) δ = -5.1, 13.2, 14.4, 18.5, 26.0, 41.5, 61.5, 63.8, 70.7, 128.7, 131.8, 133.7, 136.0, 
189.2; HRMS calculated for C18H35NO4SiNa [M+Na]+: 380.2233, found: 380.2232. 
 
(2E,4E,6E)-8-(tert-butyldimethylsilyloxy)-N-methoxy-N,2,5-trimethylocta-2,4,6-
trienamide 202 
 
MeO
N
O
Me
Me
OTBSMe
C18H33NO3Si
Exact Mass: 339,223
Mol. Wt.: 339,545  
 
Experimental Section 150
Rf = 0.31 (hexanes / EtOAc = 4:1); 1H NMR (400 MHz, CDCl3) δ = 0.08 (s, 6H), 0.91 (s, 9H), 
1.90 (s, 3H), 2.00 (s, 3H), 3.23 (s, 3H), 3.63 (s, 3H), 4.28 (dd, J = 5.1, 1.0 Hz, 1H), 5.87 (dt, J 
= 15.5, 5.2 Hz, 1H), 6.24 (d, J = 11.9 Hz, 1H), 6.36 (d, J = 15.5, 1H), 6.83 (dd, J = 11.8 Hz, 
1.4, 1H); 13C NMR (100 MHz, CDCl3) δ = -5.1, 13.0, 14.4, 18.5, 26.0, 33.7, 61.0, 64.0, 125.1, 
128.9, 130.0, 131.0, 134.1, 138.9, 173.0; HRMS calculated for C18H34NO3Si [M+H]+: 
340.2308, found: 340.2306.  
 
(2R,3R,4E,6E)-((1R,2S)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 
8-(tert-butyldimethylsilyloxy)-3-(3,4-dimethoxybenzyloxy)-2,5-dimethylocta-4,6-dienoate 
205 
 
O
O
Me
O Me
OTBSN
Bn SO2Mes
Ph
Me
C50H67NO8SSi
Exact Mass: 869,4357
Mol. Wt.: 870,2194
DMPM
 
 
To a solution of the alcohol (47.5 mg, 66.0 μmol, 1.0 eq.) and PPTS (8.30 mg, 33.0 μmol, 0.5 
eq.) in abs. DCM (0.50 mL) was added a solution of imidate (41.3 mg, 132 μmol, 2.0 eq.) in 
abs. DCM (0.50 ml). The reaction mixture was stirred at RT for 17 h. PPTS (8.30 mg, 33.0 
μmol, 0.5 eq.) and a solution of imidate (41.3 mg, 132 μmol, 2.0 eq.) in abs. DCM (0.50 ml) 
was added. After 4 h stirring at room temperature, sat. aq. NaHCO3 (2 mL) were added, the 
organic phase separated, and the aq. phase extracted with DCM (3 × 4 mL). The combined 
organic extracts were dried over MgSO4 and concentrated in vacuo. LC-MC showed that the 
yield of the DMPM-ether was 47%. The DMPM-ether couldn’t be purified by column 
chromatography on silica gel. LC-MS calculated for C50H67NO8SSiNH4 [M+NH4]+: 887.46, 
found: 887.50.  
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(2R,3R,4E,6E)-((1R,2S)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 
3,8-bis(tert-butyldimethylsilyloxy)-2,5-dimethylocta-4,6-dienoate 206 
 
O
O
Me
O Me
OTBSN
Bn SO2Mes
Ph
Me
C47H71NO6SSi2
Exact Mass: 833,4541
Mol. Wt.: 834,3057
TBS
 
 
To a stirred solution (-78 °C) of alcohol (86.4 mg, 0.120, mmol, 1.0 eq.) in CH2Cl2 (1 mL) 
was added 2,6-lutidine (24 μL, 0.203 mmol, 1.7 eq.) and TBSOTf (36 μL, 0.203 mmol, 1.7 
eq.). The mixture was stirred at -78 °C for 60 min. The cooling bath was removed and the 
reaction quenched with sat. aqueous NaHCO3 (2 mL). The mixture was warmed to room 
temperature. CH2Cl2 (10 mL) were added. The organic layer was separated and the aqueous 
layer was extracted with CH2Cl2 (3 × 5 mL). The combined organics were washed with sat. 
aqueous NaHCO3 (3 mL), dried over MgSO4, filtered and evaporated in vacuo. Silica gel 
chromatography (hexanes / EtOAc 9:1) afforded the desired TBS-ether (97.2 mg, 0.116 mmol, 
98%) as a white solid.  
Rf = 0.59 (hexanes / EtOAc = 9:1); [α]20D = (c =, CHCl3); 1H NMR (300 MHz, CDCl3) δ = -
0.06 (s, 3H), -0.03 (s, 3H), 0.07 (s, 6H), 0.80 (s, 9H), 0.88 (d, J = 7.2 Hz, 3H), 0.91 (s, 9H), 
1.14 (d, J = 7.0 Hz, 3H), 1.64 (d, J = 0.9 Hz, 3H), 2.29 (s, 3H), 2.42 (s, 1H), 2.49 (m, 1H), 
4.02 (m, 1H), 4.23 (dd, J = 5.2, 1.2 Hz, 2H), 4.45 (A of ABq, JAB=16.2, 1H), 4.63 (dd, J = 9.3, 
8.4 Hz, 1H), 4.83 (B of ABq, JAB=16.4, 1H), 5.26 (d, J = 9.4 Hz, 1H), 5.64-5.73 (m, 2H),  
6.17 (d, J = 15.6 Hz, 1H), 6.71 (m, 2H), 6.86 (s, 2H), 7.05-7.30 (m, 6H), 7.34 (m, 2H); 13C 
NMR (75 MHz, CDCl3) δ = -5.1, -4.7, -4.4, 13.1, 13.3, 14.4, 18.1, 18.5, 20.9, 22.9, 25.9, 26.0, 
47.5, 48.2, 56.8, 64.0, 70.9, 77.8, 126.4, 126.7, 127.3, 127.7, 127.9, 128.3, 128.4, 128.5, 132.1, 
132.2, 133.2, 134.0,134.5, 138.3, 138.7, 140.4, 142.5, 173.1; HRMS calculated for 
C47H71NO6SSi2Na [M+Na]+: 856.4438, found: 856.4448. 
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(2S,4R,5R,6E,8E)-10-(tert-butyldimethylsilyloxy)-5-hydroxy-4,7-dimethyl-3-oxodeca-6,8-
dien-2-yl benzoate 210 
 
BzO OTBS
O MeOH
Me
C25H38O5Si
Exact Mass: 446,2489
Mol. Wt.: 446,6517  
 
To a stirred solution (-78 °C) of (S)-3-oxopentan-2-yl benzoate (1.88 g, 9.12 mmol, 1.0 eq.) in 
Et2O (8 mL) was added chlorodicyclohexylborane (3.05 mL, 13.7 mmol, 1.5 eq.) and Me2NEt 
(1.9 mL, 18 mmol, 2 eq.). The mixture was warmed to 0 °C, stirred for 2 h and then recooled 
to -78 °C. A solution of aldehyde (2.63 g, 10.9 mmol, 1.2 eq.) in Et2O (8 mL) was added 
dropwise over 2 min. After 3 h, the reaction was kept in the freezer (-22 °C) overnight (14 h). 
The mixture was warmed to 0 °C and quenched by dropwise addition of MeOH (15 mL), pH7 
phosphate buffer (15 mL) and 30% H2O2 (15 mL) and stirred for 2 h. Water (60 mL) was 
added, the organic layer was separated and the aqueous layer was extracted with Et2O (4 × 50 
mL). The combined organics were dried over MgSO4, filtered and evaporated in vacuo. Silica 
gel chromatography (hexanes / EtOAc, gradient elution, 9:1 to 6:1) afforded ketone (3.95 g, 
8.85 mmol, 97%) as a colorless oil.  
Rf = 0.61 (hexanes / EtOAc = 4:1); [α]20D = +30.0 (c = 2.16, CHCl3); 1H NMR (300 MHz, 
CDCl3) δ = 0.07(s, 6H), 0.91 (s, 9H), 1.13 (d, J = 7.2 Hz, 3H), 1.55 (d, J = 7.2 Hz, 3H), 1.81 
(s, 3H), 2.17 (d, J = 4.3 Hz, 1H), 2.92 (m, 1H), 4.24 (dd,  J = 5.0, 1.4 Hz, 2H), 4.70 (m, 1H), 
5.36 (d, J = 9.2 Hz, 1H), 5.44 (q, J = 7.0 Hz, 1H), 5.77 (dt,  J = 15.5, 5.1 Hz, 1H), 6.23 (d, J = 
15.6 Hz, 1H), 7.45 (tm, J = 7.5 Hz, 2H), 7.57 (tm, J = 7.4 Hz, 1H), 8.07 (dm, J = 7.2 Hz, 2H); 
13C NMR (75 MHz, CDCl3) δ = -5.2, 13.3, 14.2, 15.6, 18.4, 26.0, 48.8, 63.7, 70.4, 75.0, 128.5, 
129.3, 129.8, 130.9, 133.4, 136.7, 165.9, 211.1; HRMS calculated for C25H38O5SiNa [M+Na]+: 
469.2386, found: 469.2390. 
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(2S,4R,5R,6E,8E)-10-(tert-butyldimethylsilyloxy)-5-(3,4-dimethoxybenzyloxy)-4,7-
dimethyl-3-oxodeca-6,8-dien-2-yl benzoate 210 
 
O
Me
O Me
OTBS
BzO
C34H48O7Si
Exact Mass: 596,3169
Mol. Wt.: 596,8262
DMPM
 
 
To a solution of the alcohol (180 mg, 0.403 mmol, 1.0 eq.) and PPTS (50.6 mg, 0.201 mmol, 
0.5 eq.) in abs. DCM (3 mL) was added a solution of imidate (252 mg, 0.806 mmol, 2.0 eq.) 
in abs. DCM (2 ml). The reaction mixture was stirred at RT for 23 h. Sat. aq. NaHCO3 (6 mL) 
were added, the organic phase separated, and the aq. phase extracted with DCM (3 × 10 mL). 
The combined organic extracts were dried over MgSO4 and concentrated in vacuo. 
Purification by flash chromatography (hexanes / Et2O = 15:1) gave DMPM-ether (90.4 mg, 
0.151 mmol, 37%, two steps) as a white solid. 
Rf = 0.41 (hexanes / EtOAc = 6:1); [α]20D = -1.63 (c = 1.24, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ = 0.08(s, 6H), 0.92 (s, 9H), 1.01 (d, J = 7.1 Hz, 3H), 1.51 (d, J = 7.1 Hz, 3H), 1.77 
(s, 3H), 3.00 (m, 1H), 3.85 (s, 3H), 3.87 (s, 3H), 4.16 (d, J = 11.2 Hz, 1H), 4.26 (d,  J = 5.1 
Hz, 2H), 4.36 (d, J = 11.2 Hz, 1H), 4.44 (t, J = 9.7 Hz, 1H), 5.28 (d, J = 9.7 Hz, 1H), 5.41 (q, 
J = 7.1 Hz, 1H), 5.78 (dt,  J = 15.8, 5.1 Hz, 1H), 6.31 (d, J = 15.8 Hz, 1H), 6.72 (m, 3H), 7.44 
(t, J = 7.6 Hz, 2H), 7.56 (t, J = 7.4 Hz, 1H), 8.05 (d, J = 7.1 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ = -5.2, 13.4, 13.9, 15.3, 18.5, 26.0, 47.6, 55.8, 63.7, 70.3, 75.4, 110.6, 111.1, 120.0, 
128.4, 128.9, 129.7, 130.9, 133.2, 133.4, 138.6, 148.3, 148.8, 165.8, 209.7; HRMS calculated 
for C34H48O7SiNa [M+Na]+: 619.3067, found: 619.3067. 
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(4R,5R,6E,8E)-10-(tert-butyldimethylsilyloxy)-5-(3,4-dimethoxybenzyloxy)-3,4,7-
trimethyldeca-6,8-diene-2,3-diol 211 
 
OH
Me
O Me
OTBS
HO
C28H48O6Si
Exact Mass: 508,322
Mol. Wt.: 508,7626
DMPM
 
 
To a solution of the ketone (74.8 mg, 0.125 mmol, 1.0 eq.) in Et2O (2 mL) was added MeLi 
((235 μL, 1.6 M in Et2O, 0.376 mmol, 3.0 eq) at -78 °C. The reaction mixture was warmed up 
to -20 °C for 4 h and quenched with sat. aq. NH4Cl (6 mL). After warming to room 
temperature, the organic layer was separated and the aqueous layer was extracted with EtOAc 
(3 × 10 mL). The combined organics were dried over MgSO4, filtered and evaporated in 
vacuo. Silica gel chromatography (hexanes / EtOAc, 2:1) afforded the diol (14.0 mg, 27.5 
μmol, 22%) as a colorless oil. 
Rf = 0.21 (hexanes / EtOAc = 2:1); 1H NMR (300 MHz, CDCl3) δ = 0.09(s, 6H), 0.63 (d, J = 
7.0 Hz, 3H),0.93 (s, 9H), 1.14 (d, J = 6.2 Hz, 3H), 1.21 (s, 3H), 1.61 (s, 1H), 1.80 (s, 3H), 
1.93 (m, 1H), 2.32 (s, 1H), 3.47 (m, 1H), 3.86 (s, 3H), 3.87 (s, 3H), 4.21 (d, J = 10.9 Hz, 1H), 
4.28 (m, 3H), 4.47 (d, J = 11.1 Hz, 1H), 5.33 (d, J = 9.6 Hz, 1H), 5.80 (dt,  J = 15.6, 5.1 Hz, 
1H), 6.33 (d, J = 15.6 Hz, 1H), 6.81 (m, 3H); 13C NMR (75 MHz, CDCl3) δ = -5.1, 12.2, 13.6, 
16.9, 18.5, 19.1, 26.0, 43.0, 55.9, 63.7, 70.2, 72.3, 76.4, 78.7, 111.0, 111.7, 121.1, 129.1, 
129.8, 130.5, 133.4, 137.9, 148.9, 149.0; HRMS calculated for C28H48O6SiNa [M+Na]+: 
531.3118, found: 531.3110. 
 
(3R,4R,5E,7E)-9-(tert-butyldimethylsilyloxy)-4-(3,4-dimethoxybenzyloxy)-3,6-dimethyl 
nona-5,7-dien-2-one 212 
 
O
Me
O Me
OTBS
C26H42O5Si
Exact Mass: 462,2802
Mol. Wt.: 462,6942
DMPM
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To a solution of the diol (2.3 mg, 4.5 μmol, 1.0 eq.) in THF (200 μL) was added a sulotion of 
NaIO4 in H2O (50 μL, 12.0 mg / 500 μL, 5.6 μmol, 1.2 eq.) at room temperature. After 2.5 h, 
(3.0 mg, 14.0 μmol, 3.1 eq.) was added as solid. After 3.5 h, a sluotion of NaIO4 in H2O (100 
μL, 12.0 mg / 500 μL, 11.2 μmol, 2.4 eq.) was added. After 6.5 h, the reaction was quenched 
with H2O (4 mL). The organic layer was separated and the aqueous layer was extracted with 
DCM (3 × 3 mL). The combined organics were dried over MgSO4, filtered and evaporated in 
vacuo. Silica gel chromatography (hexanes / EtOAc, 2:1) afforded the methyl ketone (1.8 mg, 
3.9 μmol, 86%) as a colorless oil. 
Rf = 0.72 (hexanes / EtOAc = 2:1); [α]20D = -36.0 (c = 0.13, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ = 0.09(s, 6H), 0.90 (d, J = 7.1 Hz, 3H), 0.92 (s, 9H), 1.78 (s, 3H), 2.19 (s, 3H), 2.75 
(m, 1H), 3.85 (s, 3H), 3.87 (s, 3H), 4.19 (d, J = 11.2 Hz, 1H), 4.27 (d, J = 5.1 Hz, 2H), 4,32 (t, 
J = 9.7 Hz, 1H), 4.41 (d, J = 11.7 Hz, 1H), 5.28 (d, J = 9.7 Hz, 1H), 5.79 (dt, J = 15.8, 5.1 Hz, 
1H), 6.31 (d, J = 16.3 Hz, 1H), 6.75 (m, 3H); 13C NMR (100 MHz, CDCl3) δ = -5.1, 13.1, 
13.5, 18.5, 26.0, 30.8, 51.5, 55.8, 55.9, 63.8, 70.1, 110.8, 111.2, 120.2, 128.9, 129.8, 130.9, 
133.6, 138.4, 148.5, 148.9, 211.9; HRMS calculated for C26H42O5SiNa [M+Na]+: 485.2699, 
found: 485.2695. 
 
(3R,4R,5E,7E)-4-(3,4-dimethoxybenzyloxy)-9-hydroxy-3,6-dimethylnona-5,7-dien-2-one 
213 
 
O
Me
O Me
OH
DMPM
C20H28O5
Exact Mass: 348,1937
Mol. Wt.: 348,4333  
To a solution of diol (11.7 mg, 23.0 μmol, 1.0 eq.) in THF / H2O (200 μL / 50 μL) was added 
NaIO4 (29.5 mg, 138 μmol, 6.0 eq.) at room temperature. After stirring for 6.5 h, the reaction 
was quenched with H2O (4 mL). The organic layer was separated and the aqueous layer was 
extracted with DCM (3 × 6 mL). The combined organics were dried over MgSO4, filtered and 
evaporated in vacuo. Silica gel chromatography (hexanes / EtOAc, 2:1) afforded the methyl 
ketone (7.5 mg, 21.5 μmol, 93%) as a colorless oil. 
Rf = 0.09 (hexanes / EtOAc = 2:1); [α]20D = -20.4 (c = 0.37, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ = 0.90 (d, J = 7.1 Hz, 3H), 1.41 (t, J = 5.9 Hz, 1H), 1.79 (d, J = 1.5 Hz, 3H), 2.19 (s, 
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3H), 2.75 (m, 1H), 3.85 (s, 3H), 3.87 (s, 3H), 4.19 (d, J = 11.2 Hz, 1H), 4.25 (t, J = 5.1 Hz, 
2H), 4,33 (t, J = 9.7 Hz, 1H), 4.40 (d, J = 11.7 Hz, 1H), 5.32 (d, J = 9.7 Hz, 1H), 5.87 (dt, J = 
15.8, 5.8 Hz, 1H), 6.33 (d, J = 15.8 Hz, 1H), 6.75 (m, 3H); 13C NMR (100 MHz, CDCl3) δ = 
13.1, 13.5, 30.8, 51.4, 55.8, 55.9, 63.6, 70.3, 110.8, 111.2, 120.2, 128.3, 130.7, 135.2, 138.1, 
148.5, 148.9, 211.8; HRMS calculated for C20H28O5Na [M+Na]+: 371.1834, found: 371.1838. 
 
(2S,4R,5R,6E,8E)-5,10-bis(tert-butyldimethylsilyloxy)-4,7-dimethyl-3-oxodeca-6,8-dien-
2-yl benzoate 214 
 
BzO OTBS
O MeO
Me
TBS
C31H52O5Si2
Exact Mass: 560,3353
Mol. Wt.: 560,9126  
 
To a stirred solution (-78 °C) of the alcohol (2.70 g, 6.04 mmol, 1.0 eq.) in CH2Cl2 (5 mL) 
was slowly added a solution of proton sponge® (1.81 g, 8.46 mmol, 1.4 eq.) in CH2Cl2 (15 mL) 
and TBSOTf (1.52 mL, 6.64 mmol, 1.1 eq.). The mixture was stirred at -78 °C for 20 min. 
The cooling bath was removed and the reaction quenched with sat. aqueous NaHCO3 (22 mL). 
The mixture was warmed to room temperature. Et2O (80 mL) and sat. aqueous NaHCO3 (20 
mL) were added. The organic layer was separated and the aqueous layer was extracted with 
Et2O (3 × 40 mL). The combined organics were washed with sat. aqueous NaHCO3 (50 mL), 
dried over MgSO4, filtered and evaporated in vacuo. Silica gel chromatography (hexanes / 
Et2O, gradient elution, 9:1 to 6:1) afforded the desired TBS-ether (2.95 g, 5.26 mmol, 87%) as 
a white solid.  
Rf = 0.63 (hexanes / EtOAc = 9:1); [α]20D = +5.0 (c = 0.52, CHCl3); 1H NMR (300 MHz, 
CDCl3) δ = -0.06 (s, 3H), -0.04 (s, 3H), 0.07 (s, 6H), 0.80 (s, 9H), 0.91 (s, 9H), 0.99 (d, J = 
7.1 Hz, 3H), 1.52 (d, J = 7.1 Hz, 3H), 1.78 (d, J = 1.0 Hz, 3H), 2.89 (m, 1H), 4.24 (dd, J = 5.1, 
1.5, 2H), 4.72 (t, J = 9.7 Hz, 1H), 5.26 (d, J = 9.2 Hz, 1H), 5.41 (q, J = 7.0 Hz, 1H), 5.73 (dt, 
J = 15.3, 5.1 Hz, 1H), 6.21 (d, J = 15.8 Hz, 1H), 7.44 (tm, J = 7.6 Hz, 2H), 7.56 (tm, J = 7.4 
Hz, 1H), 8.07 (dm, J = 7.1 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ = -5.1, -4.9, -4.4, 13.5, 
14.0, 15.1, 18.0, 18.5, 25.8, 26.0, 49.5, 63.9, 71.7, 75.4, 128.4 (2C), 129.8, 132.8, 133.2, 
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133.9, 134.6, 165.8, 209.4; HRMS calculated for C31H52O5Si2Na [M+Na]+:  583.3251, found: 
583.3253. 
 
(2S,3R,4S,5R,6E,8E)-5,10-bis(tert-butyldimethylsilyloxy)-4,7-dimethyldeca-6,8-diene-
2,3-diol 216 
 
HO OTBS
OH MeO
Me
TBS
C24H50O4Si2
Exact Mass: 458,3248
Mol. Wt.: 458,8224  
 
To a cooled (–78 °C) solution of the protected aldol product (1.00 g, 1.78 mmol, 1.0 eq.) in 
THF (15 mL) was added a solution of LiBH4 (777 mg, 35.6 mmol, 20 eq.) in THF (20 mL). 
The reaction mixture was warmed slowly to r.t. and stirring was continued for 24 h, before 
cooling to 0 °C and careful quenching with H2O (10 mL) and Sat. aq. NH4Cl (5 mL). The 
organic layer was separated and the aqueous layer was extracted with Et2O (4 × 15 mL) and 
the combined organic extracts washed with brine (20 mL), dried (MgSO4) and concentrated in 
vacuo. The colorless residue (1.06 g) was used for the next step without further purification. 
Rf = 0.010 (hexanes / EtOAc = 9:1); [α]20D =  -9.3 (c = 0.67, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ = 0.005 (s, 3H), 0.06 (s, 3H), 0.07 (s, 6H), 0.74 (d, J = 7.1, 3H), 0.88 (s, 9H), 0.91 (s, 
9H), 1.15 (d, J = 6.6 Hz, 3H), 1.64 (m, 1H), 1.77 (d, J = 1.5 Hz, 3H), 2.52 (d, J = 7.6 Hz, 1H), 
359 (m, 1H), 3.78 (m, 1H), 3.81 (d, J = 2.0 Hz, 1H), 4.25 (dd, J = 5.3, 1.3, 2H), 4.51 (dd, J = 
9.2, 7.6 Hz, 1H), 5.36 (d, J = 9.7 Hz, 1H), 5.74 (dt, J = 15.8, 5.1 Hz, 1H), 6.22 (d, J = 15.8 Hz, 
1H); 13C NMR (100 MHz, CDCl3) δ = -5.1, -4.9, -3.9, 12.0, 13.5, 16.3, 18.0, 18.5, 25.8, 26.0, 
42.3, 63.9, 68.4, 75.0, 77.6, 128.6, 133.1, 133.8, 133.9; HRMS calculated for C24H50O4Si2Na 
[M+Na]+: 481.3145, found: 481.3148. 
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(2R,3R,4E,6E)-3,8-bis(tert-butyldimethylsilyloxy)-2,5-dimethylocta-4,6-dienal 217 
 
H
OTBS
O MeO
Me
TBS
C22H44O3Si2
Exact Mass: 412,2829
Mol. Wt.: 412,754  
 
To a stirring solution of the crude diol (1.06 g) in toluene (10 mL) under an atmosphere of Ar, 
at r.t., was added Pb(OAc)4 (868 mg, 1.96 mmol, 1.1 equiv) in three portions over 5 min. 
After 25 min., direct silica gel chromatography (hexanes / Et2O, 9:1) afforded aldehyde (662 
mg, 1.60 mmol, 90%, two steps) as a colorless oil. 
Rf = 0.62 (hexanes / Et2O = 6:1); [α]20D = -15.2 (c = 1.29, CHCl3); 1H NMR (300 MHz, 
CDCl3) δ = -0.03 (s, 3H), 0.008 (s, 3H), 0.07 (s, 6H), 0.83 (s, 9H), 0.91 (s, 9H), 0.96 (d, J = 
7.2 Hz, 3H), 1.78 (s, 3H), 2.47 (m, 1H), 4.25 (dd, J = 5.3, 1.5 Hz, 2H), 4.63 (dd, J = 9.1, 7.6 
Hz, 1H), 5.39 (d, J = 9.2 Hz, 1H), 5.75 (dt, J = 15.6, 5.2 Hz, 1H), 6.22 (d, J = 15.6 Hz, 1H), 
9.77 (d, J = 2.8 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ = -5.1, -4.1, 10.5, 13.3, 18.1, 18.5, 
25,7, 26.0, 53.3, 63.9, 71.2, 128.8, 132.4, 133.7, 134.2, 204.7. 
 
(3R,4R,5E,7E)-4,9-bis(tert-butyldimethylsilyloxy)-3,6-dimethylnona-5,7-dien-2-one 219 
 
OTBS
O MeO
Me
TBS
C23H46O3Si2
Exact Mass: 426,2985
Mol. Wt.: 426,7805  
 
To a cold (-78 °C) stirred, solution of the aldehyde (1.21 g, 2.93 mmol, 1.0 eq) was added 
MeLi (5.50 mL, 1.6 M in Et2O, 8.79 mmol, 3.0 eq). After stirring for 30 min., the reaction 
mixture was warmed to -30 °C, and stirred at this temperature for 30 min. The reaction 
mixture was quenched by addition of pH7 phosphate buffer (15 mL). The organic phase was 
separated, and the aq. phase thoroughly extracted with Et2O (3 × 15 mL). The combined 
Experimental Section 159
organics were dried over MgSO4, filtered and evaporated in vacuo. Silica gel chromatography 
(hexanes / EtOAc, gradient elution, 9:1 to 2:1) afforded the respective secondary alcohol 
(1.02 g, 2.39 mmol, 82%) as a colorless oil.  
1H NMR (300 MHz, CDCl3) δ = -0.01 (s, 3H), 0.05 (s, 3H), 0.07 (s, 6H), 0.87 (s, 9H), 0.91 (s, 
9H), 0.93 (d, J = 7.3 Hz, 3H), 1.11 (d, J = 6.4 Hz, 3H), 1.73 (d, J = 1.1 Hz, 3H), 1.51 (m, 1H), 
3.54 (d, J = 2.8 Hz, 1H), 4.17 (m, 1H), 4.24 (dd, J = 5.4, 1.4 Hz, 2H), 4.52 (dd, J = 8.7, 4.7 Hz, 
1H), 5.56 (d, J = 8.7 Hz, 1H), 5.72 (dt, J = 15.6, 5.3 Hz, 1H), 6.22 (d, J = 15.6 Hz, 1H); 13C 
NMR (75 MHz, CDCl3) δ = -5.1, -4.2, 10.9, 13.1, 18.0, 18.5, 25,8, 26.0, 44.2, 64.0, 67.7, 75.1, 
128.1, 132.8, 134.0, 134.2. 
To a solution of the above prepared alcohol (1.02 g, 2.39 mmol, 1.0 eq.) in CH2Cl2 (3 mL) 
were added NaHCO3 (462 mg, 5.50 mmol, 2.3 eq) and a solution of Dess-Martin-Periodinan 
(1.22 g, 2.87 mmol, 1.2 eq) in CH2Cl2 (13 mL). The resulting solution was stirred 90 min at 
room temperature. Sat. aq. Na2SO3 (15 mL) and sat. aq. NaHCO3 (15 mL) were added, the 
organic phase separated, and the aq. phase thoroughly extracted with CH2Cl2 (3 x 15 mL). 
The combined organic phases were dried over MgSO4. Evaporation of the solvent in vacuo 
and flash chromatography (hexanes / Et2O = 9:1) afforded the ketone (932 mg, 2.18 mmol, 
92%) as a colorless oil. 
Rf = 0.50 (hexanes / Et2O = 9:1); [α]20D = -7.1 (c = 0.17, CHCl3); 1H NMR (400 MHz, CDCl3) 
δ = -0.07 (s, 3H), -0.04 (s, 3H), 0.07 (s, 6H), 0.80 (s, 9H), 0.85 (d, J = 6.6 Hz, 3H), 0.90 (s, 
9H), 1.78 (s, 3H), 2.18 (s, 3H), 2.67 (m, 1H), 4.24 (dd, J = 5.3, 1.3 Hz, 2H), 4.55 (t, J = 9.4 
Hz, 1H), 5.26 (d, J = 9.2 Hz, 1H), 5.72 (dt, J = 15.3, 5.7 Hz, 1H), 6.21 (d, J = 15.8 Hz, 1H); 
13C NMR (100 MHz, CDCl3) δ = -5.1, -4.2, 13.0, 13.5, 18.0, 18.5, 25,8, 26.0, 31.5, 53.3, 63.9, 
72.5, 128.5, 132.9, 133.9, 134.3, 212.4; HRMS calculated for C23H46O3Si2Na [M+Na]+: 
449.2883, found: 449.2881. 
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8.4.2 Connection of the C15-C23 and the C24-C31 Subunits 
4-phenylbutanal 221 
 
H
O
C10H12O
Exact Mass: 148,0888
Mol. Wt.: 148,2017  
 
To a solution of the alcohol (148 mg, 0.985 mmol, 1.0 eq.) in CH2Cl2 (2 mL) were added 
Dess-Martin-Periodinan (500 mg, 1.18 mmol, 1.2 eq). The resulting solution was stirred 60 
min at room temperature. Sat. aq. Na2SO3 (5 mL) and sat. aq. NaHCO3 (5 mL) were added, 
the organic phase separated, and the aq. phase thoroughly extracted with CH2Cl2 (3 × 5 mL). 
The combined organic phases were dried over MgSO4. Evaporation of the solvent in vacuo 
and flash chromatography (pentane / CH2Cl2 = 1:1) afforded the aldehyde (137 mg, 0.924 
mmol, 94%) as a colorless oil. 
Rf = 0.56 (pentane / CH2Cl2 = 1:1); 1H NMR (400 MHz, CDCl3) δ = 1.96 (m, 2H), 2.45 (dt, J 
= 7.1, 1.5 Hz, 2H), 2.66 (t, J = 7.6 Hz, 2H), 7.19 (m, 3H), 7.29 (m, 2H), 9.75 (t, J = 1.5 Hz, 
1H); 13C NMR (100 MHz, CDCl3) δ = 23.7, 35.0, 43.2, 126.1, 141.2, 202.3. 
 
(4R,7R,8R,9E,11E)-8,13-bis(tert-butyldimethylsilyloxy)-4-hydroxy-7,10-dimethyl-1-
phenyltrideca-9,11-dien-6-one 222 
 
O
Me
O Me
OTBS
OH
C33H58O4Si2
Exact Mass: 574,3874
Mol. Wt.: 574,9822
TBS
 
 
To a solution of (+)-DIPCl (23.4 mg, 73.1 μmol, 2.6 eq.) in dry Et2O (50 μL) was added dry 
Et3N (16.0 μL, 113 mmol, 4.0 eq.) and a solution of ketone (12.0 mg, 28.1 μmol, 1.0 eq.) in 
dry Et2O (200 μL + 50 μL washing) at 0 °C. The resulting white suspension was stirred at 0 
°C for 90 min and then cooled to −78 °C. A solution of the aldehyde (12.5 mg, 84.3 μmol, 3.0 
eq.) in dry Et2O (100 μL) was added via cannula, and the suspension was stirred at -78 °C for 
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3 h, and then at room temperature for 15 h. The reaction was quenched by the addition of pH7 
phosphate buffer (60 μL) and a 30% aqueous solution of H2O2 (100 μL) at 0 °C. After 
warming to room temperature, the layers were separated. The aqueous phase was extracted 
with CH2Cl2 (3 × 3 mL) and the combined organic extracts were dried (MgSO4) and 
concentrated in vacuo. The crude oil was flash chromatographed (hexanes / EtOAc, gradient 
elution, 15:1 to 9:1) to yield an aldol adduct (8.0 mg, 13.9 μmol, 50%) as a yellow oil. 
Rf = 0.34 (hexanes / EtOAc = 9:1); [α]20D = -39.4 (c = 0.04, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ = -0.07 (s, 3H), -0.05 (s, 3H), 0.07 (s, 6H), 0.79 (s, 9H), 0.84 (d, J = 7.1 Hz, 3H), 
0.91 (s, 9H), 1.40 (m, 1H), 1.52 (m, 1H), 1.70 (m, 2H), 1.78 (d, J = 1.0, 3H), 2.54 (m, 1H), 
2.63 (m, 3H), 2.73 (m, 1H), 3.16 (d, J = 3.0 Hz, 1H), 4.07 (m, 1H), 4.25 (dd, J = 5.1, 1.5 Hz, 
2H), 4.56 (t, J = 9.4 Hz, 1H), 5.24 (d, J = 9.7 Hz, 1H), 5.74 (dt, J = 15.3, 5.1 Hz, 1H), 6.21 (d, 
J = 15.8 Hz, 1H), 7.17 (m, 3H), 7.26 (m, 2H); 13C NMR (100 MHz, CDCl3) δ = -5.1, -4.2, 
13.0, 13.5, 18.0, 18.5, 25.8, 26.0, 27.2, 35.7, 51.4, 53.0, 63.9, 67.0, 72.6, 125.7, 128.3, 128.4, 
128.7, 132.6, 133.8, 134.6, 142.3, 215.9; HRMS calculated for C33H58IO4Si2Na [M+Na]+: 
597.3771, found: 597.3770. 
 
(R)-((4R,7R,8R,9E,11E)-8,13-bis(tert-butyldimethylsilyloxy)-7,10-dimethyl-6-oxo-1-
phenyltrideca-9,11-dien-4-yl) 3,3,3-trifluoro-2-methoxy-2-phenylpropanoate 223 
 
(R)
(R)
O
Me
O Me
OTBS
(R)
O
(R)
Ph
O
F3C
MeO
C43H65F3O6Si2
Exact Mass: 790,4272
Mol. Wt.: 791,1388
TBS
 
 
To a stirred solution of (2R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoic acid (3.7 mg, 15.6 
μmol, 3.0 eq.), Et3N (2.0 μL, 17.2 μmol, 3.3 eq.) and DMAP (2.1 mg, 17.2 μmol, 3.3 eq.) in 
toluene (50 μL) were added 2,4,6-trichlorobenzoyl chloride (2.4 μL, 15.6 μmol, 3.0 eq.) and a 
solution of alcohol (3.0 mg, 5.2 μmol, 1.0 eq.) in toluene (100 μL) at room temperature. The 
resulted white slurry was stirred at room temperature for 20 minutes before being quenched 
with pH7 phosphate buffer (0.5 mL) and H2O (1 mL) at 0 °C. DCM (2 mL) was added and 
the layers were separated. The aqueous layer was extracted with DCM (3 × 2 mL). The 
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combined organic extracts were dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography (hexanes / EtOAc = 9:1) afforded the ester (3.6 mg, 4.6 mmol, 88%) as a 
colorless oil. 
Rf = 0.67 (hexanes / EtOAc = 9:1); 1H NMR (400 MHz, CDCl3) δ = -0.08 (s, 3H), -0.07 (s, 
3H), 0.07 (s, 6H), 0.77 (s, 9H), 0.78 (d, J = 7.0 Hz, 3H), 0.91 (s, 9H), 1.62 (m, 4H), 1.77 (d, J 
= 1.0, 3H), 2.58 (m, 3H), 2.71 (dd, J = 18.3, 4.1 Hz, 1H), 2.93 (dd, J = 18.3, 8.6 Hz, 1H), 3.48 
(d, J = 1.0 Hz, 3H), 4.24 (dd, J = 5.1, 1.0 Hz, 2H), 4.54 (t, J = 9.4 Hz, 1H), 5.21 (d, J = 9.7 Hz, 
1H), 5.58 (m, 1H), 5.73 (dt, J = 15.8, 5.1 Hz, 1H), 6.20 (d, J = 15.3 Hz, 1H), 7.07 (m, 2H), 
7.16 (m, 1H), 7.24 (m, 2H), 7.35 (m, 3H), 7.49 (m, 2H). 
 
(S)-((4R,7R,8R,9E,11E)-8,13-bis(tert-butyldimethylsilyloxy)-7,10-dimethyl-6-oxo-1-
phenyltrideca-9,11-dien-4-yl) 3,3,3-trifluoro-2-methoxy-2-phenylpropanoate 224 
 
(R) (R)
O
Me
O Me
OTBS
(R)
O
(S)
Ph
O
MeO
F3C
C43H65F3O6Si2
Exact Mass: 790,4272
Mol. Wt.: 791,1388
TBS
 
 
To a stirred solution of (2S)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoic acid (3.7 mg, 15.6 
μmol, 3.0 eq.), Et3N (2.0 μL, 17.2 μmol, 3.3 eq.) and DMAP (2.1 mg, 17.2 μmol, 3.3 eq.) in 
toluene (50 μL) were added 2,4,6-trichlorobenzoyl chloride (2.4 μL, 15.6 μmol, 3.0 eq.) and a 
solution of alcohol (3.0 mg, 5.2 μmol, 1.0 eq.) in toluene (100 μL) at room temperature. The 
resulting white slurry was stirred at room temperature for 20 minutes before being quenched 
with pH7 phosphate buffer (0.5 mL) and H2O (1 mL) at 0 °C. DCM (2 mL) was added and 
the layers were separated. The aqueous layer was extracted with DCM (3 × 2 mL). The 
combined organic extracts were dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography (hexanes / EtOAc = 9:1) afforded the ester (3.6 mg, 4.6 mmol, 98%) as a 
colorless oil. 
Rf = 0.71 (hexanes / EtOAc = 9:1); 1H NMR (400 MHz, CDCl3) δ = -0.08 (s, 6H), 0.07 (s, 
6H), 0.67 (d, J = 7.0 Hz, 3H), 0.77 (s, 9H), 0.91 (s, 9H), 1.68 (m, 4H), 1.76 (d, J = 1.0, 3H), 
2.53 (m, 1H), 2.61 (m, 2H), 2.68 (dd, J = 18.3, 4.1 Hz, 1H), 2.88 (dd, J = 18.1, 7.9 Hz, 1H), 
3.49 (d, J = 1.0 Hz, 3H), 4.24 (dd, J = 5.3, 1.3 Hz, 2H), 4.51 (t, J = 9.4 Hz, 1H), 5.20 (d, J = 
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9.7 Hz, 1H), 5.60 (m, 1H), 5.72 (dt, J = 15.3, 5.1 Hz, 1H), 6.19 (d, J = 15.3 Hz, 1H), 7.12 (m, 
2H), 7.17 (m, 1H), 7.25 (m, 2H), 7.35 (m, 3H), 7.50 (m, 2H). 
 
(2E,4Z,6R,7R,10R,14S,16Z)-1,6-bis(tert-butyldimethylsilyloxy)-10-hydroxy-17-iodo-14-
methoxy-4,7-dimethylheptadeca-2,4,16-trien-8-one 225 
 
O
OHOCH3
O
OTBS
TBS
I
C32H61IO5Si2
Exact Mass: 708,3102
Mol. Wt.: 708,8992  
 
To a solution of ketone (230 mg, 0.540 mmol, 1.0 eq.) in dry Et2O (0.7 mL) was added dry 
Et3N (227 μL, 1.62 mmol, 3.0 eq.) and a solution of (+)-DIPCl (449 mg, 1.40 mmol, 2.6 eq. 
under high vacuum for 4 h to remove any traces of HCl) in dry Et2O (2 mL) at 0 °C. The 
resultant white suspension was stirred at 0 °C for 60 min and then cooled to −78 °C. A 
solution of the aldehyde (198 mg, 0.702 mmol, 1.3 eq.) in dry Et2O (1 mL + 2 × 0.5 mL for 
washings) was added via cannula, and the suspension was stirred at −78 °C for 2 h, −60 °C 
for 1 h and then at −20 °C for 18 h. The reaction was quenched by the addition of pH7 
phosphate buffer (6 mL) and after warming to room temperature, the layers were separated. 
The aqueous phase was extracted with Et2O (3 × 6 mL) and the combined organic extracts 
were concentrated in vacuo. The resultant residue was taken up in MeOH (6 mL) and pH7 
phosphate buffer (3 mL) and cooled to 0 °C. A 30% aqueous solution of H2O2 (1 mL) was 
added and the mixture was warmed to RT and stirred for 2.5 h. CH2CCl2 (6 mL) and H 2O (6 
mL) were added and the layers were separated. The aqueous phase was extracted with 
CH2CCl2 (4×8 mL). The combined organic extracts were dried (MgSO4) and concentrated in 
vacuo. The crude oil was flash chromatographed (hexanes / EtOAc, gradient elution, 9:1 to 
4:1) to yield an aldol adduct (289 mg, 0.408 mmol, 76%) as a colorless oil. 
Rf = 0.11 (hexanes / EtOAc = 9:1); [α]20D = -34.1 (c = 0.73, CHCl3); 1H NMR (600 MHz, 
CDCl3) δ = -0.06 (s, 3H), -0.04 (s, 3H), 0.07 (s, 6H), 0.80 (s, 9H), 0.85 (d, J = 7.0 Hz, 3H), 
0.91 (s, 9H), 1.44 (m, 6H), 1.79 (s, 3H), 2.35 (m, 2H), 2.56 (dd, J = 18.3, 9.5 Hz, 1H), 2.65 
(m, 3H), 2.75 (dd, J = 18.3, 2.2 Hz, 1H), 3.18 (s, 1H), 3.30 (m, 1H), 3.34 (s, 3H), 4.05 (m, 
1H), 4.25 (d, J = 5.3 Hz, 2H), 4.57 (t, J = 9.3 Hz, 1H), 5.24 (d, J = 9.2 Hz, 1H), 5.74 (dt, J = 
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15.8, 5.1 Hz, 1H), 6.21 (d, J = 15.8 Hz, 1H), 6.24 (q, J = 6.6 Hz, 1H), 6.29 (d, J = 7.3 Hz, 1H); 
13C NMR (100 MHz, CDCl3) δ = -5.1, -4.2, 13.0, 13.5, 18.0, 18.5, 21.4, 25.8, 26.0, 33.6, 36.2, 
38.5, 51.4, 53.0, 56.7, 63.9, 67.0, 72.6, 79.5, 84.2, 128.7, 132.6, 133.7, 134.6, 137.6, 215.9; 
HRMS calculated for C32H61IO5Si2Na [M+Na]+: 731.3000, found: 731.3000. 
 
(R)-((1Z,4S,8R,11R,12R,13E,15E)-12,17-bis(tert-butyldimethylsilyloxy)-1-iodo-4-
methoxy-11,14-dimethyl-10-oxoheptadeca-1,13,15-trien-8-yl) 3,3,3-trifluoro-2-methoxy-
2-phenylpropanoate 225a 
 
O
(R)(S)
(R) (R)
OOCH3
O
OTBS
TBS
I
(R)
Ph
O CF3
OMe
C42H68F3IO7Si2
Exact Mass: 924,35
Mol. Wt.: 925,0558  
 
To a stirred solution of (2R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoic acid (3.5 mg, 14.8 
μmol, 2.1 eq.), Et3N (2.0 μL, 16.2 μmol, 2.3 eq.) and DMAP (2.0 mg, 16.4 μmol, 2.3 eq.) in 
toluene (50 μL) were added 2,4,6-trichlorobenzoyl chloride (2.3 μL, 14.8 μmol, 2.1 eq.) and a 
solution of alcohol (5.0 mg, 7.0 μmol, 1.0 eq.) in toluene (100 μL) at room temperature. The 
resulting white slurry was stirred at room temperature for 20 minutes before being quenched 
with pH7 phosphate buffer (0.5 mL) and H2O (1 mL) at 0 °C. DCM (2 mL) was added and 
the layers were separated. The aqueous layer was extracted with DCM (3 × 2 mL). The 
combined organic extracts were dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography (hexanes / EtOAc = 6:1) afforded the ester (5.7 mg, 6.2 mmol, 89%) as a 
colorless oil. 
Rf = 0.46 (hexanes / EtOAc = 9:1); 1H NMR (400 MHz, CDCl3) δ = -0.07 (s, 3H), -0.05 (s, 
3H), 0.07 (s, 6H), 0.79 (d, J = 6.6 Hz, 3H), 0.80 (s, 9H), 0.91 (s, 9H), 1.40 (m, 4H), 1.61 (m, 
2H), 1.78 (s, 3H), 2.30 (t, J = 5.6 Hz, 2H), 2.61 (m, 1H), 2.74 (dd, J = 18.6, 3.8 Hz, 1H), 2.95 
(dd, J = 18.3, 8.6 Hz, 1H), 3.18 (m, 1H), 3.29 (s, 3H), 3.50 (s, 3H), 4.25 (d, J = 5.1 Hz, 2H), 
4.55 (t, J = 9.4 Hz, 1H), 5.23 (d, J = 9.7 Hz, 1H), 5.54 (m, 1H), 5.73 (dt, J = 15.8, 5.1 Hz, 1H), 
6.21 (m, 2H), 6.29 (m, 1H), 7.37 (m, 3H), 7.50 (m, 2H). 
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(S)-((1Z,4S,8R,11R,12R,13E,15E)-12,17-bis(tert-butyldimethylsilyloxy)-1-iodo-4-
methoxy-11,14-dimethyl-10-oxoheptadeca-1,13,15-trien-8-yl) 3,3,3-trifluoro-2-methoxy-
2-phenylpropanoate 225b 
 
O
(R)(S)
(R) (R)
OOCH3
O
OTBS
TBS
I
(S)
Ph
O OMe
CF3
C42H68F3IO7Si2
Exact Mass: 924,35
Mol. Wt.: 925,0558  
 
To a stirred solution of (2S)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoic acid (3.5 mg, 14.8 
μmol, 5.1 eq.), Et3N (2.0 μL, 16.2 μmol, 5.6 eq.) and DMAP (2.0 mg, 16.4 μmol, 5.6 eq.) in 
toluene (50 μL) were added 2,4,6-trichlorobenzoyl chloride (2.3 μL, 14.8 μmol, 5.1 eq.) and a 
solution of alcohol (2.0 mg, 2.9 μmol, 1.0 eq.) in toluene (100 μL) at room temperature. The 
resulting white slurry was stirred at room temperature for 20 minutes before being quenched 
with pH7 phosphate buffer (0.5 mL) and H2O (1 mL) at 0 °C. DCM (2 mL) was added and 
the layers were separated. The aqueous layer was extracted with DCM (3 × 2 mL). The 
combined organic extracts were dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography (hexanes / EtOAc = 6:1) afforded the ester (2.4 mg, 2.6 mmol, 90%) as a 
colorless oil. 
Rf = 0.50 (hexanes / EtOAc = 9:1); 1H NMR (300 MHz, CDCl3) δ = -0.07 (s, 3H), -0.06 (s, 
3H), 0.07 (s, 6H), 0.68 (d, J = 7.0 Hz, 3H), 0.79 (s, 9H), 0.91 (s, 9H), 1.49 (m, 4H), 1.68 (m, 
2H), 1.76 (s, 3H), 2.33 (t, J = 5.6 Hz, 2H), 2.55 (m, 1H), 2.68 (dd, J = 18.3, 4.1 Hz, 1H), 2.90 
(dd, J = 18.3, 8.1 Hz, 1H), 3.25 (m, 1H), 3.32 (s, 3H), 3.52 (s, 3H), 4.25 (d, J = 5.1 Hz, 2H), 
4.52 (t, J = 9.4 Hz, 1H), 5.21 (d, J = 9.2 Hz, 1H), 5.55 (m, 1H), 5.73 (dt, J = 15.6, 5.1 Hz, 1H), 
6.22 (m, 2H), 6.30 (m, 1H), 7.37 (m, 3H), 7.52 (m, 2H). 
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(1Z,4S,8R,10S,11S,12R,13E,15E)-12,17-bis(tert-butyldimethylsilyloxy)-10-hydroxy-1-
iodo-4-methoxy-11,14-dimethylheptadeca-1,13,15-trien-8-yl acetate 226 
 
I
OCH3 OAc
OTBS
HO
O
TBS
C34H65IO6Si2
Exact Mass: 752,3364
Mol. Wt.: 752,9518  
 
To a solution of acetaldehyde (320 μL) in THF (400 μL) was added SmI2 (0.1 M in THF, 352 
μL, 35.2 μmol, 1.25 eq.) at -10 °C. After stirring for 10 min at the same temperature, a 
solution of the ketone (20.0 mg, 28. 2 μmol, 1.0 eq.) in THF (50 μL, 2 × 50 washings) was 
added at -10 °C. The mixture was stirred 1 h at -10 °C and then placed in a -20 °C freezer for 
16 h (without stirring). The reaction was quenched at -20 °C with sat. aq. NaHCO3 (1 mL) 
and was stirred for 30 min while warming to room temperature. The mixture was diluted with 
Et2O (3 mL) and the layers were separated.  The aqueous phases were extracted with Et2O (3 
× 3 mL). The combined organic phases were dried over MgSO4, filtered, and concentrated in 
vacuo. Purification by flash chromatography (hexanes / EtOAc, 4:1) afforded alcohol (19.7 
mg, 26.2 μmol, 93%) as colorless oil.  
Rf = 0.30 (hexanes / EtOAc = 4:1); [α]20D = -11.4 (c = 0.19, CHCl3); 1H NMR (300 MHz, 
CDCl3) δ = -0.03 (s, 3H), 0.01 (s, 3H), 0.07 (s, 6H), 0.75 (d, J = 7.0 Hz, 3H), 0.85 (s, 9H), 
0.90 (s, 9H), 1.29-1.77 (m, 9H), 1.74 (s, 3H), 2.20 (s, 3H), 2.34 (m, 2H), 3.27 (m, 1H), 3.33 (s, 
3H), 3.41 (m, 1H), 3.54 (d, J = 3.5 Hz, 1H), 4.24 (dd, J = 5.2, 1.0 Hz, 2H), 4.55 (dd, J = 9.2, 
6.6 Hz, 1H), 5.08 (m, 1H), 5.32 (d, J = 9.2 Hz, 1H), 5.70 (dt, J = 15.6, 5.4 Hz, 1H), 6.20 (d, J 
= 15.6 Hz, 1H), 6.23 (q, J = 7.0 Hz, 1H), 6.29 (d, J = 7.3 Hz, 1H); 13C NMR (75 MHz, CDCl3) 
δ = -5.1, -4.9, -4.0, 10.9, 13.3, 18.1, 18.5, 21.2, 21.4, 25,9, 26.0, 33.4, 35.2, 38.4, 39.0, 45.6, 
56.7, 64.0, 68.6, 71.6, 72.2, 79.4, 84.2, 127.8, 133.4, 133.6, 134.4, 137.5, 172.1; HRMS 
calculated for C34H65IO6Si2Na [M+Na]+: 775.3262, found: 775.3257. 
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(1Z,4S,8R,10S,11S,12R,13Z,15E)-12,17-bis(tert-butyldimethylsilyloxy)-1-iodo-4-
methoxy-11,14-dimethylheptadeca-1,13,15-triene-8,10-diol 227 
 
HO
OHOCH3
O
OTBS
TBS
I
C32H63IO5Si2
Exact Mass: 710,3259
Mol. Wt.: 710,9151  
 
To a solution of acetic acid (1.6 mL) in acetonitrile (1.6 mL) was added 
tetramethylammonium triacetoxyborohydride (274 mg, 1.04 mmol, 4.7 eq.). After stirring for 
15 min at room temperature, the mixture was added to a cold (-40 °C) stirred, solution of the 
β-hydroxy ketone (157 mg, 0.221 mmol, 1.0 eq.) in 5:2 acetonitrile/THF (3.2 mL) via cannula. 
The mixture was then placed in a -20 °C freezer for 40 h (without stirring). The reaction was 
quenched at -20 °C with a saturated aqueous solution of potassium sodium tartrate 
tetrahydrate (20 mL) and was stirred for 30 min while warming to room temperature. The 
mixture was diluted with CH2Cl2 (25 mL) and the layers were separated.  The aqueous phases 
were extracted with CH2Cl2 (4 × 15 mL). The combined organic phasees were washed with 
saturated aqueous NaHCO3 (1 × 20 mL), and dried (MgSO4), filtered, and concentrated to 
give a yellow oil. Purification by flash chromatography (hexanes / EtOAc, gradient elution, 
6:1 to 4:1) afforded the diol (144 mg, 0.203 mmol, 92%) as a clear, colorless oil.  
Rf = 0.33 (hexanes / EtOAc = 4:1); [α]20D = -19.0 (c = 0.76, CHCl3); 1H NMR (600 MHz, 
CDCl3) δ = 0.003 (s, 3H), 0.06 (s, 3H), 0.07 (s, 6H), 0.67 (d, J = 7.0 Hz, 3H), 0.87 (s, 9H), 
0.91 (s, 9H), 1.41 (m, 2H), 1.54 (m, 4H), 1.65 (m, 2H), 1.74 (m, 1H), 1.76 (s, 3H), 2.35 (m, 
2H), 3.30 (m, 1H), 3.34 (s, 3H), 3.50 (s, 1H), 3.93 (m, 2H), 4.25 (dd, J = 5.3, 1.2 Hz, 2H), 
4.42 (t, J = 8.9 Hz, 1H), 4.76 (s, 1H), 5.34 (d, J = 9.1 Hz, 1H), 5.74 (dt, J = 15.5, 5.3 Hz, 1H), 
6.22 (d, J = 15.3 Hz, 1H), 6.26 (m, 2H); 13C NMR (75 MHz, CDCl3) δ = -5.1, -3.7, 12.8, 13.6, 
18.0, 18.5, 21.7, 25,8, 26.0, 33.8, 37.6, 38.5, 39.4, 44.1, 56.7, 63.9, 68.7, 74.2, 76.5, 79.5, 84.1, 
128.8, 133.5, 133.8, 133.9, 137.7; HRMS calculated for C32H63IO5Si2Na [M+Na]+: 733.3157, 
found: 733.3156. 
 
 
 
Experimental Section 168
(5R,7S,8S,9R,10Z,12E)-9-(tert-butyldimethylsilyloxy)-5-((S,Z)-7-iodo-4-methoxyhept-6-
enyl)-2,2,3,3,8,11,16,16,17,17-decamethyl-4,15-dioxa-3,16-disilaoctadeca-10,12-dien-7-ol 
229 
 
HO
OTBSOCH3
O
OTBS
TBS
I
C38H77IO5Si3
Exact Mass: 824,4123
Mol. Wt.: 825,1759  
 
A flask containing the diole (235 mg, 0.330 mmol, 1.0 eq.), imidazol (112 mg, 1.65 mmol, 5.0 
eq.) and TBSCl (124 mg, 0.826 mmol, 2.5 eq.) was charged with argon and abs. DCM (1.1 ml) 
was added. The reaction mixture was stirred at RT for 30 min. Sat. aq. NaHCO3 (5 mL) were 
added, the organic phase separated, and the aq. phase thoroughly extracted with DCM (3 × 10 
mL). The combined organic extracts were dried over MgSO4 and concentrated in vacuo. 
Purification by flash chromatography (hexanes / Et2O = 9:1) gave TBS-ether (172 mg, 0.208 
mmol, 63%, 77%) as colourless oil. 
Rf = 0.60 (hexanes / EtOAc = 9:1); [α]20D = -14.4 (c = 1.18, CHCl3);  1H NMR (600 MHz, 
CDCl3) δ = -0.025 (s, 3H), 0.029 (s, 3H), 0.066 (s, 3H), 0.072 (s, 6H), 0.083 (s, 3H), 0.75 (d, J 
= 7.0 Hz, 3H), 0.86 (s, 9H), 0.88 (s, 9H), 0.91 (s, 9H), 1,32 (m, 1H), 1.41 (m, 2H), 1.49 (m, 
4H), 1.63 (m, 2H), 1.77 (d, J = 1.1 Hz, 3H), 2.34 (m, 2H), 3.27 (m, 1H), 3.33 (s, 3H), 3.76 (m, 
1H), 3.85 (d, J = 2.2 Hz, 1H), 4.00 (m, 1H), 4.24 (dd, J = 5.5, 1.1 Hz, 2H), 4.52 (dd, J = 9.2, 
6.6 Hz, 1H), 5.36 (d, J = 9.2 Hz, 1H), 5.70 (dt, J = 15.4, 5.5 Hz, 1H), 6.21 (d, J = 15.4 Hz, 
1H), 6.24 (q, J = 6.8 Hz, 1H), 6.29 (d, J = 7.7 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ = -5.1, -
4.8, -4.5, -4.2, -3.9, 11.8, 13.4, 18.1, 18.5, 21.3, 25.9, 26.0, 34.0, 37.5, 38.5, 40.0, 46.0, 56.7, 
64.1, 70.2, 70.5, 73.5, 79.5, 84.2, 127.9, 133.3, 133.9, 134.4, 137.6; HRMS calculated for 
C38H77IO5Si3Na [M+Na]+: 847.4021, found: 847.4019. 
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(1Z,4S,8R,10S,11S,12R,13E,15E)-10,12,17-tris(tert-butyldimethylsilyloxy)-1-iodo-4-
methoxy-11,14-dimethylheptadeca-1,13,15-trien-8-ol 228 
 
TBSO
OHOCH3
O
OTBS
TBS
I
C38H77IO5Si3
Exact Mass: 824,4123
Mol. Wt.: 825,1759  
 
Rf = 0.51 (hexanes / EtOAc = 9:1); [α]20D = -23.3 (c = 1.80, CHCl3); 1H NMR (600 MHz, 
CDCl3) δ = -0.061 (s, 3H), 0.006 (s, 3H), 0.055 (s, 3H), 0.072 (s, 9H), 0.73 (d, J = 7.0, 3H), 
0.86 (s, 9H), 0.88 (s, 9H), 0.91 (s, 9H), 1.46 (m, 8H), 1.74 (s, 3H),  1.80 (m, 1H), 2.02 (d, J = 
5.1 Hz, 1H), 2.34 (m, 2H), 3.30 (m, 1H), 3.34 (s, 3H), 3.79 (m, 1H), 4.21 (t, J = 8.8 Hz, 1H), 
4.24 (d, J = 5.1 Hz, 2H), 4.38 (m, 1H), 5.31 (d, J = 9.2 Hz, 1H), 5.70 (dt, J = 15.5, 5.3 Hz, 
1H), 6.21 (d, J = 15.4 Hz, 1H), 6.25 (q, J = 6.8 Hz, 1H), 6.29 (d, J = 7.5 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) δ = -5.0, -4.8, -4.6, -4.2, -3.8, 9.8, 13.4, 18.1, 18.5, 21.8, 25.9, 26.0, 33.7, 
38.1, 38.3, 38.5, 46.1, 56.7, 64.1, 68.9, 69.3, 71.4, 79.6, 84.1, 121.9, 133.0, 133.3, 134.8, 
137.6; HRMS calculated for C38H77IO5Si3Na [M+Na]+: 847.4021, found: 847.4025. 
 
(6E,8E,10R,11S,12S,14R)-10,12-bis(tert-butyldimethylsilyloxy)-14-((S,Z)-7-iodo-4-
methoxyhept-6-enyl)-2,2,3,3,8,11,16,16,17,17-decamethyl-4,15-dioxa-3,16-disilaoctadeca-
6,8-diene 230 
 
TBSO
OTBSOCH3
O
OTBS
TBS
I
C44H91IO5Si4
Exact Mass: 938,4988
Mol. Wt.: 939,4368  
 
Rf = 0.87 (hexanes / EtOAc = 9:1); [α]20D = -16.3 (c = 0.97, CHCl3); 1H NMR (600 MHz, 
CDCl3) δ = -0.06 (s, 3H), -0.01 (s, 3H), -0.005 (s, 3H), 0.01 (s, 3H), 0.05 (s, 3H), 0.06 (s, 3H), 
0.07 (s, 6H), 0.80 (d, J = 7.0 Hz, 3H), 0.85 (s, 9H), 0.86 (s, 9H), 0.89 (s, 9H), 0.91 (s, 9H), 
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1.42 (m, 7H), 1.73 (d, J = 0.7 Hz, 3H),  1.75 (m, 1H), 2.34 (m, 2H), 3.27 (m, 1H), 3.33 (s, 3H), 
3.77 (m, 1H), 4.09 (m, 1H), 4.24 (dd, J = 5.5, 1.1 Hz, 2H), 4.33 (dd, J = 8.8, 6.6 Hz, 1H), 5.41 
(d, J = 8.8 Hz, 1H), 5.68 (dt, J = 15.8, 5.5 Hz, 1H), 6.20 (d, J = 15.8 Hz, 1H), 6.25 (m, 1H), 
6.28 (m, 1H); 13C NMR (100 MHz, CDCl3) δ = -5.0, -4.8, -4.2, -3.9, -3.7, 10.3, 13.1, 18.1, 
18.2, 18.5, 20.9, 26.0, 26.1, 34.0, 38.5, 38.8, 40.4, 46.7, 56.7, 64.2, 70.2, 70.9, 71.7, 79.7, 84.0, 
127.5, 132.1, 134.4, 135.2, 137.7;  HRMS calculated for C44H91IO5Si4Na [M+Na]+: 961.4886, 
found: 961.4870. 
 
8.4.3 Connection of the C15-C31 and the C32-C42 Subunits 
(3R,4S)-((2E,4E,6R,7S,8S,10R,14S,16Z)-10-acetoxy-1,6-bis(tert-butyldimethylsilyloxy)-
17-iodo-14-methoxy-4,7-dimethylheptadeca-2,4,16-trien-8-yl) 3-(tert-butyldimethylsilyl 
oxy)-4-((4R,5S,6R)-2,2,5-trimethyl-6-((S)-pent-4-en-2-yl)-1,3-dioxan-4-yl)pentanoate 231 
 
O
O
OAcOCH3
O
O
O
OTBS
OTBS
TBS
I
C57H107IO10Si3
Exact Mass: 1162,6217
Mol. Wt.: 1163,6144  
 
Et3N (4.4 μL, 31.2 μmol, 2.5 eq.) and 2,4,6-trichlorobenzoyl chloride (5.0 μL, 31.2 μmol, 2.5 
eq.) were added to a stirred solution of alcohol (9.4 mg, 12.5 μmol, 1.0 eq.), the acid (6.8 mg, 
15.9 μmol, 1.3 eq.), DMAP (7.6 mg, 62.5 μmol, 5.0 eq.) in toluene (300 μL) at 0 °C. The 
resulted white slurry was stirred at 0 °C for 30 minutes before being quenched with pH7 
phosphate buffer (0.5 mL) and H2O (0.5 mL). Et2O (6 mL) was added and the layers were 
separated. The aqueous layer was extracted with Et2O (4 × 3 mL). The combined organic 
extracts were dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
(hexanes / Et2O = 20:1) afforded the ester (12.7 mg, 10.9 μmol, 87%) as a colorless oil. 
Rf = 0.36 (hexanes / Et2O = 9:1); [α]20D = -3.0 (c = 0.11, CHCl3); 1H NMR (600 MHz, CDCl3) 
δ = -0.04 (s, 3H), -0.03 (s, 3H), 0.02 (s, 3H), 0.07 (s, 9H), 0.74 (d, J = 7.3 Hz, 3H), 0.82 (s, 
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9H), 0.89 (s, 9H), 0.91 (s, 9H), 0.90-0.93 (m, 9H), 1.37 (s, 3H), 1.38 (s, 3H), 1.44 (m, 3H), 
1.52 (m, 3H), 1.63 (m, 2H), 1.75 (s, 3H),  1.72-1.78 (m, 3H), 1.83 (m, 1H), 1.94 (s, 3H), 1.97 
(m, 1H), 2.11 (m, 1H), 2.16 (m, 1H), 2.34 (m, 3H), 3.27 (m, 1H), 3.40 (s, 3H), 3.38 (m, 2H), 
4.23 (m, 2H), 4.25 (d, J = 5.1 Hz, 2H), 4.94 (m, 1H), 5.01 (m, 1H), 5.28 (d, J = 9.2 Hz, 1H), 
5.34 (m, 1H), 5.71 (dt, J = 15.8, 5.4 Hz, 1H), 5.75 (m, 1H), 6.20 (d, J = 15.8 Hz, 1H), 6.23 (q, 
J = 7.0 Hz, 1H),  6.30 (d, J = 8.1 Hz, 1H); 13C NMR (600 MHz, CDCl3) δ = -5.0, -4.8, -4.7, -
4.4, -3.6, 5.5, 10.1, 10.4,  13.4, 16.2, 18.0, 18.1, 18.5, 19.7, 21.1, 21.2, 25.9, 26.0, 26.1, 30.1, 
30.9, 32.4, 33.8, 33.9, 35.4, 35.8, 37.4, 38.5, 40.3, 42.9, 56.8, 64.1, 68.2, 69.6, 69.9, 71.3, 76.2, 
77.9, 79.4, 84.3, 99.0, 116.4, 128.2, 133.5, 134.1, 134.3, 136.7, 137.5, 170.7, 171.4; HRMS 
calculated for C57H107IO10Si3Na [M+Na]+: 1185.6115, found: 1185.6115. 
 
(3R,4S)-((5R,7S,8S,9R,10E,12E)-9-(tert-butyldimethylsilyloxy)-5-((S,Z)-7-iodo-4-
methoxyhept-6-enyl)-2,2,3,3,8,11,16,16,17,17-decamethyl-4,15-dioxa-3,16-disilaoctadeca-
10,12-dien-7-yl) 3-(tert-butyldimethylsilyloxy)-4-((4R,5S,6R)-2,2,5-trimethyl-6-((S)-pent-
4-en-2-yl)-1,3-dioxan-4-yl)pentanoate 232 
 
O
O
OTBSOCH3
O
O
O
OTBS
OTBS
TBS
I
C61H119IO9Si4
Exact Mass: 1234,6976
Mol. Wt.: 1235,8386  
 
Et3N (67.0 μL, 0.482 mmol, 2.5 eq.) and 2,4,6-trichlorobenzoyl chloride (76.0 μL, 0.482 
mmol, 2.5 eq.) were added to a stirred solution of alcohol (159 mg, 0.193 mmol, 1.0 eq.), the 
acid (140 mg, 0.326 mmol, 1.7 eq.), DMAP (118 mg, 0.965 mmol, 5.0 eq.) in toluene (7.0 mL) 
at 0 °C. The resulted white slurry was stirred at room temperature for 30 minutes before being 
quenched with pH7 phosphate buffer (7.0 mL) and H2O (7.0 mL) at 0 °C. Et2O (20 mL) was 
added and the layers were separated. The aqueous layer was extracted with Et2O (4 × 15 mL). 
The combined organic extracts were dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography (hexanes / Et2O = 9:1) afforded the ester (232 mg, 0.188 mmol, 97%) as a 
colorless oil. 
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Rf = 0.71 (hexanes / Et2O = 9:1); [α]20D = -1.9 (c = 0.56, CHCl3); 1H NMR (600 MHz, CDCl3) 
δ = -0.05 (s, 3H), -0.02 (s, 3H), -0.006 (s, 3H), -0.001 (s, 3H), 0.01 (s, 3H), 0.07 (s, 9H), 0.82 
(d, J = 6.0 Hz, 3H), 0.83 (s, 9H), 0.87 (s, 9H), 0.89 (s, 9H), 0.91 (s, 9H), 0.89 (d, J = 5.9 Hz, 
3H), 0.90 (d, J = 6.6 Hz, 3H), 0.92 (d, J = 6.6 Hz, 3H), 1.34 (s, 3H), 1.37 (s, 3H), 1.37-1.50 
(m, 6H), 1.73 (s, 3H),  1.80-1.86 (m, 2H), 2.05 (dd, J = 16.1, 1.5 Hz, 1H), 2.10 (m, 1H), 2.15 
(dd, J = 10.6, 5.9 Hz, 3H), 2.30-2.40 (m, 3H), 3.27 (m, 1H), 3.30 (dd, J = 9.2, 1.5 Hz, 1H), 
3.34 (s, 3H), 3.32-3.37 (m, 1H), 3.72 (m, 1H), 4.24 (d, J = 5.2 Hz, 2H), 4.23-4.27 (m, 1H), 
4.34 (dd, J = 8.8, 5.9 Hz, 1H), 4.99 (m, 2H), 5.21 (m, 1H), 5.40 (d, J = 9.2 Hz, 1H), 5.68 (dt, J 
= 15.4, 5.5 Hz, 1H), 5.72 (m, 1H), 6.19 (d, J = 15.8 Hz, 1H), 6.25 (q, J = 6.9 Hz, 1H), 6.30 (d, 
J = 7.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = -5.0, -4.8, -4.7, -4.5, -4.4, -4.2, -4.0, 5.5, 
10.4, 10.7, 13.2, 14.1, 16.2, 17.9, 18.1, 18.5, 19.5, 20.3, 22.7, 25.8, 26.0, 26.1, 30.1, 31.2, 31.6, 
33.8, 34.2, 35.9, 36.2, 37.6, 38.2, 38.5, 40.3, 42.7, 56.8, 64.2, 68.1, 68.8, 71.7, 72.6, 76.1, 77.9, 
79.6, 84.2, 99.0, 116.4, 127.6, 132.8, 134.0, 134.5, 136.3, 137.5, 171.1; HRMS calculated for 
C61H119IO9Si4Na [M+Na]+: 1257.6874, found: 1257.6882. 
 
8.4.4 Completion of the Macrolide Moiety 
(1R,2S,3R,7S,9R,13S,15Z,17E,20S,21R,25S)-7-((2S,3R,4E,6E)-3,8-bis(tert-butyldimethyl 
silyloxy)-5-methylocta-4,6-dien-2-yl)-3-(tert-butyldimethylsilyloxy)-13-methoxy-2,20,23, 
23,25-pentamethyl-5-oxo-6,22,24-trioxabicyclo[19.3.1]pentacosa-15,17-dien-9-yl acetate 
233 
 
O
O
OAcOCH3
O
O
O
OTBS
OTBS
TBS
C57H106O10Si3
Exact Mass: 1034,7094
Mol. Wt.: 1035,702  
 
To a solution of iodide (11.6 mg, 9.97 μmol, 1.0 eq.) in DMF (3.3 mL) was added Pd(OAc)2 
(2.71 mg, 12.0 μmol, 1.2 eq.), Bu4NCl (3.30 mg, 12.0 μmol, 1.2 eq.) and K2CO3 (3.42 mg, 
24.9 μmol, 2.5 eq.) at room temperature. The resulting yellow suspension was stirred at 60 °C 
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for 1 h. After removal of the solvent, the residue was purified by column chromatography 
(hexanes / Et2O = 20:1) to give dien (3.50 mg, 3.38 μmol, 34%) as a colorless oil. 
Rf = 0. 61 (hexanes / EtOAc = 9:1); [α]20D = +11.6 (c = 0.30, CHCl3); 1H NMR (600 MHz, 
CDCl3) δ = -0.04 (s, 3H), 0.02 (s, 3H), 0.03 (s, 3H), 0.07 (s, 6H), 0.09 (s, 3H), 0.77 (d, J = 7.0 
Hz, 3H), 0.84 (s, 9H), 0.88 (s, 9H), 0.90 (d, J = 6.6 Hz, 3H), 0.91 (s, 9H), 0.93 (d, J = 6.6 Hz, 
3H), 0.94 (d, J = 6.6 Hz, 3H), 1.30 (m, 2H), 1.34 (s, 3H), 1.37 (s, 3H), 1.40-1.46 (m, 3H), 
1.56 (m, 1H), 1.74 (s, 3H),  1.72-1.83 (m, 6H), 1.88 (m, 1H), 1.98 (s, 3H), 2.10 (m, 1H), 2.22 
(m, 1H), 2.32 (m, 2H), 2.50 (m, 1H), 3.20 (m, 1H), 3.32 (s, 3H), 3.35 (dd, J = 9.2, 1.5 Hz, 1H), 
3.42 (m, 1H), 4.18 (m, 1H), 4.24 (dd, J = 5.1, 0.9 Hz, 2H), 4.27 (t, J = 8.4 Hz, 1H), 4.88 (m, 
1H), 5.30 (d, J = 9.2 Hz, 1H), 5.37 (m, 2H), 5.66 (m, 1H), 5.70 (dt, J = 15.8, 5.4 Hz, 1H), 6.06 
(t, J = 10.8 Hz, 1H), 6.20 (d, J = 15.8 Hz, 1H),  6.28 (dd, J = 14.7, 11.0 Hz, 1H); 13C NMR 
(600 MHz, CDCl3) δ = -5.1, -4.8, -4.6, -4.5, -3.8, 5.6, 10.5, 13.4, 16.0, 18.1, 18.5, 19.5, 20.6, 
21.4, 25.9, 26.0, 29.7, 30.1, 30.4, 30.8, 31.8, 33.6, 35.2, 35.5, 40.3, 43.4, 56.6, 64.1, 69.4, 70.0, 
71.0, 76.1, 77.9, 80.9, 99.0, 125.8, 127.3, 128.1, 130.3, 132.2, 133.4, 134.2, 170.4, 171.9; 
HRMS calculated for C57H106O10Si3Na [M+Na]+: 1057.6992, found: 1057.6980. 
 
(1R,2S,3R,7S,9R,13S,15Z,17E,20S,21R,25S)-7-((2S,3R,4E,6E)-3,8-bis(tert-butyldimethyl 
silyloxy)-5-methylocta-4,6-dien-2-yl)-3,9-bis(tert-butyldimethylsilyloxy)-13-methoxy-
2,20 ,23,23,25-pentamethyl-6,22,24-trioxabicyclo[19.3.1]pentacosa-15,17-dien-5-one 234 
 
O
O
OTBSOCH3
O
O
O
OTBS
OTBS
TBS
C61H118O9Si4
Exact Mass: 1106,7853
Mol. Wt.: 1107,9262  
 
To iodide (88.0 mg, 71.2 μmol, 1.0 eq.), Pd(OAc)2 (16.0 mg, 71.2 μmol, 1.0 eq.), Bu4NCl 
(49.5 mg, 178 μmol, 2.5 eq.) and K2CO3 (78.5 mg, 569 μmol, 8.0 eq.) was added DMF (18.0 
mL) at room temperature. The resulting yellow suspension was stirred at 70 °C for 50 min. 
The mixture was cooled to room temperature, diluted with Et2O (40 mL) and filtered through 
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a celite plug (3 × 10 mL Et2O). After removal of the solvent, the residue was purified by 
column chromatography (hexanes / Et2O = 20:1) to give dien (55.1 mg, 49.7 μmol, 70%) as a 
colorless oil. 
Rf = 0.55 (hexanes / Et2O = 9:1); [α]20D = +6.3 (c = 0.57, CHCl3); 1H NMR (600 MHz, CDCl3) 
δ = -0.04 (s, 3H), 0.005 (s, 3H), 0.02 (s, 3H), 0.04 (s, 3H), 0.07 (s, 9H), 0.08 (s, 3H), 0.83 (d, 
J = 7.1 Hz, 3H), 0.84 (s, 9H), 0.87 (s, 9H), 0.89 (s, 9H), 0.90 (d, J = 6.6 Hz, 3H), 0.91 (s, 9H), 
0.91 (d, J = 7.0 Hz, 3H), 0.93 (d, J = 6.6 Hz, 3H), 1.34 (s, 3H), 1.37 (s, 3H), 1.39-1.53 (m, 
6H), 1.61 (m, 1H), 1.68-1.75 (m, 2H), 1.73 (s, 3H), 1.80-1.85 (m, 2H), 1.89-1.93 (m, 2H), 
2.11 (m, 1H), 2.20 (m, 2H), 2.34 (dd, J = 16.1, 8.8 Hz, 1H), 2.46 (m, 1H), 3.20 (m, 1H), 3.31 
(s, 3H), 3.31-3.36 (m, 2H), 3.78 (m, 1H), 4.24-4.26 (m, 3H), 4.40 (dd, J = 9.2, 6.6 Hz, 1H), 
5.17 (m, 1H), 5.36 (d, J = 9.5 Hz, 1H), 5.38 (m, 1H), 5.64 (m, 1H), 5.69 (dt, J = 15.8, 5.3 Hz, 
1H), 6.04 (t, J = 10.8 Hz, 1H), 6.20 (d, J = 15.8 Hz, 1H), 6.23 (dd, J = 14.7, 11.0 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ = -5.1, -4.7, -4.5, -4.4, -4.3, -4.1, -3.8, 5.8, 11.3, 13.3, 16.3, 18.0, 
18.1, 18.5, 19.6, 25.9, 26.0, 26.1, 30.1, 31.1, 31.8, 35.0, 37.2, 38.3, 40.1, 44.1, 56.5, 64.1, 70.7, 
71.0, 72.9, 80.3, 99.1, 126.0, 127.1, 127.9, 130.2, 132.2, 133.1, 133.6, 134.4, 171.0; HRMS 
calculated for C61H118O9Si4Na [M+Na]+: 1129.7751, found: 1129.7743. 
 
(1R,2S,3R,7S,9R,13S,15Z,17E,20S,21R,25S)-3,9-bis(tert-butyldimethylsilyloxy)-7-
((2S,3R,4E,6E)-3-(tert-butyldimethylsilyloxy)-8-hydroxy-5-methylocta-4,6-dien-2-yl)-13-
methoxy-2,20,23,23,25-pentamethyl-6,22,24-trioxabicyclo[19.3.1]pentacosa-15,17-dien-5-
one 235 
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OH
TBS
C55H104O9Si3
Exact Mass: 992,6988
Mol. Wt.: 993,6654  
 
To a solution of the TBS-ether (26.0 mg, 23.5 μmol, 1.0 eq.) was added NH4F (26.1 mg. 704 
μmol, 30 eq.).The yellow reaction mixture was stirred at room temperature for 18 h. After 
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removing of the solvent, the residue was purified by column chromatography (hexanes / 
EtOAc = 4:1) to give the alcohol (16.3 mg, 16.4 μmol, 70%) as colorless oil. 
Rf = 0.20 (hexanes / EtOAc = 9:1); [α]20D = +9.3 (c = 0.10, CHCl3); 1H NMR (600 MHz, 
CDCl3) δ = -0.04 (s, 3H), 0.01 (s, 3H), 0.02 (s, 3H), 0.04 (s, 3H), 0.06 (s, 3H), 0.07 (s, 3H), 
0.84 (s, 9H), 0.87 (s, 9H), 0.89 (d, J = 6.6 Hz, 3H), 0.90 (s, 9H), 0.91 (d, J = 6.6 Hz, 3H), 0.93 
(d, J = 6.6 Hz, 3H), 1.34 (s, 3H), 1.37 (s, 3H), 1.34-1.43 (m, 7H), 1.48-1.52 (m, 3H), 1.59 (m, 
1H), 1.69 (m, 1H), 1.73-1.84 (m, 3H), 1.75 (s, 3H), 1.89-1.94 (m, 2H), 2.13 (m, 1H), 2.19 (m, 
2H), 2.34 (dd, J = 15.8, 8.8 Hz, 1H), 2.47 (m, 1H), 3.21 (m, 1H), 3.31 (s, 3H), 3.31-3.36 (m, 
2H), 3.77 (m, 1H), 4.21 (m, 3H), 4.42 (dd, J = 9.2, 6.2 Hz, 1H), 5.16 (m, 1H), 5.37 (m, 1H), 
5.43 (d, J = 9.2 Hz, 1H), 5.64 (m, 1H), 5.78 (dt, J = 15.8, 6.0 Hz, 1H), 6.04 (t, J = 10.8 Hz, 
1H), 6.23 (m, 2H); 13C NMR (100 MHz, CDCl3) δ =  -4.7, -4.5, -4.4, -4.3, -4.1, -3.9, 5.7, 11.2, 
13.3, 16.3, 18.0, 18.1, 19.6, 25.9, 26.1, 30.1, 31.1, 31.4, 35.0, 37.4, 38.2, 40.2, 44.1, 56.4, 64.0, 
70.4, 70.9, 72.9, 80.3, 99.1, 126.0, 127.1, 127.4, 130.3, 132.4, 132.8, 134.3, 135.9, 171.1; 
HRMS calculated for C55H104O9Si3Na [M+Na]+: 1015.6886, found: 1015.6887. 
 
8.4.5 Synthesis of Analogues of Etnangien Macrolide Structure 
(3R,4S)-((1Z,4S,8R,10S,11S,12R,13E,15E)-10,12,17-tris(tert-butyldimethylsilyloxy)-1-
iodo-4-methoxy-11,14-dimethylheptadeca-1,13,15-trien-8-yl) 3-(tert-butyldimethylsilyl 
oxy) -4-((4R,5S,6R)-2,2,5-trimethyl-6-((S)-pent-4-en-2-yl)-1,3-dioxan-4-yl)pentanoate 236 
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O
C61H119IO9Si4
Exact Mass: 1234,6976
Mol. Wt.: 1235,8386  
 
Et3N (7.6 μL, 54 μmol, 2.5 eq.) and 2,4,6-trichlorobenzoyl chloride (8.6 μL, 54 μmol, 2.5 eq.) 
were added to a stirred solution of alcohol (18.0 mg, 21.8 μmol, 1.0 eq.), the acid (15.9 mg, 
37.1 μmol, 1.7 eq.), DMAP (13.3 mg, 109 μmol, 5.0 eq.) in toluene (0.8 mL) at 0 °C. The 
resulting white slurry was stirred at room temperature for 30 minutes before being quenched 
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with pH7 phosphate buffer (1.0 mL) and H2O (1.0 mL) at 0 °C. DCM (2 mL) was added and 
the layers were separated. The aqueous layer was extracted with DCM (3 × 5 mL). The 
combined organic extracts were dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography (hexanes / Et2O = 20:1) afforded the ester (24.7 mg, 20.0 μol, 92%) as a 
colorless oil. 
Rf = 0.62 (hexanes / Et2O = 9:1); [α]20D = -7.1 (c= 0.50, CHCl3); 1H NMR (600 MHz, CDCl3) 
δ = -0.06 (s, 3H), -0.04 (s, 3H), 0.01 (s, 3H), 0.04 (s, 6H), 0.08 (s, 6H), 0.09 (s, 3H), 0.67 (d, J 
= 7.3 Hz, 3H), 0.85 (s, 9H), 0.86 (s, 9H), 0.89 (s, 9H), 0.91 (s, 9H), 0.91 (d, J = 7.0 Hz, 3H), 
0.92 (d, J = 7.0 Hz, 3H), 0.92 (d, J = 7.0 Hz, 3H), 1.35 (s, 3H), 1.38 (s, 3H), 1.40-1.45 (m, 
3H), 1.49-1.69 (m, 8H), 1.75 (s, 3H), 1.77 (m, 1H), 1.85 (m, 1H), 2.06 (dd, J = 16.3, 1.3 Hz, 
1H), 2.15 (m, 1H), 2.30-2.39 (m, 3H), 3.29 (m, 2H), 3.33 (m, 1H), 3.34 (s, 3H), 4.15 (t, J = 
9.2 Hz, 1H), 4.20 (m, 1H), 4.25 (dd, J = 5.3, 1.3 Hz, 2H), 4.27 (m, 1H), 4.86 (m, 1H), 4.99 (m, 
2H), 5.27 (d, J = 9.2 Hz, 1H), 5.71 (m, 1H), 5.71 (dt, J = 15.4, 5.5 Hz, 1H), 6.21 (d, J = 15.4 
Hz, 1H), 6.23 (m, 1H), 6.29 (m, 1H); 13C NMR (100 MHz, CDCl3) δ = -5.0, -4.8, -4.7, -4.5, -
4.4, -4.0, -3.6, 5.5, 9.2, 10.2, 13.5, 16.2, 18.0, 18.1, 18.5, 19.4, 20.7, 25.9, 26.0, 26.1, 30.1, 
31.1, 33.6, 33.8, 34.3, 34.8, 35.9, 37.7, 38.4, 46.4, 56.7, 64.1, 67.6, 67.7, 71.2, 72.2, 76.2, 78.0, 
79.4, 84.2, 99.0, 116.4, 128.0, 133.0, 134.3, 134.9, 136.4, 137.5, 171.7; HRMS calculated for 
C61H119IO9Si4Na [M+Na]+: 1257.6874, found: 1257.6892. 
 
(1R,2S,3R,7R,11S,13Z,15E,18S,19R,23S)-3-(tert-butyldimethylsilyloxy)-11-methoxy-
2,18,21,21,23-pentamethyl-7-((2S,3S,4R,5E,7E)-2,4,9-tris(tert-butyldimethylsilyloxy)-3,6-
dimethylnona-5,7-dienyl)-6,20,22-trioxabicyclo[17.3.1]tricosa-13,15-dien-5-one 237 
 
OCH3
OTBS
O
O O
TBS TBS
O
O OTBS
O
C61H118O9Si4
Exact Mass: 1106,7853
Mol. Wt.: 1107,9262  
 
To iodide (53.0 mg, 42.9 μmol, 1.0 eq.), Pd(OAc)2 (9.63 mg, 42.9 μmol, 1.0 eq.), Bu4NCl 
(29.8 mg, 107 μmol, 2.5 eq.) and K2CO3 (47.3 mg, 343 μmol, 8.0 eq.) was added DMF (11.0 
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mL) at room temperature. The resulted yellow suspension was stirred at 70 °C for 60 min. 
The mixture was cooled to room temperature, diluted with Et2O (24 mL) and filtered through 
a celite plug (3 × 10 mL Et2O). After removing of the solvent, the residue was purified by 
HPLC (Nucleosil-100-7, VP 250 × 21, hexane / EtOAc = 60:1) to give dien (15.3 mg, 13.8 
μmol, 32%) as a colorless oil. 
Rf = 0.50 (hexanes / Et2O = 9:1); [α]20D = +12.9 (c = 1.30, CHCl3); 1H NMR (600 MHz, 
CDCl3) δ = -0.05 (s, 3H), -0.02 (s, 6H), 0.03 (s, 6H), 0.05 (s, 3H), 0.08 (s, 6H), 0.69 (d, J = 
6.8 Hz, 3H), 0.85 (s, 9H), 0.87 (d, J = 7.1 Hz, 3H), 0.88 (s, 18H), 0.90 (d, J = 7.1 Hz, 3H), 
0.91 (s, 9H), 0.99 (d, J = 6.8 Hz, 3H), 1.35 (s, 3H), 1.37 (s, 3H), 1.45-1.57 (m, 6H), 1.63 (m, 
1H), 1.74-1.83 (m, 5H), 1.75 (s, 3H), 2.09 (m, 1H), 2.18 (m, 3H), 2.33 (m, 1H), 2.50 (m, 1H), 
3.31-3.46 (m, 3H), 3.35 (s, 3H), 4.17 (t, J = 9.0 Hz, 1H), 4.20 (m, 1H), 4.24 (m, 1H), 4.25 (d, 
J = 5.6 Hz, 2H), 4.80 (m, 1H), 5.29 (d, J = 9.0 Hz, 1H), 5.46 (m, 1H), 5.66 (m, 1H), 5.70 (dt, 
J = 15.8, 5.4 Hz, 1H), 6.00 (t, J = 10.9 Hz, 1H), 6.21 (d, J = 15.8 Hz, 1H), 6.43 (dd, J = 14.3, 
11.7 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ = -5.1, -4.9, -4.8, -4.4, -4.3, -4.0, -3.7, 6.0, 9.2, 
13.4, , 18.0, 18.1, 18.5, 18.8, 19.6, 21.0, 25.9, 26.0, 30.1, 30.4, 30.9, 32.0, 32.3, 33.4, 33.8, 
35.0, 40.6, 46.3, 57.1, 64.1, 67.7, 69.0, 71.3, 72.2, 78.8, 80.0, 99.0, 126.0, 126.4, 127.9, 129.9, 
132.6, 132.9, 134.3, 135.0, 172.5; HRMS calculated for C61H118O9Si4Na [M+Na]+: 1129.7751, 
found: 1129.7721. 
 
(1R,2S,3R,7R,11S,13Z,15E,18S,19R,23S)-7-((2S,3S,4R,5E,7E)-2,4-bis(tert-butyldimethyl 
silyloxy)-9-hydroxy-3,6-dimethylnona-5,7-dienyl)-3-(tert-butyldimethylsilyloxy)-11-
methoxy-2,18,21,21,23-pentamethyl-6,20,22-trioxabicyclo[17.3.1]tricosa-13,15-dien-5-
one 238 
 
OCH3
OH
O
O O
TBS TBS
O
O OTBS
O
C55H104O9Si3
Exact Mass: 992,6988
Mol. Wt.: 993,6654  
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To a solution of the TBS ether (12.0 mg, 10.8 µmol, 1.0 eq.) in THF/H2O (4:1, 100 µL) was 
added NaIO4 (13.9 mg, 65.0 µmol, 6.0 eq.) as solid at room temperature. The reaction mixture 
was stirred at RT for 15 h and H2O (1 mL) and DCM (2 mL) were added. The organic layer 
was separated and the aqueous layer was extracted with DCM (3 × 2 mL). The combined 
organics were dried over MgSO4, filtered and evaporated in vacuo. Silica gel chromatography 
(hexanes / EtOAc, gradient elution, 9:1 to 2:1) afforded the alcohol (9.0 mg, 9.1 µmol, 84%) 
as a colorless oil. 
Rf = 0.15 (hexanes / EtOAc = 9:1); 1H NMR (600 MHz, CDCl3) δ = -0.05 (s, 3H), -0.02 (s, 
6H), 0.02 (s, 3H), 0.04 (s, 3H), 0.05 (s, 3H), 0.69 (d, J = 7.1 Hz, 3H), 0.85 (s, 9H), 0.87 (d, J 
= 6.0 Hz, 3H), 0.88 (s, 9H), 0.89 (s, 9H), 0.90 (d, J = 6.8 Hz, 3H), 0.99 (d, J = 6.8 Hz, 3H), 
1.35 (s, 3H), 1.37 (s, 3H), 1.45-1.57 (m, 6H), 1.63 (m, 1H), 1.74-1.83 (m, 5H), 1.77 (s, 3H), 
2.09 (m, 1H), 2.18 (m, 3H), 2.33 (m, 1H), 2.50 (m, 1H), 3.31-3.46 (m, 3H), 3.35 (s, 3H), 4.17-
4.23 (m, 3H), 4.21 (d, J = 6.0 Hz, 2H), 4.80 (m, 1H), 5.34 (d, J = 8.7 Hz, 1H), 5.46 (m, 1H), 
5.66 (m, 1H), 5.79 (dt, J = 15.8, 5.8 Hz, 1H), 6.00 (t, J = 10.7 Hz, 1H), 6.25 (d, J = 15.1 Hz, 
1H), 6.43 (dd, J = 14.3, 11.7 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ = -4.9, -4.8, -4.4, -4.3, -
4.0, -3.7, 6.0, 9.2, 13.4, 18.0, 18.8, 19.6, 21.0, 25.9, 26.0, 30.1, 31.0, 32.0, 32.3, 33.4, 33.8, 
35.0, 40.6, 46.3, 57.1, 63.7, 63.8, 67.7, 71.3, 72.2, 78.8, 80.0, 99.0, 126.0, 126.4, 127.3, 129.9, 
132.6, 135.8, 135.9, 172.5; HRMS calculated for C55H104O9Si3Na [M+Na]+: 1015.6886, found: 
1015.6880. 
 
(3R,4S)-((1Z,4S,8R,10S,11S,12R,13E,15E)-10,12,17-tris(tert-butyldimethylsilyloxy)-1-
iodo-4-methoxy-11,14-dimethylheptadeca-1,13,15-trien-8-yl) 3-(tert-butyldimethylsilyl 
oxy)-4-((4R,5S,6R)-2,2,5-trimethyl-6-((S)-pent-4-yn-2-yl)-1,3-dioxan-4-yl)pentanoate 239 
 
OCH3
OTBSI
O
O O
TBS TBS
O
O OTBS
O
C61H117IO9Si4
Exact Mass: 1232,6819
Mol. Wt.: 1233,8228  
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Et3N (10.0 μL, 69.0 μmol, 2.5 eq.) and 2,4,6-trichlorobenzoyl chloride (11.0 μL, 69.0 μmol, 
2.5 eq.) were added to a stirred solution of alcohol (22.8 mg, 27.6 μmol, 1.0 eq.), the acid 
(22.0 mg, 51.6 μmol, 1.9 eq.), DMAP (16.8 mg, 138 μmol, 5.0 eq.) in toluene (1.0 mL) at 0 
°C. The resulting white slurry was stirred at room temperature for 20 minutes before being 
quenched with pH7 phosphate buffer (1.0 mL) and H2O (1.0 mL) at 0 °C. Et2O (3 mL) was 
added and the layers were separated. The aqueous layer was extracted with Et2O (3 × 5 mL). 
The combined organic extracts were dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography (hexanes / Et2O = 9:1) afforded the ester (28.0 mg, 22.7 μmol, 82%) as a 
colorless oil. 
Rf = 0.50 (hexanes / Et2O = 9:1); [α]20D = -9.3 (c = 1.09, CHCl3); 1H NMR (600 MHz, CDCl3) 
δ = -0.05 (s, 3H), -0.04 (s, 3H), 0.008 (s, 3H), 0.03 (s. 3H), 0.04 (s, 3H), 0.07 (s, 6H), 0.09 (s, 
3H), 0.66 (d, J = 7.3 Hz, 3H), 0.85 (s, 9H), 0.86 (s, 9H), 0.88 (s, 9H), 0.91 (s, 9H), 0.92 (d, J 
= 6.6 Hz, 3H), 0.95 (d, J = 6.6 Hz, 3H), 1.06 (d, J = 6.6 Hz, 3H), 1.35 (s, 3H), 1.38 (s, 3H), 
1.42 (m, 2H), 1.56 (m, 6H), 1.67 (m, 1H), 1.75 (s, 3H), 1.77 (m, 2H), 1.84 (m, 1H), 1.91 (t, J 
= 2.6 Hz, 1H), 1.96 (m, 1H), 2.07 (d, J = 15.0 Hz, 1H), 2.21 (m, 1H), 2.36 (m, 3H), 3.29 (m, 
1H), 3.34 (s, 3H), 3.37 (dd, J = 9.0, 1.6 Hz, 1H), 3.44 (dd, J = 9.5, 1.5 Hz, 1H), 4.15 (t, J = 
9.2 Hz, 1H), 4.20 (dt, J = 10.4, 2.4 Hz, 1H), 4.24 (d, J = 6.2 Hz, 2H), 4.25 (m, 1H), 4.85 (m, 
1H), 5.27 (d, J = 9.2 Hz, 1H), 5.70 (dt, J = 15.8, 5.5 Hz, 1H), 6.21 (d, J = 15.8 Hz, 1H), 6.24 
(dd, J = 14.1, 6.8 Hz, 1H), 6.29 (d, J = 7.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = -5.1, -
5.0, -4.8, -4.7, -4.5, -4.3, -4.0, -3.6, 5.6, 9.2, 10.2, 13.5, 16.4, 18.0, 18.1, 18.5, 19.4, 20.8, 20.2, 
25.9, 26.0, 26.1, 30.0, 31.3, 33.0, 33.5, 34.4, 34.9, 37.7, 38.4, 40.4, 46.4, 56.7, 64.1, 67.6, 68.0, 
69.9, 71.2, 72.3, 75.9, 79.4, 81.9, 84.2, 99.1, 128.0, 133.0, 134.3, 134.9, 137.5, 171.7; HRMS 
calculated for C61H117IO9Si4Na [M+Na]+: 1255.6717, found: 1255.6777. 
 
(1R,2S,3R,7R,11S,18S,19R,23S,Z)-3-(tert-butyldimethylsilyloxy)-11-methoxy-
2,18,21,21,23-pentamethyl-7-((2S,3S,4R,5E,7E)-2,4,9-tris(tert-butyldimethylsilyloxy)-3,6-
dimethylnona-5,7-dienyl)-6,20,22-trioxabicyclo[17.3.1]tricos-13-en-15-yn-5-one 240 
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OCH3
OTBS
O
O O
TBS TBS
O OTBS
O
C61H116O9Si4
Exact Mass: 1104,7696
Mol. Wt.: 1105,9103
O
 
 
A solution of the iodide (26.7 mg, 21.6 μmol, 1.0 eq.) and iPr2NEt (113 μl, 648 μmol, 30 eq.) 
in DMF (11 ml) was degassed by freeze-pump-thaw cycle (three times). After addition of CuI 
(8.26 mg, 43.2 μmol, 2.0 eq.), the mixture was vigorously stirred at room temperature in the 
dark for 30 min, producing a yellow solution. Pd(dba)3 (9.89 mg, 10.8 μmol, 0.5 eq.) was 
added to the resulting solution. The reaction mixture was stirred at room temperature for 70 
min in the dark, diluted with Et2O (12 mL) and quenched with sat. aq. NH4Cl (6 mL) and 
water (6 mL) at 0 °C. The mixture was vigorously stirred at room temperature for 1 h. The 
layers were separated, and the aqueous layers were extracted with Et2O (4 × 10 mL). The 
combined organic extracts were washed with brine (6 mL), dried over MgSO4 and 
concentrated. The residue was purified by flash column chromatography on silica gel 
(hexanes / Et2O = 20:1) to give the desired product (7.20 mg, 6.50 μmol, 30%) as a colorless 
oil. 
Rf = 0.48 (hexanes / Et2O = 9:1); 1H NMR (600 MHz, CDCl3) δ = -0.05 (s, 3H), 0.01 (s, 3H), 
0.02 (s. 3H), 0.03 (s, 3H), 0.04 (s, 3H), 0.07 (s, 6H), 0.08 (s, 3H), 0.69 (d, J = 7.0 Hz, 3H), 
0.87 (s, 27H), 0.91 (s, 9H), 0.93 (d, J = 6.8 Hz, 3H), 0.94 (d, J = 6.8 Hz, 3H), 1.04 (d, J = 6.6 
Hz, 3H), 1.31 (m, 2H), 1.36 (s, 3H), 1.37 (s, 3H), 1.48 (m, 2H), 1.58 (m, 1H), 1.65 (m, 1H), 
1.74 (s, 3H), 1.70-1.76 (m, 3H), 1.78-1.86 (m, 3H), 2.29-2.40 (m, 3H), 2.43-2.49 (m, 3H), 
3.33 (m, 1H), 3.33 (s, 3H), 3.58 (m, 2H), 4.20 (m, 3H), 4.24 (d, J = 4.4 Hz, 2H), 4.81 (m, 1H), 
5.28 (d, J = 9.2 Hz, 1H), 5.52 (d, J = 10.6 Hz, 1H), 5.70 (dt, J = 15.8, 5.3 Hz, 1H), 5.92 (m, 
1H), 6.20 (d, J = 15.8 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ = -5.1, -4.8, -4.5, -4.4, -4.2, -4.0, 
-3.7, 6.0, 9.4, 13.4, 16.9, 18.1, 18.5, 19.7, 20.3, 22.3, 25.9, 26.0, 26.1, 29.7, 30.1, 31.5, 32.3, 
32.8, 33.4, 34.0, 35.7, 39.7, 40.9, 46.6, 56.5, 64.1, 69.0, 71.2, 73.5, 78.9, 80.0, 91.9, 99.1, 
111.2, 127.9, 132.9, 134.3, 134.9, 138.0, 171.5; HRMS calculated for C61H116O9Si4Na 
[M+Na]+: 1127.7594, found: 1127.7599. 
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8.5 Selective Deprotection of Silyl ethers with NaIO4 
8.5.1 General procedure for deprotection of silyl ethers 
To a solution of the silyl ether (0.1 M) in THF/H2O (4:1) was added NaIO4 (6.0 eq.) as solid 
at room temperature. After the completion of the reaction (TLC control), workup 1; H2O and 
DCM were added. The organic layer was separated and the aqueous layer was extracted with 
DCM. The combined organic phases were dried over MgSO4, filtered and evaporated in 
vacuo; workup 2: ether and MgSO4 were added. The mixture was stirred for 5 min. After 
filtration, the organic phases were evaporated in vacuo. Silica gel chromatography (hexanes / 
EtOAc, gradient elution, 9:1 to 2:1) afforded the alcohol. 
 
(E)-3-iodo-2-methylprop-2-en-1-ol 90 
 
I OH
C4H7IO
Exact Mass: 197,9542
Mol. Wt.: 198,0023  
 
Rf = 0.20 (hexanes / EtOAc 9:1); 1H NMR (400 MHz, CDCl3) δ = 1.58 (m, 1H), 1.83 (s, 3H), 
4.12 (d, J = 4.1 Hz, 2H), 6.28 (s, 1H); 13C NMR (100 MHz, CDCl3) δ = 21.4, 67.2, 77.3, 
147.2. Spectroscopic data were identical to those previously reported. 
 
(2S,4R,5R,6E,8E)-5-(tert-butyldimethylsilyloxy)-10-hydroxy-4,7-dimethyl-3-oxodeca-6,8-
dien-2-yl benzoate 246 
 
BzO OH
O MeO
Me
TBS
C25H38O5Si
Exact Mass: 446,2489
Mol. Wt.: 446,6517  
 
Rf = 0.18 (hexanes / EtOAc = 4:1); [α]20D = +12.2 (c = 0.32, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ = -0.06 (s, 3H), -0.04 (s, 3H), 0.80 (s, 9H), 0.99 (d, J = 7.1 Hz, 3H), 1.41 (t, J = 4.8 
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Hz, 1H) 1.52 (d, J = 7.1 Hz, 3H), 1.79 (s, 3H), 2.90 (m, 1H), 4.21 (t, J = 5.1 2H), 4.73 (t, J = 
9.4 Hz, 1H), 5.31 (d, J = 9.2 Hz, 1H), 5.40 (q, J = 7.0 Hz, 1H), 5.81 (dt, J = 15.8, 5.8 Hz, 1H), 
6.24 (d, J = 15.8 Hz, 1H), 7.44 (tm, J = 7.6 Hz, 2H), 7.56 (tm, J = 7.4 Hz, 1H), 8.07 (dm, J = 
7.1 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ = -4.9, -4.4, 13.5, 13.9, 15.2, 18.0, 25.8, 49.5, 
63.7, 71.5, 75.4, 127.9, 128.4 (2C), 129.8, 133.2, 133.6, 134.4, 135.4, 165.8, 209.2; HRMS 
calculated for C25H38O5SiNa [M+Na]+: 469.2386, found: 469.2386. 
 
4-hydroxybutan-2-one 247 
 
O
OH
C4H8O2
Exact Mass: 88,0524
Mol. Wt.: 88,1051  
 
Rf = 0.12 (hexanes / EtOAc = 1:1); 1H NMR (400 MHz, CDCl3) δ = 2.18 (s, 3H), 2.69 (t, J = 
5.3 Hz, 2H), 3.83 (t, J = 5.3 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ = 30.5, 45.3, 57.8, 209.5. 
Spectroscopic data were identical to those previously reported. 
 
4-phenylbutan-1-ol 248 
 
OH
C10H14O
Exact Mass: 150,1045
Mol. Wt.: 150,2176  
 
Rf = 0.13 (hexanes / EtOAc = 9:1); 1H NMR (400 MHz, CDCl3) δ = 1.33 (s, 1H), 1.60 (m, 
2H), 1.69 (m, 2H), 2.65 (t, J = 7.6 Hz, 2H), 3.65 (t, J = 6.4 Hz, 2H), 7.17 (m, 3H), 7.27 (m, 
2H); 13C NMR (100 MHz, CDCl3) δ = 27.5, 32.3, 35.6, 62.8, 125.8, 128.3, 128.4, 142.3. 
Spectroscopic data were identical to those previously reported. 
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(E)-methyl 5-hydroxy-3-methylpent-2-enoate 249 
 
O OH
MeO
C7H12O3
Exact Mass: 144,0786
Mol. Wt.: 144,1684  
 
Rf = 0.35 (hexanes / EtOAc = 2:1); 1H NMR (300 MHz, CDCl3) δ = 2.19 (d, J = 1.3 Hz, 3H), 
2.40 (dt, J = 6.4, 1.0 Hz, 2H), 3.68 (s, 3H), 3.78, (t, J = 6.3 Hz, 2H), 5.74 (m, 1H); 13C NMR 
(75 MHz, CDCl3) δ = 18.8, 43.7, 50.9, 60.2, 117.3, 156.3, 166.9. Spectroscopic data were 
identical to those previously reported. 
 
(2S,3S,E)-3-(tert-butyldimethylsilyloxy)-5-iodo-2,4-dimethylpent-4-en-1-ol 250 
 
HO I
OTBS
C13H27IO2Si
Exact Mass: 370,0825
Mol. Wt.: 370,3423  
 
Rf = 0.25 (hexanes / EtOAc = 9:1); 1H NMR (300 MHz, CDCl3) δ = -0.01 (s, 3H), 0.07 (s, 
3H), 0.79 (d, J = 7.0 Hz, 3H), 0.88 (s, 9H), 1.77 (s, 3H), 1.84 (m, 1H), 2.45 (t, J = 5.6 Hz, 1H), 
3.61 (t, J = 5.2 Hz, 2H), 4.01 (d, J = 7.9 Hz, 1H), 6.19 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 
= -5.3, -4.7, 14.0, 18.1, 19.5, 25.8, 38.8, 66.2, 79.3, 82.8, 148.9; HRMS calculated for 
C13H27IO2SiNa [M+Na]+: 393.0723, found: 393.0728. 
 
(S)-2-((4R,5S,6R)-6-((2S,3R)-3-(tert-butyldimethylsilyloxy)-5-(4-methoxybenzyloxy) 
pentan-2-yl)-2,2,5-trimethyl-1,3-dioxan-4-yl)propan-1-ol 251 
 
OH O O O OPMB
TBS
C29H52O6Si
Exact Mass: 524,3533
Mol. Wt.: 524,8051  
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Rf = 0.47 (hexanes / EtOAc = 4:1); [α]20D = +9.8 (c = 1.40, CHCl3); 1H NMR (300 MHz, 
CDCl3) δ = 0.04 (s, 3H), 0.06 (s, 3H), 0.87 (s, 9H), 0.89 (d, J = 6.6 Hz, 3H), 0.91 (d, J = 6.6 
Hz, 3H), 0.96 (d, J = 6.6 Hz, 3H), 1.10 (m, 1H), 1.35 (s, 3H); 1.38 (s, 3H), 1.49-1.67 (m, 4H), 
1.80 (m, 1H), 3.28 (m, 2H), 3.43 (dd, J = 9.7 1.8 Hz, 1H), 3.52 (m, 3H), 3.80 (s, 3H), 3.93 (m, 
1H), 4.37 (s, 2H), 6.88 (m, 2H), 7.24 (m, 2H); 13C NMR (75 MHz, CDCl3) δ = -4.7, -4.0, 5.8, 
9.9, 14.1, 18.1, 19.6, 25.9, 30.1, 30.6, 32.0, 36.5, 40.1, 55.4, 63.9, 67.3, 67.4, 72.8, 75.9, 99.2, 
113.8, 129.4, 130.8, 159.3. HRMS calculated for C29H52O6SiNa [M+Na]+: 547.3431, found: 
547.3433. 
 
(E)-ethyl 4-hydroxy-3-methylhexa-2,5-dienoate 258 
 
EtO2C
OH
C9H14O3
Exact Mass: 170,0943
Mol. Wt.: 170,2057  
 
Rf = 0.33 (hexanes / EtOAc = 6:1); 1H NMR (400 MHz, CDCl3) δ = 1.26 (t, J = 7.1 Hz, 3H), 
1.99 (d, J = 4.1 Hz, 1H), 2.08 (s, 3H), 4.15 (q, J = 7.1 Hz, 2H), 4.55 (m, 1H), 5.23 (dm, J = 
10.2 Hz, 1H), 5.34 (dm, J = 17.3 Hz, 1H), 5.79 (m, 1H), 6.00 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ = 14.3, 15.1, 59.9, 77.6, 115.4, 117.4, 137.6, 157.8, 166.9. 
 
(2R,3S,E)-((1R,2S)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl)-3-
hydroxy-5-iodo-2,4-dimethylpent-4-enoate 114 
 
O
Me
Ph
N
O
SO2MesBn
I
OH
 C32H38INO5S
Exact Mass: 675,1515
Mol. Wt.: 675,6173  
 
Rf = 0.43 (hexanes / EtOAc = 8:1); [α]20D = +38.9 (c = 0.97, CHCl3); 1H NMR (300 MHz, 
CDCl3) δ = 0.95 (d, J = 7.2 Hz, 3H), 1.17 (d, J = 7.0 Hz, 3H), 1.81 (d, J = 1.1 Hz, 3H), 2.27 (s, 
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3H), 2.50 (s, 6H), 2.54-2.65 (m, 1H), 2.77 (d, J = 3.8 Hz, 1H, OH), 4.10 (dq, J = 4.1, 7.0 Hz, 
1H), 4.24 (dd, J = 3.4 Hz, 1H), 4.56 (A of ABq, JAB=16.6, 1H), 4.74 (B of ABq, JAB=16.6, 
1H), 5.85 (d, J = 4.1 Hz, 1H), 6.29 (s, 1H), 6.82-6.85 (m, 2H), 6.87 (s, 2H), 7.13-7.35 (m, 8H); 
13C NMR (75 MHz, CDCl3) δ = 13.4, 14.1, 18.9, 20.9, 23.0, 43.3, 48.3, 56.8, 78.6, 78.7, 81.2, 
125.9, 127.2, 127.6, 128.0, 128.4 128.5, 132.2, 133.4, 138.1, 138.6, 140.3, 142.6, 146.9, 174.1; 
HRMS calculated for C32H38INO5SNa [M+Na]+: 698.1413, found: 698.1409. 
 
(5R,6R,8S,9S,10S)-9-hydroxy-5-(2-(4-methoxybenzyloxy)ethyl)-2,2,3,3,6,8,10,14,14-nona 
methyl-13,13-diphenyl-4,12-dioxa-3,13-disilapentadecan-7-one 259 
 
OPMBOO
TBS
OHO
C42H64O6Si2
Exact Mass: 720,4241
Mol. Wt.: 721,125
TBDPS
 
 
Rf = 0.32 (hexanes / EtOAc = 9:1); [α]20D = +2.9 (c = 0.43, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ = 0.08 (s, 3H), 0.02 (s, 3H), 0.84 (s, 9H), 0.98 (d, J = 7.1 Hz, 3H), 1.04 (s, 9H), 1.04 
(d, J = 7.0 Hz, 3H), 1.05 (d, J = 6.8 Hz, 3H), 1.70 (m, 2H), 1.84, (m, 1H), 2.96 (m, 2H), 3.31 
(d, J = 6.1 Hz, 1H, OH), 3.50 (m, 2H), 3.59 (m, 1H), 3.71 (m, 2H), 3.77 (s, 3H), 4.17 (m, 1H), 
4.39 (s, 2H), 6.83 (d, J = 8.6 Hz, 2H), 7.22 (d, J = 8.1 Hz, 2H), 7.39 (m, 6H), 7.67 (m, 4H); 
13C NMR (100 MHz, CDCl3) δ = -4.8, -4.5, 10.9, 14.2, 15.2, 18.0, 19.2, 25.9, 26.9, 32.7, 37.2, 
48.9, 51.9, 55.3, 65.7, 66.3, 69.9, 72.6, 113.8, 127.7, 129.3, 129.7, 130.7, 133.4, 135.6, 135.7, 
159.1, 217.5; HRMS calculated for C42H64O6Si2Na [M+Na]+: 743.4139, found: 743.4143. 
 
Experimental Section 186
8.5.2 Preparation of Silyl Ethers 
(E)-tert-butyl(3-iodo-2-methylallyloxy)dimethylsilane 241 
 
I OTBDMS
C10H21IOSi
Exact Mass: 312,0406
Molr. Wt.: 312,2631  
 
To a stirred solution (-78 °C) of alcohol (130 mg, 0.656 mmol, 1.0 eq.) in CH2Cl2 (2 mL) was 
added 2,6-lutidine (132 μL, 1.12 mmol, 1.7 eq.) and TBSOTf (198 μL, 0.853 mmol, 1.3 eq.). 
The mixture was stirred at -78 °C for 30 min. The cooling bath was removed and the reaction 
quenched with sat. aqueous NaHCO3 (3 mL). The mixture was warmed to room temperature. 
CH2Cl2 (10 mL) were added. The organic layer was separated and the aqueous layer was 
extracted with CH2Cl2 (3 × 5 mL). The combined organics were dried over MgSO4, filtered 
and evaporated in vacuo. Silica gel chromatography (hexanes / Et2O 9:1) afforded the desired 
TBS-ether (194 mg, 0.621 mmol, 91%) as a colorless oil. 
Rf = 0.91 (hexanes / EtOAc = 9:1); 1H NMR (400 MHz, CDCl3) δ = 0.06 (s, 1H),0.90 (s, 9H), 
1.77 (s, 3H), 4.09 (s, 2H), 6.19 (s, 1H); 13C NMR (100 MHz, CDCl3) δ = -5.4, 18.4, 21.2, 25.9, 
67.1, 75.9, 146.9. 
 
4-(tert-butyldimethylsilyloxy)butan-2-one 242 
 
O
OTBS
C10H22O2Si
Exact Mass: 202,1389
Mol. Wt.: 202,366  
 
To a stirred solution (-78 °C) of alcohol (86.0 mg, 0.976 mmol, 1.0 eq.) in CH2Cl2 (1 mL) was 
added 2,6-lutidine (197 μL, 1.66 mmol, 1.7 eq.) and TBSOTf (295 μL, 1.27 mmol, 1.3 eq.). 
The mixture was stirred at -78 °C for 30 min. The cooling bath was removed and the reaction 
quenched with sat. aqueous NaHCO3 (3 mL). The mixture was warmed to room temperature. 
CH2Cl2 (10 mL) were added. The organic layer was separated and the aqueous layer was 
extracted with CH2Cl2 (3 × 5 mL). The combined organics were dried over MgSO4, filtered 
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and evaporated in vacuo. Silica gel chromatography (hexanes / Et2O 9:1) afforded the desired 
TBS-ether (184 mg, 0.909 mmol, 93%) as a colorless oil. 
Rf = 0.57 (hexanes / EtOAc = 9:1); 1H NMR (400 MHz, CDCl3) δ = 0.04 (s, 6H), 0.86 (s, 9H), 
2.16 (s, 3H), 2.60 (t, J = 6.4 Hz, 2H), 3.87 (t, J = 6.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 
= -5.4, 18.2, 25.9, 30.8, 46.6, 58.9, 208.1. 
 
tert-Butyldimethyl(4-phenylbutoxy)silane 243 
 
OTBDMS
C16H28OSi
Exact Mass: 264,1909
Mol. Wt.: 264,4784  
 
To a stirred solution (-78 °C) of alcohol (114 mg, 0.759 mmol, 1.0 eq.) in CH2Cl2 (2 mL) was 
added 2,6-lutidine (153 μL, 1.29 mmol, 1.7 eq.) and TBSOTf (229 μL, 0.987 mmol, 1.3 eq.). 
The mixture was stirred at -78 °C for 30 min. The cooling bath was removed and the reaction 
quenched with sat. aqueous NaHCO3 (3 mL). The mixture was warmed to room temperature. 
CH2Cl2 (10 mL) were added. The organic layer was separated and the aqueous layer was 
extracted with CH2Cl2 (3 × 5 mL). The combined organics were dried over MgSO4, filtered 
and evaporated in vacuo. Silica gel chromatography (hexanes / Et2O 9:1) afforded the desired 
TBS-ether (198 mg, 0.749 mmol, 99%) as a colorless oil. 
Rf = 0.57 (hexanes / EtOAc = 9:1); 1H NMR (400 MHz, CDCl3) δ = 0.04 (s, 6H), 0.89 (s, 9H), 
1.56 (m, 2H), 1.67 (m, 2H), 2.63 (t, J = 7.6 Hz, 2H), 3.63 (t, J = 6.4 Hz, 2H), 7.17 (m, 3H), 
7.27 (m, 2H); 13C NMR (100 MHz, CDCl3) δ = -5.2, 18.4, 26.0, 27.7, 32.5, 35.7, 63.0, 125.7, 
128.3, 128.4, 142.7. 
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(E)-Methyl 5-(tert-butyldimethylsilyloxy)-3-methylpent-2-enoate 244 
 
O OPMB
MeO
C15H20O4
Exact Mass: 264,1362
Mol. Wt.: 264,3169
O OH
MeO
C7H12O3
Exact Mass: 144,0786
Mol. Wt.: 144,1684
O OTBS
MeO
C13H26O3Si
Exact Mass: 258,1651
Mol. Wt.: 258,4292  
 
The PMB ether (136 mg, 0.514 μmol, 1.0 eq.) was dissolved in CH2Cl2 / aq. pH 7 buffer (10:1, 
3.3 mL) under argon atmosphere. Then DDQ (350 mg, 1.54 μmol, 3.0 eq.) was added fast and 
the resulting suspension was stirred for 60 min at ambient temperature. The reaction mixture 
was quenched by addition of 7 mL saturated, aqueous NaHCO3 solution. The organic layer 
was seperated and the aqueous phase was extracted with CH2Cl2 (3 × 5 mL). Then the 
combined organic layer was dried over MgSO4, filtered and the solvent was removed under 
reduced pressure, before the crude product was purificated by flash chromatography on silica 
gel (hexanes / EtOAc = 9:1 to 1:1) to give the desired free alcohol (59.3 mg, 0.411 mmol, 
80%, E/Z: 3:1). 
Rf = 0.35 (hexanes / EtOAc = 2:1); 1H NMR (300 MHz, CDCl3) δ = 2.19 (d, J = 1.3 Hz, 3H), 
2.40 (dt, J = 6.4, 1.0 Hz, 2H), 3.68 (s, 3H), 3.78, (t, J = 6.3 Hz, 2H), 5.74 (m, 1H); 13C NMR 
(75 MHz, CDCl3) δ = 18.8, 43.7, 50.9, 60.2, 117.3, 156.3, 166.9. 
To a stirred solution (-78 °C) of alcohol (22.8 mg, 0.158 mmol, 1.0 eq.) in CH2Cl2 (200 μL) 
was added 2,6-lutidine (32.0 μL, 0.269 mmol, 1.7 eq.) and TBSOTf (47.6 μL, 0.987 mmol, 
1.3 eq.). The mixture was stirred at -78 °C for 30 min. The cooling bath was removed and the 
reaction quenched with sat. aqueous NaHCO3 (2 mL). The mixture was warmed to room 
temperature. CH2Cl2 (5 mL) were added. The organic layer was separated and the aqueous 
layer was extracted with CH2Cl2 (3 × 3 mL). The combined organics were dried over MgSO4, 
filtered and evaporated in vacuo. Silica gel chromatography (hexanes / Et2O 20:1) afforded 
the desired TBS-ether (36.7 mg, 0.142 mmol, 90%; 16.0 mg for E double bond) as a colorless 
oil. 
1H NMR (400 MHz, CDCl3) δ = 0.03 (s, 6H), 0.87 (s, 9H), 2.17 (s, 3H), 2.33 (t, J = 6.6 Hz, 
2H), 3.67 (s, 3H), 3.73, (t, J = 6.6 Hz, 2H), 5.68 (s, 1H); 13C NMR (100 MHz, CDCl3) δ = -
5.4, 18.3, 19.2, 25.9, 44.0, 50.8, 61.3, 116.8, 157.3, 167.1. 
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(5S,6S)-5-((E)-1-Iodoprop-1-en-2-yl)-2,2,3,3,6,9,9,10,10-nonamethyl-4,8-dioxa-3,9-
disilaundecane 245 
 
O
Me
Ph
N
O
SO2MesBn
I
OH
C32H38INO5S
Exact Mass: 675,1515
Mol. Wt.: 675,6173
HO I
OH
C7H13IO2
Exact Mass: 255,996
Mol. Wt.: 256,0814
TBSO I
OTBS
C19H41IO2Si2
Exact Mass: 484,169
Mol. Wt.: 484,6031
 
 
To a solution of the ester (124 mg. 0.184 mmol, 1.0 eq.) in THF (2 mL) was added BH3.SMe2 
(19.4 µL, 0.184 mmol, 1.0 eq.) at -20 °C. The reaction mixture was warmed to room 
tempratue and stirred for 1 h and quenched with MeOH (0.2 mL), pH7 buffer (1 mL) and 30% 
H2O2 (0.1 mL) and stirred for 1 h at RT. The organic layer was seperated and the aqueous 
phase was extracted with EtOAc (3 × 5 mL). Then the combined organic layer was dried over 
MgSO4, filtered and the solvent was removed under reduced pressure, before the crude 
product was purificated by flash chromatography on silica gel (hexanes / EtOAc = 2:1 to 1:1) 
to give the desired free alcohol (36.0 mg, 0.141 mmol, 78%). 
Rf = 0.24 (hexanes / EtOAc = 2:1); [α]20D = +18.3 (c = 0.58, CHCl3);1H NMR (300 MHz, 
CDCl3) δ = 0.74 (d, J = 7.0 Hz, 3H), 1.81 (s, 3H), 1.90 (m, 1H), 3.18 (m, 2H), 3.62 (m, 1H), 
3.72 (m, 1H), 4.06 (d, J = 8.5 Hz, 1H), 6.27 (s, 1H); 13C NMR (75 MHz, CDCl3) δ = 13.6, 
19.1, 37.5, 67.6, 80.1, 83.0, 148.8. 
To a stirred solution (-78 °C) of the diol (21.0 mg, 82.0 μmol, 1.0 eq.) in CH2Cl2 (200 μL) 
was added 2,6-lutidine (33.0 μL, 279 μmol, 3.4 eq.) and TBSOTf (50.0 μL, 213 μmol, 2.6 eq.). 
The mixture was stirred at -78 °C for 30 min. The cooling bath was removed and the reaction 
quenched with sat. aqueous NaHCO3 (3 mL). The mixture was warmed to room temperature. 
CH2Cl2 (6 mL) were added. The organic layer was separated and the aqueous layer was 
extracted with CH2Cl2 (3 × 3 mL). The combined organics were dried over MgSO4, filtered 
and evaporated in vacuo. Silica gel chromatography (hexanes / Et2O 9:1) afforded the desired 
TBS-ether (33.1 mg, 68.3 μmol, 90%) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ = -0.05 (s, 3H), -0.02 (s, 9H), 0.72 (d, J = 7.0 Hz, 3H), 0.86 
(9H), 0.88 (s, 9H), 1.68 (m, 1H), 1.73 (s, 3H), 3.60 (m, 2H), 3.99 (d, J = 8.7 Hz, 1H), 6.09 (s, 
1H); 13C NMR (75 MHz, CDCl3) δ = -5.4, -5.3, -4.9, 13.6, 18.2, 18.4, 19.0, 25.8, 26.0, 40.0, 
64.3, 78.5, 78.8, 149.6. 
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(E)-tert-butyl(3-iodo-2-methylallyloxy)diphenylsilane 252 
 
I OTBDPS
C20H25IOSi
Exact Mass: 436,0719
Mol. Wt.: 436,4019  
 
A flask containing the alcohol (200 mg, 1.01 mmol, 1.0 eq.), imidazol (89.0 mg, 1.31 mmol, 
1.3 eq.) and TBDPSCl (270 µL, 1.04 mmol, 1.0 eq.) was charged with argon and abs. DCM 
(10 ml) was added. The reaction mixture was stirred at RT for 60 min. Sat. aq. NaHCO3 (5 
mL) were added, the organic phase separated, and the aq. phase thoroughly extracted with 
DCM (3 × 10 mL). The combined organic extracts were dried over MgSO4 and concentrated 
in vacuo. After flash chromatography (hexanes / Et2O = 9:1) gave the TBDPS-ether (416 mg, 
0.953 mmol, 94%) as yellow oil. 
Rf = 0.91 (hexanes / Et2O = 30:1); 1H NMR (300 MHz, CDCl3) δ = 1.06 (s, 9H), 1.75 (s, 3H), 
4.12 (s, 2H), 6.28 (s, 1H), 7.41 (m, 6H), 7.65 (m, 4H); 13C NMR (75 MHz, CDCl3) δ = 19.3, 
21.3, 26.8, 67.7, 76.1, 127.8, 129.9, 133.3, 135.5, 146.4. 
 
(E)-triethyl(3-iodo-2-methylallyloxy)silane 253 
 
I OTES
C10H21IOSi
Exact Mass: 312,0406
Molr. Wt.: 312,2631  
 
To a stirred solution (-78 °C) of the alcohol (130 mg, 0.656 mmol, 1.0 eq.) in CH2Cl2 (2 mL) 
was added 2,6-lutidine (132 μL, 1.12 mmol, 1.7 eq.) and TESOTf (193 μL, 0.853 mmol, 1.3 
eq.). The mixture was stirred at -78 °C for 30 min. The cooling bath was removed and the 
reaction quenched with sat. aqueous NaHCO3 (3 mL). The mixture was warmed to room 
temperature. CH2Cl2 (10 mL) were added. The organic layer was separated and the aqueous 
layer was extracted with CH2Cl2 (3 × 10 mL). The combined organics were dried over MgSO4, 
filtered and evaporated in vacuo. Silica gel chromatography (hexanes / Et2O 9:1) afforded the 
desired TES-ether (205 mg, 0.655 μmol, 100%) as a colorless oil. 
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Rf = 0.84 (hexanes / EtOAc = 9:1); 1H NMR (300 MHz, CDCl3) δ = 0.60 (q, J = 8.1 Hz, 6H), 
0.95 (t, J = 8.1 Hz, 9H), 1.77 (s, 3H), 4.10 (s, 2H), 6.21 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 
= 4.4, 6.7, 21.2, 66.8, 76.1, 146.8. 
 
Triethyl(4-phenylbutoxy)silane 254 
 
OTES
C16H28OSi
Exact Mass: 264,1909
Mol. Wt.: 264,4784  
 
To a stirred solution (-78 °C) of alcohol (132 mg, 0.656 mmol, 1.0 eq.) in CH2Cl2 (2 mL) was 
added 2,6-lutidine (177 μL, 1.49 mmol, 1.7 eq.) and TESOTf (258 μL, 1.14 mmol, 1.3 eq.). 
The mixture was stirred at -78 °C for 30 min. The cooling bath was removed and the reaction 
quenched with sat. aqueous NaHCO3 (3 mL). The mixture was warmed to room temperature. 
CH2Cl2 (10 mL) were added. The organic layer was separated and the aqueous layer was 
extracted with CH2Cl2 (3 × 10 mL). The combined organics were dried over MgSO4, filtered 
and evaporated in vacuo. Silica gel chromatography (hexanes / Et2O 9:1) afforded the desired 
TES-ether (228 mg, 0.861 μmol, 98%) as a colorless oil. 
Rf = 0.53 (hexanes / EtOAc = 9:1); 1H NMR (400 MHz, CDCl3) δ = 0.59 (q, J = 7.6 Hz, 6H), 
0.95 (t, J = 8.1 Hz, 9H), 1.57 (m, 2H), 1.67 (m, 2H), 2.62 (t, J = 7.6 Hz, 2H), 3.62 (t, J = 6.4 
Hz, 2H), 7.16 (m, 3H), 7.26 (m, 2H); 13C NMR (100 MHz, CDCl3) δ = 4.5, 6.8, 27.7, 32.5, 
35.7, 62.7, 125.7, 128.3, 128.4, 142.6. 
 
(E)-Ethyl 3-methyl-4-(triethylsilyloxy)hexa-2,5-dienoate 255 
 
EtO2C
OH
C9H14O3
Exact Mass: 170,0943
Mol. Wt.: 170,2057
EtO2C
OTES
C15H28O3Si
Exact Mass: 284,1808
Mol. Wt.: 284,4665
CHO
EtO2C
 C7H10O3
Exact Mass: 142,063
Mol. Wt.: 142,1525  
 
To a rapidly stirring solution of (E)-ethyl 3-methyl-4-oxobut-2-enoate (1.30 g, 9.15 mol, 1.0 
eq.) in Et2O (20 mL) under an argon atmosphere at -20 °C was added a solution of 
vinylmagnesium bromide in THF (1.0 M, 9.6 mL, 9.60mmmol, 1.05 eq.) over a period of 1 h. 
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After the addition was complete, the mixture was stirred for 10 min and was then diluted with 
Et2O (10 mL) and poured over 20 g of crushed ice. The pH of the solution is adjusted to 5-6, 
and the ether layer is separated and washed with water (15 mL) and brine (15 mL) and then 
dried over Na2SO4. Removal of solvent under reduced pressure affords alcohol as a pale 
yellow liquid (1.36 g, 7.99 mmol, 87%), which is sufficiently pure to use in the next step. 
Rf = 0.33 (hexanes / EtOAc = 6:1); 1H NMR (400 MHz, CDCl3) δ = 1.26 (t, J = 7.1 Hz, 3H), 
1.99 (d, J = 4.1 Hz, 1H), 2.08 (s, 3H), 4.15 (q, J = 7.1 Hz, 2H), 4.55 (m, 1H), 5.23 (dm, J = 
10.2 Hz, 1H), 5.34 (dm, J = 17.3 Hz, 1H), 5.79 (m, 1H), 6.00 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ = 14.3, 15.1, 59.9, 77.6, 115.4, 117.4, 137.6, 157.8, 166.9. Spectroscopic data were 
identical to those previously reported.16 
To a stirred solution (-78 °C) of alcohol (95.0 mg, 0.558 mmol, 1.0 eq.) in CH2Cl2 (2 mL) was 
added 2,6-lutidine (112 μL, 0.949 mmol, 1.7 eq.) and TESOTf (164 μL, 0.725 mmol, 1.3 eq.). 
The mixture was stirred at -78 °C for 30 min. The cooling bath was removed and the reaction 
quenched with sat. aqueous NaHCO3 (3 mL). The mixture was warmed to room temperature. 
CH2Cl2 (10 mL) were added. The organic layer was separated and the aqueous layer was 
extracted with CH2Cl2 (3 × 10 mL). The combined organics were dried over MgSO4, filtered 
and evaporated in vacuo. Silica gel chromatography (hexanes / Et2O 9:1) afforded the desired 
TES-ether (146 mg, 0.513 μmol, 92%) as a colorless oil. 
Rf = 0.45 (hexanes / Et2O = 20:1); 1H NMR (400 MHz, CDCl3) δ = 0.51 (q, J = 8.0 Hz, 6H), 
0.92 (t, J = 8.0 Hz, 9H), 1.27 (t, J = 7.1 Hz, 3H), 2.05 (s, 3H), 4.15 (q, J = 7.5 Hz, 2H), 4.47 
(d, J = 5.6 Hz, 1H), 5.13 (dt, J = 10.2, 1.5 Hz, 1H), 5.29 (dt, J = 16.8, 1.5 Hz, 1H), 5.70 (m, 
1H), 5.97 (s, 1H); 13C NMR (100 MHz, CDCl3) δ = 4.8, 6.5, 6.8, 14.3, 14.8, 59.7, 78.1, 114.9, 
115.8, 138.6, 159.0, 167.1. 
 
 
 
 
 
 
 
 
 
                                                 
16 Davalian, D.; Heathcock, C. H. J. Org. Chem. 1979, 44, 4458-4461. 
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(2R,3S,E)-((1R,2S)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 5-
iodo-2,4-dimethyl-3-(triethylsilyloxy)pent-4-enoate 256 
 
O
Me
Ph
N
O
SO2MesBn
I
OTES
C38H52INO5SSi
Exact Mass: 789,238
Mol. Wt.: 789,8782  
 
To a solution of alcohol (92.0 mg, 136 µmol, 1.0 eq.) in DCM (2.5 mL) was added pyridine 
(30 µL, 350 µmol, 2.5 eq.) and TESCl (40 µL, 210 µmol, 1.5 eq.) at 0 °C. After stirring at 
room temperature for 18 h, the reaction mixture was quenched with sat. aqueous NaHCO3 (3 
mL). The organic layer was seperated and the aqueous phase was extracted with DCM (3 × 10 
mL). Then the combined organic layer was dried over MgSO4, filtered and the solvent was 
removed under reduced pressure, before the crude product was purificated by flash 
chromatography on silica gel (hexanes / EtOAc = 9:1) to give the desired TES-ether (105 mg, 
133 µmol, 95%). 
Rf = 0.57 (hexanes / EtOAc = 9:1); [α]20D = +27.6 (c = 0.88, CHCl3); 1H NMR (300 MHz, 
CDCl3) δ = 0.50 (q, J = 8.0 Hz, 6H), 0.77 (d, J = 7.3 Hz, 3H), 0.86 (t, J = 8.0 Hz, 9H), 1.11 (d, 
J = 7.0 Hz, 3H), 1.77 (s, 3H), 2.31 (s, 3H), 2.43 (s, 6H), 2.64 (m, 1H), 4.00 (m, 1H), 4.35 (m, 
2H), 4.91 (d, J =16.0, 1H), 5.70 (d, J = 5.3 Hz, 1H), 6.21 (s, 1H), 6.68 (d, J = 7.0 Hz, 2H), 
6.88 (s, 2H), 7.07 (m, 2H), 7.16, (m, 1H), 7.26 (m, 3H), 7.41 (m, 2H); 13C NMR (75 MHz, 
CDCl3) δ = 4.6, 6.8, 14.0, 14.6, 18.6, 20.9, 22.9, 44.9, 48.3, 56.8, 77.8, 79.4, 80.7, 126.2, 
127.4, 127.8, 128.2, 128.3 128.4, 132.2, 133.1, 138.1, 138.8, 140.4, 142.4, 147.7, 173.1. 
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(5R,6R,8S,9S,10S)-5-(2-(4-methoxybenzyloxy)ethyl)-2,2,3,3,6,8,10,14,14-nonamethyl-
13,13-diphenyl-9-(triethylsilyloxy)-4,12-dioxa-3,13-disilapentadecan-7-one 257 
 
OPMBOO
TBS
OO
TBDPS
TES
C48H78O6Si3
Exact Mass: 834,5106
Mol. Wt.: 835,3858  
 
To a stirred solution (-78 °C) of alcohol (24.2 mg, 33.5 µmol, 1.0 eq.) in CH2Cl2 (0.5 mL) 
was added 2,6-lutidine (6.7 μL, 57 µmol, 1.7 eq.) and TESOTf (9.8 μL, 44 µmol, 1.3 eq.). 
The mixture was stirred at -78 °C for 30 min. The cooling bath was removed and the reaction 
quenched with sat. aqueous NaHCO3 (1 mL). The mixture was warmed to room temperature. 
CH2Cl2 (3 mL) were added. The organic layer was separated and the aqueous layer was 
extracted with CH2Cl2 (3 × 3 mL). The combined organics were dried over MgSO4, filtered 
and evaporated in vacuo. Silica gel chromatography (hexanes / Et2O 9:1) afforded the desired 
TES-ether (26.0 mg, 31.1 μmol, 93%) as a colorless oil. 
1H NMR (300 MHz, CDCl3) δ = 0.006 (s, 3H), 0.01 (s, 3H), 0.51 (q, J = 7.7 Hz, 6H), 0.84 (s, 
9H), 0.86 (t, J = 8.0 Hz, 9H), 0.93 (d, J = 6.4 Hz, 3H), 0.95 (d, J = 6.6 Hz, 3H), 1.05 (s, 9H), 
1.09 (d, J = 7.2 Hz, 3H), 1.68 (m, 2H), 1.92, (m, 1H), 2.66 (m, 1H), 2.93 (m, 1H), 3.47 (m, 
3H), 3.78 (dd, J = 10.2, 6.3 Hz, 1H), 3.78 (s, 3H), 3.94 (dd, J = 7.2, 3.8 Hz, 1H), 4.12 (m, 1H), 
4.40 (s, 2H), 6.85 (d, J = 8.6 Hz, 2H), 7.23 (d, J = 8.1 Hz, 2H), 7.36 (m, 6H), 7.66 (m, 4H); 
13C NMR (75 MHz, CDCl3) δ = -4.8, -4.5, 5.2, 6.5, 6.8, 7.0, 10.8, 13.6, 14.6, 18.1, 19.2, 25.9, 
26.9, 33.0, 39.7, 48.2, 51.7, 55.3, 65.7, 67.0, 69.9, 72.4, 113.7, 127.6, 129.2, 129.6, 130.8, 
133.9, 135.7, 159.1, 215.2. 
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8.6 Direct Reductive Amination 
General procedure: 
The amine (1.0 mmol), a first carbonyl (1.0 mmol), Hantsch ester (1.5 mmol), and 5 Å 
molecular sieves were treated with catalytic amounts of thiourea (0.1 mmol) in toluene under 
argon atmosphere at 60 °C. After 24 h, a second carbonyl (1.0 mmol), Hantzsch ester (1.5 
mmol) and thiourea (0.1 mmol) was added. The reaction mixture was stirred under argon 
atmosphere at 60 °C until complete conversion (24–72 h). After filtration over Celite, the 
solvent is evaporated and the residue purified by flash chromatography on silica gel using 
mixtures of petroleum ether and ethyl acetate as eluants to give the product amines in a pure 
form. 
 
N-benzyl-4-methoxy-N-(4-nitrobenzyl)aniline 287-a 
 
N
OMe
O2N
C21H20N2O3
Exact Mass: 348,1474
Mol. Wt.: 348,3951  
 
1H-NMR (400 MHz, CDCl3) δ = 8.13 (d, J = 12.0 Hz, 2 H), 7.43 (d, J = 12.0 Hz, 2 H), 7.24 
(m, 5 H), 6.71 (m, 4 H), 4.55 (d, J = 12.0 Hz, 4 H), 3.72 (s, 3 H); 13C (100 MHz, CDCl3) δ = 
152.29, 147.17, 143.19, 138.34, 128.68, 127.19, 123.84, 115.47, 114.91, 56.08, 55.70, 54.98. 
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N-isobutyl-4-methoxy-N-(4-nitrobenzyl)aniline 287-b 
 
N
OMe
O2N
C18H22N2O3
Exact Mass: 314,163
Mol. Wt.: 314,3789  
 
1H-NMR (400 MHz, CDCl3) δ = 8.11 (d, J =12, 2 H), 7.25 (d, J = 56, 2 H) 6.64 (dd, J = 12 
Hz, 52 Hz, 4 H), 4.55 (s, 2 H), 3.72 (s, 3 H), 3.12 (d, J = 8 Hz, 2 H), 2.04 (m, 1 H), 0.93 (d, J 
= 8 Hz, 6 H); 13C (100 MHz, CDCl3) δ = 152.16, 147.55, 147.06, 142.97, 127.70, 123.76, 
115.42, 114.85, 61.17, 56.42, 55.72, 27.45, 20.57. 
 
N-benzyl-4-methoxy-N-(2-methoxybenzyl)aniline 287-c 
 
N
OMe
OMe
C22H23NO2
Exact Mass: 333,1729
Mol. Wt.: 333,4235  
 
1H-NMR (400 MHz, CDCl3), δ = 6.62 (m, 13 H), 4.58 (d, J = 8 Hz, 4 H), 3.71 (d, J = 40 Hz, 
6 H); 13C (100 MHz, CDCl3) δ 157.38, 151.38, 143.86, 139.40, 128.57, 126.74, 126.59, 
120.47, 114.85, 113.62, 110.07, 55.81, 55.17, 50.35. 
 
 
 
 
 
 
 
Experimental Section 197
N-isobutyl-4-methoxy-N-(2-methoxybenzyl)aniline 287-d 
 
N
OMe
OMe
C19H25NO2
Exact Mass: 299,1885
Mol. Wt.: 299,4073  
 
1H-NMR (400 MHz, CDCl3) δ = 6.57 (m, 8 H), 4.50 (s, 2 H), 3.86 (s, 3 H), 3.71 (d, J = 4 Hz, 
3 H), 3.15 (d, J = 8 Hz, 2 H), 2.10 (m, 1 H), 0.85 (m, 6 H); 13C (100 MHz, CDCl3) δ = 157.28, 
150.89, 143.77, 127.58, 127.39, 126.72, 120.34, 114.81, 113.52, 109.93, 60.35, 55.84, 55.20, 
50.86, 27.60, 20.59. 
 
 
N-benzyl-N-isobutyl-4-methoxyaniline 287-e 
 
N
OMe
C18H23NO
Exact Mass: 269,178
Mol. Wt.: 269,3813  
 
1H-NMR (300 MHz, CDCl3) δ = 7.25 (m, 5 H), 6.67 (dd, J = 6 Hz, 9 Hz, 33 Hz, 4 H), 4.49 (s, 
2 H), 3.72 (s, 3 H), 3.11 (d, J = 6 Hz, 2 H), 2.07 (m, 1 H), 0.93 (d, J = 6 Hz, 6 H), 13C ( 300 
MHz, CDCl3) δ 151.35, 143.72, 139.32, 128.42, 126.59, 114.71, 60.43, 56.40, 55.75, 27.38, 
20.59. 
 
 
 
 
 
 
Experimental Section 198
N-benzyl-N-isobutyl-4-methylaniline 289-f 
 
N
C18H23N
Exact Mass: 253,183
Mol. Wt.: 253,3819  
 
1H-NMR (400 MHz, CDCl3) δ = 7.21 (m, 5 H), 6.98 (d, J = 12 Hz, 2 H), 4.57 (s, 2 H), 3.20 (d, 
J = 4 Hz, 2 H), 2.23 (s, 3 H), 2.14 (m, 1 H), 0.95 (d, J = 8 Hz, 6 H); 13C (100 MHz, CDCl3) δ 
146.84, 139.22, 129.65, 128.50, 126.71, 126.60, 125.17, 112.83, 59.86, 55.61, 29.75, 27.43, 
20.58, 20.18. 
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6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
 
O
Me
O Me
OH
DMPM
216 208 200 192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8
Chemical Shift (ppm)
 
O
Me
O Me
OH
DMPM
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
BzO OTBS
O MeO
Me
TBS
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Chemical Shift (ppm)
 
BzO OTBS
O MeO
Me
TBS
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
HO OTBS
OH MeO
Me
TBS
136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
HO OTBS
OH MeO
Me
TBS
10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
Chemical Shift (ppm)
 
H OTBS
O MeO
Me
TBS
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Chemical Shift (ppm)
 
H OTBS
O MeO
Me
TBS
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
OTBS
OH MeO
Me
TBS
136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
OTBS
OH MeO
Me
TBS
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
Chemical Shift (ppm)
 
OTBS
O MeO
Me
TBS
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Chemical Shift (ppm)
 
OTBS
O MeO
Me
TBS
10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0
Chemical Shift (ppm)
 
H
O
208 200 192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16
Chemical Shift (ppm)
 
H
O
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
O
Me
O Me
OTBS
OH
TBS
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Chemical Shift (ppm)
 
O
Me
O Me
OTBS
OH
TBS
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
(R) (R)
O
Me
O Me
OTBS
(R)
O
(R)
Ph
O
F3C
MeO
TBS
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
(R) (R)
O
Me
O Me
OTBS
(R)
O
(S)
Ph
O
MeO
F3C
TBS
6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
O
OHOCH3
O
OTBS
TBS
I
216 208 200 192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
O
OHOCH3
O
OTBS
TBS
I
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
O
(R)(S)
(R) (R)
OOCH3
O
OTBS
TBS
I
(R)
Ph
O CF3
OMe
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
O
(R)(S)
(R) (R)
OOCH3
O
OTBS
TBS
I
(S)
Ph
O OMe
CF3
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
I
OCH3 OAc
OTBS
HO
O
TBS
176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
I
OCH3 OAc
OTBS
HO
O
TBS
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
HO
OHOCH3
O
OTBS
TBS
I
144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
HO
OHOCH3
O
OTBS
TBS
I
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
HO
OTBSOCH3
O
OTBS
TBS
I
144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
HO
OTBSOCH3
O
OTBS
TBS
I
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
TBSO
OHOCH3
O
OTBS
TBS
I
136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
TBSO
OHOCH3
O
OTBS
TBS
I
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
TBSO
OTBSOCH3
O
OTBS
TBS
I
136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
TBSO
OTBSOCH3
O
OTBS
TBS
I
6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
O
O
OAcOCH3
O
O
O
OTBS
OTBS
TBS
I
184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8 -16
Chemical Shift (ppm)
 
O
O
OAcOCH3
O
O
O
OTBS
OTBS
TBS
I
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
O
O
OTBSOCH3
O
O
O
OTBS
OTBS
TBS
I
168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
O
O
OTBSOCH3
O
O
O
OTBS
OTBS
TBS
I
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
O
O
OAcOCH3
O
O
O
OTBS
OTBS
TBS
176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
O
O
OAcOCH3
O
O
O
OTBS
OTBS
TBS
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
O
O
OTBSOCH3
O
O
O
OTBS
OTBS
TBS
168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
O
O
OTBSOCH3
O
O
O
OTBS
OTBS
TBS
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
O
O
OTBSOCH3
O
O
O
OTBS
OH
TBS
176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
O
O
OTBSOCH3
O
O
O
OTBS
OH
TBS
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
OCH3
OTBSI O
O O
TBS TBS
O
O OTBS
O
176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
OCH3
OTBSI O
O O
TBS TBS
O
O OTBS
O
6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
OCH3
OTBSO
O O
TBS TBS
O
O OTBS
O
168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
OCH3
OTBSO
O O
TBS TBS
O
O OTBS
O
6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
OCH3
OHO
O O
TBS TBS
O
O OTBS
O
176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
OCH3
OHO
O O
TBS TBS
O
O OTBS
O
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
OCH3
OTBSI
O
O O
TBS TBS
O
O OTBS
O
168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
OCH3
OTBSI O
O O
TBS TBS
O
O OTBS
O
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
OCH3
OTBSO
O O
TBS TBS
O OTBS
O
O
176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
OCH3
OTBSO
O O
TBS TBS
O OTBS
O
O
6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5
Chemical Shift (ppm)
 
I OH
152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16
Chemical Shift (ppm)
 
I OH
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
BzO OH
O MeO
Me
TBS
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Chemical Shift (ppm)
 
BzO OH
O MeO
Me
TBS
4.0 3.9 3.8 3.7 3.6 3.5 3.4 3.3 3.2 3.1 3.0 2.9 2.8 2.7 2.6 2.5 2.4 2.3 2.2 2.1
Chemical Shift (ppm)
 
O
OH
208 200 192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24
Chemical Shift (ppm)
 
O
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5
Chemical Shift (ppm)
 
OH
145 140 135 130 125 120 115 110 105 100 95 90 85 80 75 70 65 60 55 50 45 40 35 30 25
Chemical Shift (ppm)
 
OH
5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0
Chemical Shift (ppm)
 
O OH
MeO
176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
 
O OH
MeO
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
HO I
OTBS
152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
HO I
OTBS
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
OH O O O OPMB
TBS
160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
OH O O O OPMB
TBS
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)
 
EtO2C
OH
168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8
Chemical Shift (ppm)
 
EtO2C
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
 
OMe
Ph
N
O
SO2MesBn
I
OH
184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
 
OMe
Ph
N
O
SO2MesBn
I
OH
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
OPMBOO
TBS
OHOTBDPS
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Chemical Shift (ppm)
 
OPMBOO
TBS
OHOTBDPS
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
I OTBDMS
152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
I OTBDMS
4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
O
OTBS
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Chemical Shift (ppm)
 
O
OTBS
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
OTBDMS
152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
OTBDMS
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0
Chemical Shift (ppm)
 
O OH
MeO
168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16
Chemical Shift (ppm)
 
O OH
MeO
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
Chemical Shift (ppm)
 
O OTBS
MeO
168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8 -16
Chemical Shift (ppm)
 
O OTBS
MeO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
 
HO I
OH
160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
 
HO I
OH
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
Chemical Shift (ppm)
 
TBSO I
OTBS
160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8 -16
Chemical Shift (ppm)
 
TBSO I
OTBS
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
 
I OTBDPS
152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8
Chemical Shift (ppm)
 
I OTBDPS
6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
 
I OTES
152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
 
I OTES
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
 
OTES
152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
 
OTES
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
 
EtO2C
OTES
168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
 
EtO2C
OTES
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
 
OMe
Ph
N
O
SO2MesBn
I
OTES
176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
 
OMe
Ph
N
O
SO2MesBn
I
OTES
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
OPMBOO
TBS
OOTBDPS
TES
216 208 200 192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0 -8
Chemical Shift (ppm)
 
OPMBOO
TBS
OOTBDPS
TES
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5
Chemical Shift (ppm)
 
N
OMe
O2N
160 155 150 145 140 135 130 125 120 115 110 105 100 95 90 85 80 75 70 65 60 55 50
Chemical Shift (ppm)
 
N
OMe
O2N
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
 
N
OMe
O2N
160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16
Chemical Shift (ppm)
 
N
OMe
O2N
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5
Chemical Shift (ppm)
 
N
OMeOMe
165 160 155 150 145 140 135 130 125 120 115 110 105 100 95 90 85 80 75 70 65 60 55 50 45
Chemical Shift (ppm)
 
N
OMeOMe
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
 
N
OMeOMe
160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16
Chemical Shift (ppm)
 
N
OMeOMe
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
 
N
OMe
160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16
Chemical Shift (ppm)
 
N
OMe
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
 
N
152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16
Chemical Shift (ppm)
 
N
